UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-CSR CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES Investment Company Act file number 811-10325 MARKET VECTORS ETF TRUST (Exact name of registrant as specified in charter) 666 Third Avenue, New York, NY 10017 (Address of principal executive offices) (Zip code) Van Eck Associates Corporation 666 THIRD AVENUE, NEW YORK, NY 10017 (Name and address of agent for service) Registrant's telephone number, including area code: (212) 293-2000 Date of fiscal year end: SEPTEMBER 30 Date of reporting period: SEPTEMBER 30, 2015
Item 1. Report to Shareholders
ANNUAL REPORT S E P T E M B E R 3 0 , 2 0 1 5 |
MARKET VECTORS®
INDUSTRY ETFs
Biotech ETF | BBH |
Environmental Services ETF | EVX® |
Gaming ETF | BJK® |
Pharmaceutical ETF | PPH® |
Retail ETF | RTH® |
Semiconductor ETF | SMH® |
800.826.2333
vaneck.com
The information contained in the management discussion represents the opinions of Market Vectors ETF Trust and may differ from other persons. This information is not intended to be a forecast of future events, a guarantee of future results or investment advice. The information contained herein regarding each index has been provided by the relevant index provider. Also, unless otherwise specifically noted, any discussion of the Funds’ holdings and the Funds’ performance, and the views of Market Vectors ETF Trust are as of September 30, 2015, and are subject to change.
(unaudited)
We are pleased to present this annual report for the six industry exchange-traded funds (ETFs) of the Market Vectors ETF Trust for the 12-month period ended September 30, 2015.
The top performing fund in our suite of industry ETFs was the Market Vectors Retail ETF (NYSE Arca: RTH) which returned 18.63%, for the period under review. Much of its notable performance was attributable to its focus on the 25 largest U.S. listed retail companies.
Large-capitalization stocks were key drivers of RTH’s returns. The Fund benefited from the inclusion, and weightings in the portfolio, of the internet retailer Amazon (12.5% of Fund net assets†), and home improvement retailers, Home Depot (8.2% of Fund assets†), and Lowe’s (5.1% of Fund net assets†). These particular stocks were either absent from or had minimal weightings in (compared with RTH) the portfolios of other similar ETFs.
In the case of retail companies, the Internet has proven to be transformative. While the traditional retail industry could quite validly be described as having been an “early adopter” of the Internet of Things (IoT), there are now an increasing number of different technologies available to be leveraged. These are apart from the increasing use by retailers of “big data” in merchandising decision-making, i.e., deciding what it is that customers are going to buy.
The efficiencies and opportunities offered by the IoT are potentially good news not only for retailers (both traditional and online), but also for the companies that make the cores of many of the devices used by the IoT, e.g., semiconductors. Since it invests in 25 of the largest U.S. listed, publicly traded semiconductor companies, some of these are to be found in another of our industry ETFs, the Market Vectors Semiconductor ETF (NYSE Arca: SMH). We believe SMH continues to provide interesting exposure to the expanding IoT space.
Semiconductors – Worldwide Market Billings: 3-Month Moving Averages ($bn)
Source: Semiconductor Industry Association. Not illustrative of an investment in the Fund. Historical information is not a forecast of future events, a guarantee of future results or investment advice. Current market conditions may not continue.
We will, as always, continue to seek out and evaluate the most attractive opportunities for you as a shareholder. We encourage you to stay in touch with us through the videos, email subscriptions, and blogs available on our website (www.vaneck.com). And should you have any questions, please contact us at 1.800.826.2333 or visit www.vaneck.com.
1 |
MARKET VECTORS INDUSTRY ETFs
(unaudited)
Thank you for participating in the Market Vectors ETF Trust. On the following pages, you will find the performance record of each of the funds for the 12 months ended September 30, 2015. You will also find their financial statements. We value your continuing confidence in us and look forward to helping you meet your investment goals in future.
Jan F. van Eck
Trustee and President
Market Vectors ETF Trust
October 22, 2015
Represents the opinions of the investment adviser. Past performance is no guarantee of future results. Not intended to be a forecast of future events, a guarantee of future results or investment advice. Current market conditions may not continue.
† | All Fund assets referenced are total net assets as of September 30, 2015. |
2 |
Management Discussion (unaudited)
Three of the six Market Vectors Industry ETFs realized positive performance in the 12 months ended September 30, 2015. The Market Vectors Retail ETF posted an impressive total return of 18.63%, with the Market Vectors Biotech and Market Vectors Pharmaceutical ETFs also posting positive performance.
October 1, 2014 through September 30,
2015 Market Vectors Industry ETFs Total Return |
||
Source: Van Eck Global. Returns based on NAV. The performance data quoted represent past performance. Past performance is not a guarantee of future results. Performance information for the Funds reflects temporary waivers of expenses and/or fees. Had the Funds incurred all expenses, investment returns would have been reduced. Investment return and value of the shares of the Funds will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Current performance may be lower or higher than performance data quoted.
After October 14, 2014 (the day the Dow Jones Industrial Average dropped over 223 points1 in a single day), biotech stocks rose fitfully, if steadily, through the first six-month period. Activity in both licensing agreements and mergers & acquisitions (M&As) was particularly brisk throughout 20142 and there were also some interesting U.S. Food and Drug Administration (FDA) product approvals3 during the last quarter of the year. These included Gilead Sciences’ (16.0% of Fund net assets†) new hepatitis C virus treatment Harvoni, and Amgen’s (11.8% of Fund net assets†) Blincyto, a leukemia drug. In the first quarter of 2015, M&A activity continued apace with, toward the end of the period, the agreement by AbbVie (not held by Fund) to purchase Pharmacyclics (sold by end of period), for US$21 billion in cash and stock,4 of particular note. The second six months of the Fund’s financial year essentially saw biotech stocks treading water. However, both the market’s swoon at the end of August,5 and comments from both Hillary Clinton6 and Democrat lawmakers7 at the end of September, hit the Fund hard. Despite this, though, the Fund ended up 8.1% for the 12-month period as a whole.
U.S. companies contributed by far the most to total return, but there was also a small contribution from the Netherlands. Spain detracted from performance, but only minimally. Incyte (4.5% of Fund net assets†), Pharmacyclics, subsequently acquired by AbbVie (not held by the Fund), and BioMarin Pharmaceutical (4.1% of Fund net assets†) all made significant contributions to the Fund’s overall performance. Gilead Sciences, in particular, detracted from overall performance.
3 |
MARKET VECTORS INDUSTRY ETFs
(unaudited)
Historically, construction and home-building industries have benefitted environmental services companies. However, any upticks there may have been in either construction8 or home-building9 in the U.S. this year failed to result in positive performance in the environmental services industry. While U.S. stocks accounted for the majority of the Fund’s negative total return, positive contributions came from both the single French stock in the Fund, Veolia Environnement (sold by end of period), and the single Canadian stock, Progressive Waste Solutions (3.5% of Fund net assets†).
The Fund posted a disappointing decline of 27.91% for the 12-month period. Macau, the world’s biggest gaming hub, recorded a fall in gaming revenues in each of the 12 months of the period under review, with revenues in September—in the 16th straight monthly decline—down 33%.10 In addition to Beijing’s anti-corruption campaign, the southern Chinese territory has also been hit by the slowdown in economic growth in China.11 Gaming companies operating in Macau were some of the most significant detractors from the Fund’s overall performance. Companies in the gaming business in the U.K., Ireland, and Sweden made the only positive contributions to overall performance.
As with biotech stocks, after October 14, 2014 (the day the Dow Jones Industrial Average dropped over 223 points in a single day), pharmaceutical stocks rose erratically, if steadily, throughout the remainder of the fourth quarter of 2014. By the end of December, the FDA had approved some 4112 new molecular entities for the year, 17 of which offered a novel mechanism of action in treating a disease.13 This was 14 more than the 27 approved in 2013.14
Since the end of the year, news from the pharma market has featured strong M&A activity. In addition to the agreement by AbbVie (4.9% of Fund net assets†) to purchase Pharmacyclics (not held by Fund), for US$21 billion in cash and stock,15 in March there was also a bidding war which resulted in Canada’s Valeant Pharmaceuticals (3.7% of Fund net assets†) buying Salix Pharmaceuticals (sold by end of period) for US$10.1 billion in an all cash deal.16 Then, at the end of July, Jerusalem-based Teva Pharmaceutical (4.3% of Fund net assets†) announced that it would acquire Allergan Generics (4.9% of Fund net assets†) for $40.5 billion.17
Right at the end of the 12-month period, however, following the market’s swoon at the end of August,18 comments from both Hillary Clinton19 and Democrat lawmakers,20 not least the specific mention of Valeant Pharmaceuticals, hit the Fund hard. Consequently, the Fund ended its latest financial year only slightly up on the previous year. Canada and the U.S. were the two largest positive contributors to the Fund’s overall performance. Companies in both U.K. and Ireland were the largest detractors from the Fund’s overall performance.
The Fund returned a healthy 18.63% for the 12-month period under review. The first six months of the period brought with it commendably positive performance, anchored in part on total holiday retail sales, including sales for both November and December, which increased 4% to $616.1 billion21 and were the best since 2011.22 Following a fall in retail sales in both January and February,23 not least because of the cold weather gripping certain areas of the U.S., each month following (except April) through the end of the period under review, saw healthy retail sales.24 & 25
While stores involved in internet and catalog retail and specialty retail made by far the greatest contributions to total return, food and staples retailing also contributed healthy positive percentages to the Fund’s overall performance. The healthcare retail sector contributed the least to overall performance.
4 |
Global semiconductor sales in 2014 hit a new high (for the second consecutive year) with record sales of $335.8 billion, up 9.9% on sales of $305.6 billion in 2013.26 Sales in the last quarter of 2014 amounted to $87.4 billion, 9.3% higher than the $79.9 billion recorded in the same quarter the previous year.27 Sales in the Americas increased 12.7% in 2014. The three largest categories of semiconductor by sales were logic, memory and micro-ICs respectively.28 Year-on-year global semiconductor sales in the first two quarters were ahead of those in the same periods in 2014.29 & 30 Thereafter, reflecting concerns about the global economy, month-on-month global semiconductor sales fell in July and August 2015.31 In August they were down 0.5% from July, and 3.0% from August 2014.32 Although contributing the most to the Fund’s total return, Taiwan’s positive performance over the period, together with that of both Singapore and the Netherlands, was just not enough to offset the negative performance of companies elsewhere, primarily in the U.S., and the Fund ended the 12-month period down 1.09%.
† | All Fund assets referenced are Total Net Assets as of September 30, 2015. |
1 | Zacks: Stock Market News for October 14, 2014, http://www.zacks.com/stock/news/150152/stock-market-news-for-october-14-2014 |
2 | Zacks: 4 Biotech Stocks that Doubled in 2014, http://www.zacks.com/stock/news/158597/4-biotech-stocks-that-doubled-in-2014 |
3 | U.S. Food and Drug Administration: Novel New Drugs 2014 Summary, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM430299.pdf |
4 | Zacks: AbbVie to Buy Pharmacyclics: Biotech ETFs to Watch - ETF News And Commentary, http://finance.yahoo.com/news/abbvie-buy-pharmacyclics-biotech-etfs-184106656.html |
5 | CNN Money: After historic 1,000-point plunge, Dow dives 588 points at close, http://money.cnn.com/2015/08/24/investing/stocks-markets-selloff-china-crash-dow/ |
6 | CNBC: Biotech falls on Clinton ‘price gouging’ comments, http://www.cnbc.com/2015/09/21/biotech-falls-on-clinton-price-gouging-comments.html |
7 | Financial Times: Valeant hit by political criticism of drug company pricing, http://www.ft.com/intl/cms/s/0/6cf3be50-660c-11e5-a57f-21b88f7d973f.html#axzz3oMiymHW6 |
8 | Board of Governors of the Federal Reserve System: Industrial Production and Capacity Utilization - G.17, http://www.federalreserve.gov/releases/g17/Current/ |
9 | U.S. Census Bureau News: New Residential Construction in August 2015, https://www.census.gov/construction/nrc/pdf/newresconst.pdf |
10 | Las Vegas Review-Journal: Macau gaming revenue down 33 percent in September, 16th straight monthly dip, http://www.reviewjournal.com/business/casinos-gaming/macau-gaming-revenue-down-33-percent-september-16th-straight-monthly-dip |
11 | Reuters: Macau’s gambling revenue tumbles 35.5 pct in August, http://www.reuters.com/article/2015/09/01/macau-gambling-revenue-idUSENNF8R0S20150901 |
12 | U.S. Food and Drug Administration: Novel New Drugs 2014 Summary, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DrugInnovation/UCM430299.pdf |
13 | Chemical & Engineering News: The Year in New Drugs, http://cen.acs.org/articles/93/i5/Year-New-Drugs.html |
14 | DCAT CONNECT: Pharma Industry on Track to Outpace New Drug Approvals in 2014, http://connect.dcat.org/blogs/patricia-van-arnum/2014/08/26/pharma-industry-on-track-to-outpace-new-drug-approvals-in-2014#.VCGeHlcppMd |
15 | Zacks: AbbVie to Buy Pharmacyclics: Biotech ETFs to Watch - ETF News And Commentary, http://finance.yahoo.com/news/abbvie-buy-pharmacyclics-biotech-etfs-184106656.html |
16 | Reuters: Canada’s Valeant to buy Salix in $10.1 billion deal, http://www.reuters.com/article/2015/02/23/us-valeantpharms-salixpharms-idUSKBN0LQ0V420150223 |
17 | Teva Pharmaceutical Industries Ltd: Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare, http://www.tevapharm.com/news/?itemid={B182F7AD-88B6-4064-9D76-25178DF0C783} |
18 | CNN Money: After historic 1,000-point plunge, Dow dives 588 points at close, http://money.cnn.com/2015/08/24/investing/stocks-markets-selloff-china-crash-dow/ |
19 | CNBC: Biotech falls on Clinton ‘price gouging’ comments, http://www.cnbc.com/2015/09/21/biotech-falls-on-clinton-price-gouging-comments.html |
20 | Financial Times: Valeant hit by political criticism of drug company pricing, http://www.ft.com/intl/cms/s/0/6cf3be50-660c-11e5-a57f-21b88f7d973f.html#axzz3oMiymHW6 |
5 |
MARKET VECTORS INDUSTRY ETFs
(unaudited)
21 | National Retail Federation: Retail Holiday Sales Increase 4 Percent, https://nrf.com/news/retail-holiday-sales-increase-4-percent |
22 | Ibid |
23 | The Wall Street Journal: U.S. Retail Sales Fall Amid Rough Weather, https://nrf.com/news/retail-sales-decreased-02-percent-february http://www.wsj.com/articles/u-s-retail-sales-down-0-6-in-february-1426163489?mod=djemCFO_h |
24 | National Retail Foundation: Retail Insight Center, Seasonally Adjusted Monthly Retail Sales, http://research.nrffoundation.com/Default.aspx?pg=45#.VhaH5Zf5EXg |
25 | National Retail Foundation: National Retail Federation Forecasts Holiday Sales to Increase 3.7%, https://nrf.com/media/press-releases/national-retail-federation-forecasts-holiday-sales-increase-37 |
26 | Semiconductor Industry Association: Global Semiconductor Industry Posts Record Sales in 2014, http://www.semiconductors.org/news/2015/02/02/global_sales_report_2014/global_semiconductor_industry_posts_record_sales_in_2014/ |
27 | Ibid. |
28 | Ibid. |
29 | Semiconductor Industry Association: First Quarter Semiconductor Sales Up 6 Percent Compared to Last year, http://www.semiconductors.org/news/2015/05/04/global_sales_report_2015/first_quarter_semiconductor_sales_up_6_percent_compared_to_last_year/ |
30 | Semiconductor Industry Association: Mid-Year Global Semiconductor Sales Ahead of Last Year’s Pace by 4 Percent, http://www.semiconductors.org/news/2015/08/03/global_sales_report_2015/mid_year_global_semiconductor_sales_ahead_of_last_years_ pace_by_4_percent/ |
31 | USA Today: Tech’s biggest disasters sting investors, http://www.usatoday.com/story/money/markets/2015/09/30/tech-stocks-biggest-disasters/73100110/ |
32 | Semiconductor Industry Association: Global Semiconductor Sales Decrease Slightly in August, http://www.semiconductors.org/news/2015/10/05/global_sales_report_2015/global_semiconductor_sales_decrease_slightly_in_august/ |
6 |
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MVBBHTR2 | |||||||||
One Year | 8.01 | % | 8.13 | % | 8.31 | % | ||||||
Life* (annualized) | 36.63 | % | 36.64 | % | 36.88 | % | ||||||
Life* (cumulative) | 225.44 | % | 225.53 | % | 227.67 | % | ||||||
* since 12/20/11 |
Commencement date for the Market Vectors Biotech ETF was 12/20/11.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (12/20/11) to the first day of secondary market trading in shares of the Fund (12/21/11), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 0.40% / Net Expense Ratio 0.35%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.35% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
7 |
BIOTECH ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | Market Vectors® US Listed Biotech 25 Index (MVBBHTR) is a rules based, modified capitalization weighted, float adjusted index intended to give investors a means of tracking the overall performance of the largest and the most liquid common stocks and depositary receipts of U.S. exchange-listed companies that derive at least 50% of their revenues from biotechnology, which includes companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment (excluding pharmacies). |
Market Vectors US Listed Biotech 25 Index (the “Index”) is the exclusive property of Market Vectors Index Solutions GmbH (a wholly owned subsidiary of the Adviser), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards Market Vectors Index Solutions GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. Market Vectors Biotech ETF (the “Fund”) is not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH and Market Vectors Index Solutions GmbH makes no representation regarding the advisability of investing in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Biotech ETF (BBH)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for BBH is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
December 21, 2011* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 1 | 0.1 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 1 | 0.1 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 3 | 0.3 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 4 | 0.4 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 537 | 56.6 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 366 | 38.6 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 4 | 0.4 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 1 | 0.1 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 6 | 0.7 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 3 | 0.3 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 2 | 0.2 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 1 | 0.1 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 2 | 0.2 | % | |||||
Less Than -5.0% | 17 | 1.8 | % | |||||
949 | 100.0 | % |
* | First Day of secondary market trading. |
8 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | AXENV2 | |||||||||
One Year | (8.80 | )% | (8.18 | )% | (7.94 | )% | ||||||
Five Year | 6.24 | % | 6.39 | % | 6.91 | % | ||||||
Life* (annualized) | 5.36 | % | 5.44 | % | 5.97 | % | ||||||
Life* (cumulative) | 59.77 | % | 60.86 | % | 68.25 | % | ||||||
* since 10/10/06 |
Commencement date for the Market Vectors Environmental Services ETF was 10/10/06.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (10/10/06) to the first day of secondary market trading in shares of the Fund (10/16/06), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 1.15% / Net Expense Ratio 0.55%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.55% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
9 |
ENVIRONMENTAL SERVICES ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | NYSE Arca Environmental Services Index (AXENV) is a modified equal dollar-weighted index comprised of publicly traded companies that engage in business activities that may benefit from the global increase in demand for consumer waste disposal, removal and storage of industrial by-products, and the management of associated resources. |
NYSE Arca Environmental Services Index (the “Index”) is a trademark of NYSE or its affiliates, and is licensed for use by Van Eck Associates Corporation. NYSE neither sponsors nor endorses the Fund and makes no representation as to the accuracy and/or completeness of the Index or results to be obtained by any person from using the Index in connection with trading of the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Environmental Services ETF
(EVX)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for EVX is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
September 30, 2010 through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 1 | 0.1 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 2 | 0.2 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 6 | 0.4 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 21 | 1.7 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 41 | 3.2 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 67 | 5.3 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 354 | 28.1 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 572 | 45.4 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 123 | 9.8 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 42 | 3.3 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 20 | 1.6 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 6 | 0.5 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 2 | 0.2 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 1 | 0.1 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
1259 | 100.0 | % |
10 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MVBJKTR2 | |||||||||
One Year | (28.46 | )% | (27.91 | )% | (27.72 | )% | ||||||
Five Year | 4.13 | % | 4.17 | % | 4.59 | % | ||||||
Life* (annualized) | (1.38 | )% | (1.30 | )% | (0.53 | )% | ||||||
Life* (cumulative) | (10.14 | )% | (9.56 | )% | (4.03 | )% | ||||||
* since 1/22/08 | ||||||||||||
Index data prior to September 24, 2012 reflects that of the S-Network Global Gaming Index (WAGRT). From September 24, 2012, forward, the index data reflects that of the Fund’s underlying index, Market Vectors Global Gaming Index (MVBJKTR). Index history which includes periods prior to September 24, 2012 reflects a blend of the performance of WAGRT and MVAFKTR and is not intended for third party use. |
Commencement date for the Market Vectors Gaming ETF was 1/22/08.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (1/22/08) to the first day of secondary market trading in shares of the Fund (1/24/08), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 1.00% / Net Expense Ratio 0.66%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.65% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in cash. Shares may trade at a premium or discount to their NAV in the secondary market.
11 |
GAMING ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | Market Vectors® Global Gaming Index (MVBJKTR) is a rules based index intended to give investors a means of tracking the overall performance of the largest and most liquid companies in the global gaming industry that generate at least 50% of their revenues from casinos and hotels, sports betting (including internet gambling and racetracks) and lottery services as well as gaming services, gaming technology and gaming equipment. |
Market Vectors Global Gaming Index (the “Index”) is the exclusive property of Market Vectors Index Solutions GmbH (a wholly owned subsidiary of the Adviser), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards Market Vectors Index Solutions GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. Market Vectors Gaming ETF (the “Fund”) is not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH and Market Vectors Index Solutions GmbH makes no representation regarding the advisability of investing in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Gaming ETF (BJK)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to Show the frequency at which the closing price for BJK is at a premium or discount to Its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
September 30, 2010 through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 4 | 0.3 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 27 | 2.1 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 379 | 30.1 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 660 | 52.4 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 181 | 14.4 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 7 | 0.6 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 1 | 0.1 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
1259 | 100.0 | % |
12 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MVPPHTR2 | |||||||||
One Year | 0.85 | % | 0.96 | % | 0.96 | % | ||||||
Life* (annualized) | 18.90 | % | 18.61 | % | 18.52 | % | ||||||
Life* (cumulative) | 92.41 | % | 90.66 | % | 90.08 | % | ||||||
* since 12/20/11 |
Commencement date for the Market Vectors Pharmaceutical ETF was 12/20/11.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (12/20/11) to the first day of secondary market trading in shares of the Fund (12/21/11), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 0.41% / Net Expense Ratio 0.36%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.35% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
13 |
PHARMACEUTICAL ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | Market Vectors® US Listed Pharmaceutical 25 Index (MVPPHTR) is a rules based, modified capitalization weighted, float adjusted index intended to give investors a means of tracking the overall performance of the largest and the most liquid common stocks and depositary receipts of U.S. exchange-listed companies that derive at least 50% of their revenues from pharmaceuticals, which includes companies engaged primarily in research and development as well as production, marketing and sales of pharmaceuticals. |
Market Vectors US Listed Pharmaceutical 25 Index (the “Index”) is the exclusive property of Market Vectors Index Solutions GmbH (a wholly owned subsidiary of the Adviser), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards Market Vectors Index Solutions GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. Market Vectors Pharmaceutical ETF (the “Fund”) is not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH and Market Vectors Index Solutions GmbH makes no representation regarding the advisability of investing in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Pharmaceutical ETF (PPH)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for PPH is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
December 21, 2011* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 3 | 0.3 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 6 | 0.7 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 514 | 54.2 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 400 | 42.2 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 4 | 0.4 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 2 | 0.2 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 3 | 0.3 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 5 | 0.5 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 4 | 0.4 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 5 | 0.5 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 2 | 0.2 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
949 | 100.0 | % |
* | First Day of secondary market trading. |
14 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MVRTHTR2 | |||||||||
One Year | 18.37 | % | 18.63 | % | 18.44 | % | ||||||
Life* (annualized) | 21.06 | % | 20.73 | % | 20.51 | % | ||||||
Life* (cumulative) | 106.00 | % | 103.88 | % | 102.45 | % | ||||||
* since 12/20/11 |
Commencement date for the Market Vectors Retail ETF was 12/20/11.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (12/20/11) to the first day of secondary market trading in shares of the Fund (12/21/11), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 0.42% / Net Expense Ratio 0.35%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.35% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
15 |
RETAIL ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | Market Vectors® US Listed Retail 25 Index (MVRTHTR) is a rules based, modified capitalization weighted, float adjusted index intended to give investors a means of tracking the overall performance of the largest and the most liquid common stocks and depositary receipts of U.S. exchange-listed companies that derive at least 50% of their revenues from retail, which includes companies engaged primarily in retail distribution; wholesalers; online, direct mail and TV retailers; multi-line retailers; specialty retailers, such as apparel, automotive, computer and electronics, drug, home improvement and home furnishing retailers; and food and other staples retailers. |
Market Vectors US Listed Retail 25 Index (the “Index”) is the exclusive property of Market Vectors Index Solutions GmbH (a wholly owned subsidiary of the Adviser), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards Market Vectors Index Solutions GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. Market Vectors Retail ETF (the “Fund”) is not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH and Market Vectors Index Solutions GmbH makes no representation regarding the advisability of investing in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Retail ETF (RTH)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for RTH is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
December 21, 2011* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 2 | 0.2 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 2 | 0.2 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 519 | 54.7 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 421 | 44.4 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 3 | 0.3 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
949 | 100.0 | % |
* | First Day of secondary market trading. |
16 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MVSMHTR2 | |||||||||
One Year | (1.25 | )% | (1.09 | )% | (1.22 | )% | ||||||
Life* (annualized) | 15.83 | % | 15.97 | % | 15.82 | % | ||||||
Life* (cumulative) | 74.32 | % | 75.11 | % | 74.22 | % | ||||||
* since 12/20/11 |
Commencement date for the Market Vectors Semiconductor ETF was 12/20/11.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (12/20/11) to the first day of secondary market trading in shares of the Fund (12/21/11), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 0.41% / Net Expense Ratio 0.35%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.35% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
17 |
SEMICONDUCTOR ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | Market Vectors® US Listed Semiconductor 25 Index (MVSMHTR) is a rules based, modified capitalization weighted, float adjusted index intended to give investors a means of tracking the overall performance of the largest and the most liquid common stocks and depositary receipts of U.S. exchange-listed companies that derive at least 50% of their revenues from semiconductors, which includes the production of semiconductors and semiconductor equipment. |
Market Vectors US Listed Semiconductor 25 Index (the “Index”) is the exclusive property of Market Vectors Index Solutions GmbH (a wholly owned subsidiary of the Adviser), which has contracted with Solactive AG to maintain and calculate the Index. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards Market Vectors Index Solutions GmbH, Solactive AG has no obligation to point out errors in the Index to third parties. Market Vectors Semiconductor ETF (the “Fund”) is not sponsored, endorsed, sold or promoted by Market Vectors Index Solutions GmbH and Market Vectors Index Solutions GmbH makes no representation regarding the advisability of investing in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Semiconductor ETF (SMH)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for SMH is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
December 21, 2011* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 1 | 0.1 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 5 | 0.5 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 1 | 0.1 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 461 | 48.6 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 478 | 50.4 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 1 | 0.1 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 1 | 0.1 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 1 | 0.1 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
949 | 100.0 | % |
* | First Day of secondary market trading. |
18 |
MARKET VECTORS ETF TRUST
(unaudited)
Hypothetical $1,000 investment at beginning of period
As a shareholder of a Fund, you incur operating expenses, including management fees and other Fund expenses. This disclosure is intended to help you understand the ongoing costs (in dollars) of investing in your Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The disclosure is based on an investment of $1,000 invested at the beginning of the period and held for the entire period, April 1, 2015 to September 30, 2015.
Actual Expenses
The first line in the table below provides information about account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Period.”
Hypothetical Example for Comparison Purposes
The second line in the table below provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as program fees. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
Beginning | Ending | Annualized | Expenses Paid | |||||||||||||
Account | Account | Expense | During the Period* | |||||||||||||
Value | Value | Ratio | April 1, 2015- | |||||||||||||
April 1, 2015 | September 30, 2015 | During Period | September 30, 2015 | |||||||||||||
Biotech ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 883.00 | 0.35 | % | $1.65 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,023.31 | 0.35 | % | $1.78 | |||||||||
Environmental Services ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 911.90 | 0.55 | % | $2.64 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.31 | 0.55 | % | $2.79 | |||||||||
Gaming ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 810.50 | 0.66 | % | $3.00 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,021.76 | 0.66 | % | $3.35 | |||||||||
Pharmaceutical ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 907.40 | 0.36 | % | $1.72 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,023.26 | 0.36 | % | $1.83 | |||||||||
Retail ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 950.30 | 0.35 | % | $1.71 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,023.31 | 0.35 | % | $1.78 | |||||||||
Semiconductor ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 902.80 | 0.35 | % | $1.67 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,023.31 | 0.35 | % | $1.78 |
* | Expenses are equal to the Fund’s annualized expense ratio (for the six months ended September 30, 2015) multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half year divided by the number of days in the fiscal year (to reflect the one-half year period). | |
** | Assumes annual return of 5% before expenses |
19 |
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 100.1% | ||||||||
Ireland: 1.9% | ||||||||
207,748 | Alkermes Plc (USD) * | $ | 12,188,575 | |||||
Netherlands: 2.3% | ||||||||
587,373 | Qiagen NV (USD) * | 15,154,223 | ||||||
Spain: 1.8% | ||||||||
382,170 | Grifols SA (ADR) | 11,617,968 | ||||||
United States: 94.1% | ||||||||
190,015 | Alexion Pharmaceuticals, Inc. * | 29,716,446 | ||||||
150,849 | Alnylam Pharmaceuticals, Inc. * | 12,122,226 | ||||||
555,241 | Amgen, Inc. | 76,800,935 | ||||||
953,738 | Baxalta, Inc. | 30,052,284 | ||||||
165,319 | Biogen Idec, Inc. * | 48,241,737 | ||||||
251,304 | BioMarin Pharmaceutical, Inc. * | 26,467,337 | ||||||
60,770 | Bluebird Bio, Inc. * | 5,198,874 | ||||||
679,226 | Celgene Corp. * | 73,471,876 | ||||||
154,204 | Cepheid, Inc. * | 6,970,021 | ||||||
116,754 | Charles River Laboratories International, Inc. * | 7,416,214 | ||||||
1,060,349 | Gilead Sciences, Inc. | 104,115,668 | ||||||
165,889 | Illumina, Inc. * | 29,166,604 | ||||||
263,842 | Incyte Corp. * | 29,109,688 | ||||||
40,558 | Intercept Pharmaceuticals, Inc. * † | 6,726,950 | ||||||
265,194 | Isis Pharmaceuticals, Inc. * | 10,719,142 | ||||||
425,275 | Medivation, Inc. * | 18,074,188 | ||||||
33,409 | Puma Biotechnology, Inc. * | 2,517,702 | ||||||
266,888 | Quintiles Transnational Holdings Inc * | 18,567,398 | ||||||
68,764 | Regeneron Pharmaceuticals, Inc. * | 31,984,887 | ||||||
174,292 | Seattle Genetics, Inc. * | 6,720,700 | ||||||
103,921 | United Therapeutics Corp. * | 13,638,592 | ||||||
251,151 | Vertex Pharmaceuticals, Inc. * | 26,154,865 | ||||||
613,954,334 | ||||||||
Total Common Stocks (Cost: $722,257,690) | 652,915,100 | |||||||
Principal Amount | ||||||||
SHORT-TERM INVESTMENTS HELD AS COLLATERAL FOR SECURITIES LOANED: 1.0% | ||||||||
Repurchase Agreements: 1.0% | ||||||||
$ | 1,534,482 | Repurchase agreement dated 9/30/15 with BNP Paribas Securities Corp., 0.11%, due 10/1/15, proceeds $1,534,487; (collateralized by various U.S. government and agency obligations, 0.25% to 7.50%, due 8/1/16 to 10/1/45, valued at $1,565,174 including accrued interest) | 1,534,482 |
Principal Amount | Value | |||||||
Repurchase Agreements: (continued) | ||||||||
$ | 1,534,482 | Repurchase agreement dated 9/30/15 with Citigroup Global Markets, Inc., 0.12%, due 10/1/15, proceeds $1,534,487; (collateralized by various U.S. government and agency obligations, 0.00% to 7.00%, due 5/15/18 to 10/1/45, valued at $1,565,172 including accrued interest) | $ | 1,534,482 | ||||
1,534,482 | Repurchase agreement dated 9/30/15 with HSBC Securities USA, Inc., 0.10%, due 10/1/15, proceeds $1,534,486; (collateralized by various U.S. government and agency obligations, 0.00% to 7.25%, due 11/15/15 to 7/15/37, valued at $1,565,172 including accrued interest) | 1,534,482 | ||||||
1,534,482 | Repurchase agreement dated 9/30/15 with Mizuho Securities USA, Inc., 0.14%, due 10/1/15, proceeds $1,534,488; (collateralized by various U.S. government and agency obligations, 0.00% to 4.50%, due 10/9/19 to 10/1/45, valued at $1,565,172 including accrued interest) | 1,534,482 | ||||||
323,035 | Repurchase agreement dated 9/30/15 with Royal Bank of Scotland Plc, 0.09%, due 10/1/15, proceeds $323,036; (collateralized by various U.S. government and agency obligations, 0.09% to 3.63%, due 1/31/16 to 2/15/44, valued at $329,497 including accrued interest) | 323,035 | ||||||
Total Short-Term Investments Held as Collateral for Securities Loaned | ||||||||
(Cost: $6,460,963) | 6,460,963 | |||||||
Total Investments: 101.1% (Cost: $728,718,653) | 659,376,063 | |||||||
Liabilities in excess of other assets: (1.1)% | (7,397,671 | ) | ||||||
NET ASSETS: 100.0% | $ | 651,978,392 |
See Notes to Financial Statements
20 |
ADR | American Depositary Receipt |
USD | United States Dollar |
* | Non-income producing |
† | Security fully or partially on loan. Total market value of securities on loan is $6,634,400. |
Summary of Investments by Sector Excluding Collateral for Securities Loaned (unaudited) |
% of Investments | Value | ||||||
Biotechnology | 79.8 | % | $ | 521,101,607 | ||||
Health Care | 12.3 | 80,076,452 | ||||||
Life Sciences Tools & Services | 7.9 | 51,737,041 | ||||||
100.0 | % | $ | 652,915,100 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks* | $ | 652,915,100 | $ | — | $ | — | $ | 652,915,100 | |||||||||
Repurchase Agreements | — | 6,460,963 | — | 6,460,963 | |||||||||||||
Total | $ | 652,915,100 | $ | 6,460,963 | $ | — | $ | 659,376,063 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
21 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 100.1% | ||||||||
Canada: 3.5% | ||||||||
19,378 | Progressive Waste Solutions Ltd. (USD) | $ | 511,967 | |||||
United States: 96.6% | ||||||||
18,232 | ABM Industries, Inc. | 497,916 | ||||||
33,692 | Calgon Carbon Corp. | 524,921 | ||||||
10,065 | Cantel Medical Corp. | 570,686 | ||||||
34,576 | Ceco Environmental Corp. | 283,177 | ||||||
11,200 | Clarcor, Inc. | 534,016 | ||||||
11,219 | Clean Harbors, Inc. * | 493,299 | ||||||
28,182 | Covanta Holding Corp. | 491,776 | ||||||
45,930 | Darling International, Inc. * | 516,253 | ||||||
17,916 | Donaldson Company, Inc. | 503,081 | ||||||
48,725 | Layne Christensen Co. * | 316,713 | ||||||
51,894 | Newpark Resources, Inc. * | 265,697 | ||||||
43,745 | Rentech Inc * | 244,972 | ||||||
36,301 | Republic Services, Inc. | 1,495,601 | ||||||
21,381 | Schnitzer Steel Industries, Inc. | 289,499 | ||||||
10,676 | Stericycle, Inc. * | 1,487,274 | ||||||
8,370 | Steris Corp. † | 543,799 | ||||||
9,615 | Tennant Co. | 540,171 | ||||||
12,183 | Tenneco, Inc. * | 545,433 | ||||||
21,142 | Tetra Tech, Inc. | 513,962 | ||||||
11,223 | US Ecology, Inc. | 489,884 | ||||||
30,378 | Waste Connections, Inc. | 1,475,763 | ||||||
29,605 | Waste Management, Inc. | 1,474,625 | ||||||
14,098,518 | ||||||||
Total Common Stocks (Cost: $14,575,128) | 14,610,485 |
Number of Shares | Value | |||||||
MONEY MARKET FUND: 0.3% (Cost: $33,123) | ||||||||
33,123 | Dreyfus Government Cash Management Fund | $ | 33,123 | |||||
Total Investments Before Collateral for Securities Loaned: 100.4% | ||||||||
(Cost: $14,608,251) | 14,643,608 | |||||||
Principal Amount |
||||||||
SHORT-TERM INVESTMENT HELD AS COLLATERAL FOR SECURITIES LOANED: 3.8% | ||||||||
(Cost: $559,245) | ||||||||
Repurchase Agreement: 3.8% | ||||||||
$ | 559,245 | Repurchase agreement dated 9/30/15 with Merrill
Lynch, Pierce, Fenner and Smith, Inc., 0.13%, due 10/1/15, proceeds $559,247; (collateralized by various U.S. government and agency obligations, 3.00% to 4.50%, due 10/20/41 to 5/20/45, valued at $570,430 including accrued interest) | 559,245 | |||||
Total Investments: 104.2% (Cost: $15,167,496) | 15,202,853 | |||||||
Liabilities in excess of other assets: (4.2)% | (609,963 | ) | ||||||
NET ASSETS: 100.0% | $ | 14,592,890 |
USD | United States Dollar |
* | Non-income producing |
† | Security fully or partially on loan. Total market value of securities on loan is $543,799. |
Summary of Investments by Sector Excluding Collateral for Securities Loaned (unaudited) | % of Investments | Value | ||||||
Consumer Discretionary | 3.7 | % | $ | 545,433 | ||||
Consumer Staples | 3.5 | 516,253 | ||||||
Energy | 1.8 | 265,697 | ||||||
Health Care | 7.6 | 1,114,485 | ||||||
Industrials | 75.9 | 11,109,225 | ||||||
Materials | 7.3 | 1,059,392 | ||||||
Money Market Fund | 0.2 | 33,123 | ||||||
100.0 | % | $ | 14,643,608 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks* | $ | 14,610,485 | $ | — | $ | — | $ | 14,610,485 | |||||||||
Money Market Fund | 33,123 | — | — | 33,123 | |||||||||||||
Repurchase Agreement | — | 559,245 | — | 559,245 | |||||||||||||
Total | $ | 14,643,608 | $ | 559,245 | $ | — | $ | 15,202,853 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
22 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 97.6% | ||||||||
Australia: 15.3% | ||||||||
138,522 | Aristocrat Leisure Ltd. # | $ | 842,912 | |||||
99,009 | Crown Ltd. # | 692,862 | ||||||
156,244 | Echo Entertainment Group Ltd. # | 534,897 | ||||||
205,582 | TABCORP Holdings Ltd. # | 677,149 | ||||||
342,621 | Tatts Group Ltd. # | 909,489 | ||||||
3,657,309 | ||||||||
Canada: 2.3% | ||||||||
20,594 | Amaya, Inc. * | 373,724 | ||||||
19,284 | Intertain Group Ltd. * | 165,123 | ||||||
538,847 | ||||||||
China / Hong Kong: 20.2% | ||||||||
593,240 | Galaxy Entertainment Group Ltd. # | 1,519,457 | ||||||
37,672 | Melco Crown Entertainment Ltd. (ADR) | 518,367 | ||||||
115,400 | Melco International Development Ltd. # | 141,867 | ||||||
222,900 | MGM China Holdings Ltd. # | 259,661 | ||||||
567,600 | Sands China Ltd. # | 1,724,063 | ||||||
467,000 | SJM Holdings Ltd. # | 332,486 | ||||||
290,800 | Wynn Macau Ltd. # | 332,707 | ||||||
4,828,608 | ||||||||
Greece: 1.7% | ||||||||
44,211 | OPAP SA # | 400,331 | ||||||
Ireland: 4.4% | ||||||||
9,040 | Paddy Power Plc # | 1,044,931 | ||||||
Japan: 4.2% | ||||||||
13,579 | Sankyo Co. Ltd. # | 483,895 | ||||||
53,200 | Sega Sammy Holdings, Inc. # | 520,031 | ||||||
1,003,926 | ||||||||
Malaysia: 4.3% | ||||||||
175,017 | Berjaya Sports Toto Bhd # | 122,658 | ||||||
800,898 | Genting Malaysia Bhd # | 756,790 | ||||||
227,640 | Magnum Bhd # | 132,636 | ||||||
1,012,084 | ||||||||
New Zealand: 1.1% | ||||||||
112,735 | Sky City Entertainment Group Ltd. # | 270,203 | ||||||
Singapore: 3.2% | ||||||||
1,503,100 | Genting Singapore Plc # | 768,389 | ||||||
South Africa: 1.2% | ||||||||
159,391 | Tsogo Sun Holdings Ltd. # | 279,700 | ||||||
South Korea: 5.1% | ||||||||
26,796 | Kangwon Land, Inc. # | 957,726 | ||||||
13,089 | Paradise Co. Ltd. # | 249,157 | ||||||
1,206,883 | ||||||||
Sweden: 1.9% | ||||||||
26,959 | Betsson AB # | 453,204 | ||||||
United Kingdom: 12.5% | ||||||||
15,847 | Betfair Group Plc # | 799,722 | ||||||
182,483 | Bwin.Party Digital Entertainment Plc # | 307,833 | ||||||
208,948 | Ladbrokes Plc † # | 303,926 | ||||||
59,331 | Playtech Ltd. # | 745,997 | ||||||
155,472 | William Hill Plc # | 827,992 | ||||||
2,985,470 |
Number of Shares | Value | |||||||
United States: 20.2% | ||||||||
18,332 | Boyd Gaming Corp. * | $ | 298,812 | |||||
2,764 | Churchill Downs, Inc. | 369,851 | ||||||
25,398 | International Game Technology Plc | 389,351 | ||||||
43,447 | Las Vegas Sands Corp. | 1,649,683 | ||||||
31,517 | MGM Mirage * | 581,489 | ||||||
11,541 | Penn National Gaming, Inc. * | 193,658 | ||||||
10,193 | Pinnacle Entertainment, Inc. * | 344,931 | ||||||
10,327 | Scientific Games Corp. * † | 107,917 | ||||||
16,779 | Wynn Resorts Ltd. | 891,300 | ||||||
4,826,992 | ||||||||
Total Common Stocks (Cost: $34,537,091) | 23,276,877 | |||||||
REAL ESTATE INVESTMENT TRUSTS: 2.4% (Cost: $758,223) | ||||||||
United States: 2.4% | ||||||||
19,229 | Gaming and Leisure Properties, Inc. | 571,101 | ||||||
MONEY MARKET FUND: 0.1% (Cost: $33,761) | ||||||||
33,761 | Dreyfus Government Cash Management Fund | 33,761 | ||||||
Total
Investments Before Collateral for Securities Loaned: 100.1% | ||||||||
(Cost: $35,329,075) | 23,881,739 | |||||||
Principal | ||||||||
Amount | ||||||||
SHORT-TERM INVESTMENT HELD AS COLLATERAL FOR SECURITIES LOANED: 1.6% | ||||||||
(Cost: $384,494) | ||||||||
Repurchase Agreement: 1.6% | ||||||||
$ | 384,494 | Repurchase agreement dated 9/30/15 with Royal Bank of Scotland Plc, 0.09%, due 10/1/15, proceeds $384,495; (collateralized by various U.S. government and agency obligations, 0.09% to 3.63%, due 1/31/16 to 2/15/44, valued at $392,185 including accrued interest) | 384,494 | |||||
Total Investments: 101.7% (Cost: $35,713,569) | 24,266,233 | |||||||
Liabilities in excess of other assets: (1.7)% | (407,071 | ) | ||||||
NET ASSETS: 100.0% | $ | 23,859,162 |
See Notes to Financial Statements
23 |
GAMING ETF
SCHEDULE OF INVESTMENTS
September 30, 2015 (continued)
ADR | American Depositary Receipt |
* | Non-income producing |
† | Security fully or partially on loan. Total market value of securities on loan is $375,599. |
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $17,392,671 which represents 72.9% of net assets. |
Summary of Investments by Sector Excluding Collateral for Securities Loaned (unaudited) | % of Investments | Value | ||||||
Casino Hotels | 47.4 | % | $ | 11,320,503 | ||||
Casino Services | 13.2 | 3,148,737 | ||||||
Casinos & Gaming | 14.7 | 3,501,882 | ||||||
Computer Software | 3.1 | 745,997 | ||||||
Diversified Operations | 1.2 | 274,503 | ||||||
Gambling (Non-Hotel) | 13.9 | 3,322,718 | ||||||
Internet Gambling | 1.3 | 307,833 | ||||||
Lottery Services | 4.3 | 1,032,147 | ||||||
Racetracks | 0.8 | 193,658 | ||||||
Money Market Fund | 0.1 | 33,761 | ||||||
100.0 | % | $ | 23,881,739 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks | |||||||||||||||||
Australia | $ | — | $ | 3,657,309 | $ | — | $ | 3,657,309 | |||||||||
Canada | 538,847 | — | — | 538,847 | |||||||||||||
China / Hong Kong | 518,367 | 4,310,241 | — | 4,828,608 | |||||||||||||
Greece | — | 400,331 | — | 400,331 | |||||||||||||
Ireland | — | 1,044,931 | — | 1,044,931 | |||||||||||||
Japan | — | 1,003,926 | — | 1,003,926 | |||||||||||||
Malaysia | — | 1,012,084 | — | 1,012,084 | |||||||||||||
New Zealand | — | 270,203 | — | 270,203 | |||||||||||||
Singapore | — | 768,389 | — | 768,389 | |||||||||||||
South Africa | — | 279,700 | — | 279,700 | |||||||||||||
South Korea | — | 1,206,883 | — | 1,206,883 | |||||||||||||
Sweden | — | 453,204 | — | 453,204 | |||||||||||||
United Kingdom | — | 2,985,470 | — | 2,985,470 | |||||||||||||
United States | 4,826,992 | — | — | 4,826,992 | |||||||||||||
Real Estate Investment Trusts* | 571,101 | — | — | 571,101 | |||||||||||||
Money Market Fund | 33,761 | — | — | 33,761 | |||||||||||||
Repurchase Agreement | — | 384,494 | — | 384,494 | |||||||||||||
Total | $ | 6,489,068 | $ | 17,777,165 | $ | — | $ | 24,266,233 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
24 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 100.0% | ||||||||
Denmark: 5.1% | ||||||||
298,556 | Novo-Nordisk AS (ADR) | $ | 16,193,677 | |||||
France: 5.1% | ||||||||
335,208 | Sanofi SA (ADR) | 15,912,324 | ||||||
Ireland: 9.6% | ||||||||
68,847 | Endo International Plc (USD) * | 4,769,720 | ||||||
18,850 | Jazz Pharmaceuticals Plc (USD) * | 2,503,468 | ||||||
58,576 | Perrigo Co. Plc (USD) | 9,212,248 | ||||||
66,309 | Shire Plc (ADR) | 13,608,596 | ||||||
30,094,032 | ||||||||
Israel: 4.3% | ||||||||
240,199 | Teva Pharmaceutical Industries Ltd. (ADR) | 13,561,636 | ||||||
Switzerland: 7.9% | ||||||||
270,329 | Novartis AG (ADR) | 24,848,642 | ||||||
United Kingdom: 9.8% | ||||||||
462,680 | AstraZeneca Plc (ADR) | 14,722,478 | ||||||
417,979 | GlaxoSmithKline Plc (ADR) | 16,071,293 | ||||||
30,793,771 |
Number of Shares | Value | |||||||
United States: 58.2% | ||||||||
346,769 | Abbott Laboratories | $ | 13,947,049 | |||||
281,077 | AbbVie, Inc. | 15,293,400 | ||||||
35,010 | Akorn, Inc. * | 997,960 | ||||||
56,479 | Allergan Plc * | 15,351,557 | ||||||
78,522 | AmerisourceBergen Corp. | 7,458,805 | ||||||
258,331 | Bristol-Myers Squibb Co. | 15,293,195 | ||||||
184,867 | Eli Lilly & Co. | 15,471,519 | ||||||
249,238 | Johnson & Johnson | 23,266,367 | ||||||
38,248 | Mallinckrodt Plc * | 2,445,577 | ||||||
77,734 | McKesson Corp. | 14,383,122 | ||||||
320,749 | Merck and Co., Inc. | 15,841,793 | ||||||
155,639 | Mylan NV * | 6,266,026 | ||||||
555,101 | Pfizer, Inc. | 17,435,722 | ||||||
65,795 | Valeant Pharmaceuticals International, Inc. * | 11,736,512 | ||||||
185,856 | Zoetis, Inc. | 7,653,550 | ||||||
182,842,154 | ||||||||
Total Common Stocks: 100.0% (Cost: $354,135,221) | 314,246,236 | |||||||
Other assets less liabilities: 0.0% | 50,987 | |||||||
NET ASSETS: 100.0% | $ | 314,297,223 |
ADR | American Depositary Receipt |
USD | United States Dollar |
* | Non-income producing |
Summary of Investments | ||||||||
by Sector (unaudited) | % of Investments | Value | ||||||
Health Care | 15.4 | % | $ | 48,408,555 | ||||
Health Care Equipment | 4.4 | 13,947,049 | ||||||
Pharmaceuticals | 80.2 | 251,890,632 | ||||||
100.0 | % | $ | 314,246,236 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks* | $ | 314,246,236 | $ | — | $ | — | $ | 314,246,236 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
25 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 100.0% | ||||||||
China / Hong Kong: 3.8% | ||||||||
298,133 | JD.com Inc (ADR) * | $ | 7,769,346 | |||||
United States: 96.2% | ||||||||
49,677 | Amazon.com, Inc. * | 25,429,160 | ||||||
56,214 | AmerisourceBergen Corp. | 5,339,768 | ||||||
5,763 | AutoZone, Inc. * | 4,171,432 | ||||||
40,705 | Bed Bath & Beyond, Inc. * | 2,320,999 | ||||||
68,916 | Best Buy Co., Inc. | 2,558,162 | ||||||
77,478 | Cardinal Health, Inc. | 5,951,860 | ||||||
73,941 | Costco Wholesale Corp. | 10,689,650 | ||||||
136,455 | CVS Caremark Corp. | 13,165,179 | ||||||
78,580 | Dollar General Corp. | 5,692,335 | ||||||
143,962 | Home Depot, Inc. | 16,626,171 | ||||||
44,737 | Kohl’s Corp. | 2,071,771 | ||||||
265,532 | Kroger Co. | 9,577,739 | ||||||
69,693 | L Brands, Inc. | 6,281,430 | ||||||
151,639 | Lowe’s Cos., Inc. | 10,450,960 | ||||||
97,091 | MACY’S, Inc. | 4,982,710 | ||||||
48,200 | McKesson Corp. | 8,918,446 | ||||||
107,462 | Ross Stores, Inc. | 5,208,683 |
Number of Shares | Value | |||||||
United States: (continued) | ||||||||
154,521 | Sysco Corp. | $ | 6,021,683 | |||||
120,468 | Target Corp. | 9,476,013 | ||||||
89,487 | The Gap, Inc. | 2,550,380 | ||||||
130,808 | TJX Cos., Inc. | 9,342,307 | ||||||
128,903 | Walgreens Boots Alliance, Inc. | 10,711,839 | ||||||
236,463 | Wal-Mart Stores, Inc. | 15,332,261 | ||||||
104,977 | Whole Foods Market, Inc. | 3,322,522 | ||||||
196,193,460 | ||||||||
Total Common Stocks (Cost: $212,042,992) | 203,962,806 | |||||||
MONEY MARKET FUND: 0.0% (Cost: $28,516) | ||||||||
28,516 | Dreyfus Government Cash Management Fund | 28,516 | ||||||
Total Investments: 100.0% (Cost: $212,071,508) | 203,991,322 | |||||||
Liabilities in excess of other assets: (0.0)% | (82,790 | ) | ||||||
NET ASSETS: 100.0% | $ | 203,908,532 |
ADR | American Depositary Receipt |
* | Non-income producing |
Summary of Investments | ||||||||
by Sector (unaudited) | % of Investments | Value | ||||||
Consumer Discretionary | 56.4 | % | $ | 114,931,859 | ||||
Consumer Staples | 33.7 | 68,820,873 | ||||||
Health Care | 9.9 | 20,210,074 | ||||||
Money Market Fund | 0.0 | 28,516 | ||||||
100.0 | % | $ | 203,991,322 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows: |
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks* | $ | 203,962,806 | $ | — | $ | — | $ | 203,962,806 | |||||||||
Money Market Fund | 28,516 | — | — | 28,516 | |||||||||||||
Total | $ | 203,991,322 | $ | — | $ | — | $ | 203,991,322 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
26 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||||
COMMON STOCKS: 100.1% | ||||||||
Bermuda: 0.7% | ||||||||
143,985 | Marvell Technology Group Ltd. (USD) | $ | 1,303,064 | |||||
Netherlands: 9.3% | ||||||||
104,955 | ASML Holding NV (USD) | 9,233,941 | ||||||
96,790 | NXP Semiconductors NV (USD) * | 8,427,505 | ||||||
17,661,446 | ||||||||
Singapore: 4.4% | ||||||||
67,638 | Avago Technologies Ltd. (USD) | 8,455,426 | ||||||
Taiwan: 12.7% | ||||||||
1,170,008 | Taiwan Semiconductor Manufacturing Co. Ltd. (ADR) | 24,277,666 | ||||||
United Kingdom: 4.4% | ||||||||
191,987 | ARM Holdings Plc (ADR) | 8,303,438 | ||||||
United States: 68.6% | ||||||||
105,659 | Altera Corp. | 5,291,403 | ||||||
94,653 | Analog Devices, Inc. | 5,339,376 | ||||||
441,544 | Applied Materials, Inc. | 6,486,281 | ||||||
165,724 | Broadcom Corp. | 8,523,185 | ||||||
1,137,080 | Intel Corp. | 34,271,591 | ||||||
32,676 | KLA-Tencor Corp. | 1,633,800 | ||||||
50,712 | Lam Research Corp. | 3,313,015 | ||||||
70,078 | Linear Technology Corp. | 2,827,647 | ||||||
84,475 | Maxim Integrated Products, Inc. | 2,821,465 | ||||||
70,660 | Microchip Technology, Inc. † | 3,044,739 | ||||||
449,523 | Micron Technology, Inc. * | 6,733,855 | ||||||
165,189 | NVIDIA Corp. | 4,071,909 | ||||||
155,717 | ON Semiconductor Corp. * | 1,463,740 | ||||||
367,258 | Qualcomm, Inc. | 19,732,772 | ||||||
70,358 | SanDisk Corp. | 3,822,550 | ||||||
77,343 | Skyworks Solutions, Inc. | 6,513,054 | ||||||
58,652 | Teradyne, Inc. | 1,056,323 |
Number of Shares | Value | |||||||
United States: (continued) | ||||||||
200,751 | Texas Instruments, Inc. | $ | 9,941,190 | |||||
97,561 | Xilinx, Inc. | 4,136,586 | ||||||
131,024,481 | ||||||||
Total Common Stocks (Cost: $209,620,708) | 191,025,521 | |||||||
MONEY MARKET FUND: 0.1% (Cost: $215,733) | ||||||||
215,733 | Dreyfus Government Cash Management Fund | 215,733 | ||||||
Total Investments Before Collateral for Securities Loaned: 100.2% | ||||||||
(Cost: $209,836,441) | 191,241,254 | |||||||
Principal Amount |
||||||||
SHORT-TERM INVESTMENT HELD AS COLLATERAL FOR SECURITIES LOANED: 0.0% | ||||||||
(Cost: $662) | ||||||||
Repurchase Agreement: 0.0% | ||||||||
$662 | Repurchase agreement dated 9/30/15 with Royal Bank of Scotland Plc, 0.09%, due 10/1/15, proceeds $662; (collateralized by various U.S. government and agency obligations, 0.09% to 3.63%, due 1/31/16 to 2/15/44, valued at $675 including accrued interest) | 662 | ||||||
Total Investments: 100.2% (Cost: $209,837,103) | 191,241,916 | |||||||
Liabilities in excess of other assets: (0.2)% | (318,770 | ) | ||||||
NET ASSETS: 100.0% | $ | 190,923,146 |
ADR | American Depositary Receipt |
USD | United States Dollar |
* | Non-income producing |
† | Security fully or partially on loan. Total market value of securities on loan is $474. |
Summary of Investments | ||||||||
by Sector Excluding | ||||||||
Collateral for Securities | ||||||||
Loaned (unaudited) | % of Investments | Value | ||||||
Information Technology | 12.3 | % | $ | 23,555,322 | ||||
Semiconductor Equipment | 11.4 | 21,723,360 | ||||||
Semiconductors | 76.2 | 145,746,839 | ||||||
Money Market Fund | 0.1 | 215,733 | ||||||
100.0 | % | $ | 191,241,254 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks* | $ | 191,025,521 | $ | — | $ | — | $ | 191,025,521 | |||||||||
Money Market Fund | 215,733 | — | — | 215,733 | |||||||||||||
Repurchase Agreement | — | 662 | — | 662 | |||||||||||||
Total | $ | 191,241,254 | $ | 662 | $ | — | $ | 191,241,916 |
* | See Schedule of Investments for security type and geographic sector breakouts. |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
27 |
MARKET VECTORS ETF TRUST
STATEMENTS OF ASSETS AND LIABILITIES
September 30, 2015
Biotech ETF | Environmental Services ETF | Gaming ETF | ||||||||||
Assets: | ||||||||||||
Investments, at value (1) (2) | $ | 652,915,100 | $ | 14,643,608 | $ | 23,881,739 | ||||||
Short-term investments held as collateral for securities loaned (3) | 6,460,963 | 559,245 | 384,494 | |||||||||
Cash denominated in foreign currency, at value (4) | — | — | 124,128 | |||||||||
Receivables: | ||||||||||||
Investment securities sold | — | 29,721 | 217 | |||||||||
Shares sold | 635 | 2,884,446 | — | |||||||||
Due from Adviser | — | 18,177 | 14,505 | |||||||||
Dividends | 98,497 | 23,759 | 100,201 | |||||||||
Prepaid expenses | 10,178 | 201 | 355 | |||||||||
Total assets | 659,485,373 | 18,159,157 | 24,505,639 | |||||||||
Liabilities: | ||||||||||||
Payables: | ||||||||||||
Investment securities purchased | — | 883,966 | 218 | |||||||||
Collateral for securities loaned | 6,460,963 | 559,245 | 384,494 | |||||||||
Line of credit | 754,759 | — | 118,050 | |||||||||
Shares redeemed | — | 2,051,862 | — | |||||||||
Due to Adviser | 133,950 | — | — | |||||||||
Due to custodian | 6,447 | — | 35,216 | |||||||||
Deferred Trustee fees | 22,956 | 1,736 | 4,535 | |||||||||
Accrued expenses | 127,906 | 69,458 | 103,964 | |||||||||
Total liabilities | 7,506,981 | 3,566,267 | 646,477 | |||||||||
NET ASSETS | $ | 651,978,392 | $ | 14,592,890 | $ | 23,859,162 | ||||||
Shares outstanding | 5,696,503 | 250,000 | 800,000 | |||||||||
Net asset value, redemption and offering price per share | $ | 114.45 | $ | 58.37 | $ | 29.82 | ||||||
Net assets consist of: | ||||||||||||
Aggregate paid in capital | $ | 724,651,772 | $ | 29,600,620 | $ | 37,635,314 | ||||||
Net unrealized appreciation (depreciation) | (69,342,590 | ) | 35,357 | (11,448,891 | ) | |||||||
Undistributed net investment income | 1,271,279 | 132,857 | 869,489 | |||||||||
Accumulated net realized gain (loss) | (4,602,069 | ) | (15,175,944 | ) | (3,196,750 | ) | ||||||
$ | 651,978,392 | $ | 14,592,890 | $ | 23,859,162 | |||||||
(1) Value of securities on loan | $ | 6,634,400 | $ | 543,799 | $ | 375,599 | ||||||
(2) Cost of investments | $ | 722,257,690 | $ | 14,608,251 | $ | 35,329,075 | ||||||
(3) Cost of short-term investments held as collateral for securities loaned | $ | 6,460,963 | $ | 559,245 | $ | 384,494 | ||||||
(4) Cost of cash denominated in foreign currency | $ | — | $ | — | $ | 124,583 |
See Notes to Financial Statements
28 |
Pharmaceutical | Retail | Semiconductor | |||||||||
ETF | ETF | ETF | |||||||||
$ | 314,246,236 | $ | 203,991,322 | $ | 191,241,254 | ||||||
— | — | 662 | |||||||||
— | — | — | |||||||||
— | — | — | |||||||||
— | 469 | 2,681 | |||||||||
— | — | — | |||||||||
887,095 | 152,290 | 24,164 | |||||||||
4,796 | 2,673 | 5,387 | |||||||||
315,138,127 | 204,146,754 | 191,274,148 | |||||||||
— | — | — | |||||||||
— | — | 662 | |||||||||
666,793 | 108,233 | — | |||||||||
87 | — | 2,393 | |||||||||
59,452 | 20,071 | 20,059 | |||||||||
2,818 | 29,764 | 213,628 | |||||||||
14,698 | 2,912 | 17,272 | |||||||||
97,056 | 77,242 | 96,988 | |||||||||
840,904 | 238,222 | 351,002 | |||||||||
$ | 314,297,223 | $ | 203,908,532 | $ | 190,923,146 | ||||||
4,988,138 | 2,771,531 | 3,820,937 | |||||||||
$ | 63.01 | $ | 73.57 | $ | 49.97 | ||||||
$ | 352,767,875 | $ | 210,034,796 | $ | 205,743,121 | ||||||
(39,888,985 | ) | (8,080,186 | ) | (18,595,187 | ) | ||||||
1,423,738 | 2,973,265 | 4,823,602 | |||||||||
(5,405 | ) | (1,019,343 | ) | (1,048,390 | ) | ||||||
$ | 314,297,223 | $ | 203,908,532 | $ | 190,923,146 | ||||||
$ | — | $ | — | $ | 474 | ||||||
$ | 354,135,221 | $ | 212,071,508 | $ | 209,836,441 | ||||||
$ | — | $ | — | $ | 662 | ||||||
$ | — | $ | — | $ | — |
See Notes to Financial Statements
29 |
MARKET VECTORS ETF TRUST
For the Year Ended September 30, 2015
Biotech ETF | Environmental Services ETF | Gaming ETF | ||||||||||
Income: | ||||||||||||
Dividends | $ | 2,701,473 | $ | 227,689 | $ | 1,214,920 | ||||||
Securities lending income | 1,228,497 | 44,257 | 10,306 | |||||||||
Foreign taxes withheld | (31,689 | ) | (1,542 | ) | (25,179 | ) | ||||||
Total income | 3,898,281 | 270,404 | 1,200,047 | |||||||||
Expenses: | ||||||||||||
Management fees | 2,554,771 | 79,554 | 167,643 | |||||||||
Professional fees | 101,885 | 67,279 | 72,877 | |||||||||
Insurance | 9,474 | 325 | 922 | |||||||||
Trustees’ fees and expenses | 29,847 | 1,749 | 2,718 | |||||||||
Reports to shareholders | 92,902 | 16,393 | 19,925 | |||||||||
Indicative optimized portfolio value fee | 3,869 | — | 18,453 | |||||||||
Custodian fees | 19,750 | 2,883 | 28,912 | |||||||||
Registration fees | 8,238 | 4,220 | 5,055 | |||||||||
Transfer agent fees | 1,730 | 2,384 | 2,364 | |||||||||
Fund accounting fees | 38,561 | 1,101 | 6,721 | |||||||||
Interest | 11,451 | 434 | 1,723 | |||||||||
Other | 23,968 | 5,878 | 7,184 | |||||||||
Total expenses | 2,896,446 | 182,200 | 334,497 | |||||||||
Waiver of management fees | (330,219 | ) | (79,554 | ) | (114,837 | ) | ||||||
Expenses assumed by the Adviser | — | (14,702 | ) | — | ||||||||
Net expenses | 2,566,227 | 87,944 | 219,660 | |||||||||
Net investment income | 1,332,054 | 182,460 | 980,387 | |||||||||
Net realized gain (loss) on: | ||||||||||||
Investments | 4,028,576 | (1,501,678 | ) | (1,318,818 | ) | |||||||
In-kind redemptions | 186,143,157 | 1,162,004 | 1,183,529 | |||||||||
Foreign currency transactions and foreign denominated assets and liabilities | — | — | (4,517 | ) | ||||||||
Net realized gain (loss) | 190,171,733 | (339,674 | ) | (139,806 | ) | |||||||
Net change in unrealized appreciation (depreciation) on: | ||||||||||||
Investments | (154,774,310 | ) | (1,128,708 | ) | (11,556,971 | ) | ||||||
Foreign currency transactions and foreign denominated assets and liabilities | — | — | 738 | |||||||||
Net change in unrealized appreciation (depreciation) | (154,774,310 | ) | (1,128,708 | ) | (11,556,233 | ) | ||||||
Net Increase (Decrease) in Net Assets Resulting from Operations | $ | 36,729,477 | $ | (1,285,922 | ) | $ | (10,715,652 | ) |
See Notes to Financial Statements
30 |
Pharmaceutical | Retail | Semiconductor | |||||||||
ETF | ETF | ETF | |||||||||
$ | 8,238,522 | $ | 4,066,040 | $ | 9,715,807 | ||||||
3,075 | 1,300 | 44,371 | |||||||||
(347,506 | ) | — | (371,156 | ) | |||||||
7,894,091 | 4,067,340 | 9,389,022 | |||||||||
1,293,791 | 769,283 | 1,392,964 | |||||||||
90,265 | 79,490 | 95,372 | |||||||||
5,729 | 1,147 | 6,358 | |||||||||
17,133 | 5,974 | 13,483 | |||||||||
45,665 | 26,805 | 45,459 | |||||||||
3,976 | 3,980 | 3,981 | |||||||||
9,096 | 5,132 | 9,667 | |||||||||
8,292 | 5,607 | 7,940 | |||||||||
1,733 | 1,732 | 1,731 | |||||||||
14,718 | 9,801 | 19,145 | |||||||||
19,497 | 2,964 | 7,803 | |||||||||
15,605 | 6,643 | 12,659 | |||||||||
1,525,500 | 918,558 | 1,616,562 | |||||||||
(212,209 | ) | (146,310 | ) | (215,794 | ) | ||||||
— | — | — | |||||||||
1,313,291 | 772,248 | 1,400,768 | |||||||||
6,580,800 | 3,295,092 | 7,988,254 | |||||||||
6,564,648 | (1,004,858 | ) | (985,862 | ) | |||||||
64,028,153 | 25,312,123 | (40,424,797 | ) | ||||||||
— | — | — | |||||||||
70,592,801 | 24,307,265 | (41,410,659 | ) | ||||||||
(75,458,283 | ) | (8,434,125 | ) | (3,130,916 | ) | ||||||
— | — | — | |||||||||
(75,458,283 | ) | (8,434,125 | ) | (3,130,916 | ) | ||||||
$ | 1,715,318 | $ | 19,168,232 | $ | (36,553,321 | ) |
See Notes to Financial Statements
31 |
MARKET VECTORS ETF TRUST
STATEMENTS OF CHANGES IN NET ASSETS
Biotech ETF | Environmental Services ETF | |||||||||||||||
For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | |||||||||||||
Operations: | ||||||||||||||||
Net investment income (loss) | $ | 1,332,054 | $ | (139,447 | ) | $ | 182,460 | $ | 255,685 | |||||||
Net realized gain (loss) | 190,171,733 | 99,761,734 | (339,674 | ) | 335,675 | |||||||||||
Net change in unrealized appreciation (depreciation) | (154,774,310 | ) | 7,699,123 | (1,128,708 | ) | 397,203 | ||||||||||
Net increase (decrease) in net assets resulting from operations | 36,729,477 | 107,321,410 | (1,285,922 | ) | 988,563 | |||||||||||
Dividends to shareholders: | ||||||||||||||||
Dividends from net investment income | — | (16,340 | ) | (263,000 | ) | (225,000 | ) | |||||||||
Share transactions:** | ||||||||||||||||
Proceeds from sale of shares | 515,674,327 | 214,333,599 | 12,572,433 | 16,414,508 | ||||||||||||
Cost of shares redeemed | (439,848,484 | ) | (216,305,046 | ) | (12,572,433 | ) | (19,765,651 | ) | ||||||||
Increase (Decrease) in net assets resulting from share transactions | 75,825,843 | (1,971,447 | ) | — | (3,351,143 | ) | ||||||||||
Total increase (decrease) in net assets | 112,555,320 | 105,333,623 | (1,548,922 | ) | (2,587,580 | ) | ||||||||||
Net Assets, beginning of period | 539,423,072 | 434,089,449 | 16,141,812 | 18,729,392 | ||||||||||||
Net Assets, end of period† | $ | 651,978,392 | $ | 539,423,072 | $ | 14,592,890 | $ | 16,141,812 | ||||||||
† Including undistributed (accumulated) net investment income (loss) | $ | 1,271,279 | $ | (60,775 | ) | $ | 132,857 | $ | 214,245 | |||||||
** Shares of Common Stock Issued (no par value) | ||||||||||||||||
Shares sold | 4,100,000 | 2,250,000 | 200,000 | 250,000 | ||||||||||||
Shares redeemed | (3,500,000 | ) | (2,400,000 | ) | (200,000 | ) | (300,000 | ) | ||||||||
Net increase (decrease) | 600,000 | (150,000 | ) | — | (50,000 | ) |
See Notes to Financial Statements
32 |
Gaming ETF | Pharmaceutical ETF | ||||||||||||||
For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | ||||||||||||
$ | 980,387 | $ | 1,926,213 | $ | 6,580,800 | $ | 5,694,728 | ||||||||
(139,806 | ) | 11,837,737 | 70,592,801 | 61,446,159 | |||||||||||
(11,556,233 | ) | (18,082,672 | ) | (75,458,283 | ) | 23,818,451 | |||||||||
(10,715,652 | ) | (4,318,722 | ) | 1,715,318 | 90,959,338 | ||||||||||
(1,789,800 | ) | (802,900 | ) | (6,396,063 | ) | (5,483,238 | ) | ||||||||
5,948,582 | 31,039,908 | 276,929,722 | 267,920,405 | ||||||||||||
(12,968,022 | ) | (39,516,731 | ) | (363,840,122 | ) | (188,775,424 | ) | ||||||||
(7,019,440 | ) | (8,476,823 | ) | (86,910,400 | ) | 79,144,981 | |||||||||
(19,524,892 | ) | (13,598,445 | ) | (91,591,145 | ) | 164,621,081 | |||||||||
43,384,054 | 56,982,499 | 405,888,368 | 241,267,287 | ||||||||||||
$ | 23,859,162 | $ | 43,384,054 | $ | 314,297,223 | $ | 405,888,368 | ||||||||
$ | 869,489 | $ | 1,732,005 | $ | 1,423,738 | $ | 1,239,001 | ||||||||
150,000 | 600,000 | 4,000,000 | 4,550,000 | ||||||||||||
(350,000 | ) | (800,000 | ) | (5,400,000 | ) | (3,200,000 | ) | ||||||||
(200,000 | ) | (200,000 | ) | (1,400,000 | ) | 1,350,000 |
See Notes to Financial Statements
33 |
MARKET VECTORS ETF TRUST
STATEMENTS OF CHANGES IN NET ASSETS
(continued)
Retail ETF | Semiconductor ETF | |||||||||||||||
For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | |||||||||||||
Operations: | ||||||||||||||||
Net investment income | $ | 3,295,092 | $ | 502,509 | $ | 7,988,254 | $ | 5,600,833 | ||||||||
Net realized gain (loss) | 24,307,265 | 8,198,452 | (41,410,659 | ) | 87,768,373 | |||||||||||
Net change in unrealized appreciation (depreciation) | (8,434,125 | ) | (1,892,838 | ) | (3,130,916 | ) | (6,723,231 | ) | ||||||||
Net increase (decrease) in net assets resulting from operations | 19,168,232 | 6,808,123 | (36,553,321 | ) | 86,645,975 | |||||||||||
Dividends to shareholders: | ||||||||||||||||
Dividends from net investment income | (690,116 | ) | (408,291 | ) | (6,554,432 | ) | (4,956,298 | ) | ||||||||
Share transactions:** | ||||||||||||||||
Proceeds from sale of shares | 332,584,044 | 119,681,910 | 7,511,380,699 | 2,914,362,903 | ||||||||||||
Cost of shares redeemed | (213,877,277 | ) | (102,053,895 | ) | (7,692,308,773 | ) | (2,843,110,213 | ) | ||||||||
Increase (Decrease) in net assets resulting from share transactions | 118,706,767 | 17,628,015 | (180,928,074 | ) | 71,252,690 | |||||||||||
Total increase (decrease) in net assets | 137,184,883 | 24,027,847 | (224,035,827 | ) | 152,942,367 | |||||||||||
Net Assets, beginning of period | 66,723,649 | 42,695,802 | 414,958,973 | 262,016,606 | ||||||||||||
Net Assets, end of period† | $ | 203,908,532 | $ | 66,723,649 | $ | 190,923,146 | $ | 414,958,973 | ||||||||
† Including undistributed net investment income | $ | 2,973,265 | $ | 368,223 | $ | 4,823,602 | $ | 4,246,099 | ||||||||
** Shares of Common Stock Issued (no par value) | ||||||||||||||||
Shares sold | 4,600,000 | 2,000,000 | 140,850,000 | 62,550,000 | ||||||||||||
Shares redeemed | (2,900,000 | ) | (1,700,000 | ) | (145,150,000 | ) | (61,000,000 | ) | ||||||||
Net increase (decrease) | 1,700,000 | 300,000 | (4,300,000 | ) | 1,550,000 |
See Notes to Financial Statements
34 |
MARKET VECTORS ETF TRUST
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Annualized |
(d) | Not Annualized |
(e) | Amount represents less than $0.005 per share |
# | On February 14, 2012, the Fund effected a 3 for 1 share split (See Note 10). Per share data has been adjusted to reflect the share split. |
See Notes to Financial Statements
35 |
MARKET VECTORS ETF TRUST
FINANCIAL HIGHLIGHTS
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Annualized |
(d) | Not Annualized |
(e) | Calculated based upon average shares outstanding. |
# | On February 14, 2012, the Fund effected a 2 for 1 share split (See Note 10). Per share data has been adjusted to reflect the share split. |
See Notes to Financial Statements
36 |
FINANCIAL HIGHLIGHTS
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Annualized |
(d) | Not Annualized |
(e) | Calculated based upon average shares outstanding. |
# | On February 14, 2012, the Fund effected a 3 for 1 share split (See Note 10). Per share data has been adjusted to reflect the share split. |
See Notes to Financial Statements
37 |
MARKET VECTORS ETF TRUST
September 30, 2015
Note 1—Fund Organization—Market Vectors ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended, as an open-end management investment company. The Trust was incorporated in Delaware as a statutory trust on March 15, 2001. The Trust operates as a series fund, and as of September 30, 2015, offers fifty-eight investment portfolios, each of which represents a separate series of the Trust.
These financial statements relate only to the following investment portfolios: Biotech ETF, Environmental Services ETF, Gaming ETF, Pharmaceutical ETF, Retail ETF and Semiconductor ETF (each a “Fund” and, together, the “Funds”). Each Fund was created to provide investors with the opportunity to purchase a security representing a proportionate undivided interest in a portfolio of securities consisting of substantially all of the common stocks in substantially the same weighting, in an index published by the NYSE Euronext or Market Vectors Index Solutions GmbH, a wholly-owned subsidiary of Van Eck Associates Corporation (the “Adviser”).
The Funds’ commencement of operations dates and their respective indices are presented below:
Fund | Commencement
of Operations |
Index | ||
Biotech ETF | December 20, 2011 | Market Vectors® US Listed Biotech 25 Index* | ||
Environmental Services ETF** | October 10, 2006 | NYSE Arca Environmental Services Index | ||
Gaming ETF** | January 22, 2008 | Market Vectors® Global Gaming Index* | ||
Pharmaceutical ETF | December 20, 2011 | Market Vectors® US Listed Pharmaceutical 25 Index* | ||
Retail ETF | December 20, 2011 | Market Vectors® US Listed Retail 25 Index* | ||
Semiconductor ETF | December 20, 2011 | Market Vectors® US Listed Semiconductor 25 Index* |
* | Published by Market Vectors Index Solutions GmbH |
** | Effective January 1, 2012, the Fund changed its fiscal year end from December 31 to September 30. |
Note 2—Significant Accounting Policies—The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.
The Funds are investment companies and are following accounting and reporting requirements of Accounting Standards Codification (“ASC”) 946 Financial Services — Investment Companies.
The following is a summary of significant accounting policies followed by the Funds.
A. | Security Valuation—The Funds value their investments in securities and other assets and liabilities carried at fair value daily. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Securities traded on national exchanges or traded on the NASDAQ National Market System are valued at the last sales price as reported at the close of each business day. Securities traded on the NASDAQ Stock Market are valued at the NASDAQ official closing price. Over-the-counter securities not included in the NASDAQ National Market System and listed securities for which no sale was reported are valued at the mean of the bid and ask prices. To the extent these securities are actively traded they are categorized as Level 1 in the fair value hierarchy (described below). Certain foreign securities, whose values may be affected by market direction or events occurring before the Funds’ pricing time (4:00 p.m. Eastern Standard Time) but after the last close of the securities’ primary market, are fair valued using a pricing service and are categorized as Level 2 in the fair value hierarchy. The pricing service, using methods approved by the Board of Trustees, considers the correlation of the trading patterns of the foreign security to intraday trading in the U.S. markets, based on indices of domestic securities and other appropriate indicators such as prices of relevant ADR’s and futures contracts. The Funds may also fair value securities in other situations, such as, when a particular foreign market is closed but the Fund is open. Short-term obligations with more than sixty days remaining to maturity are valued at market value. Short-term obligations with sixty days or less to maturity are valued at amortized cost, which with accrued interest approximates fair value. Money market fund investments are valued at net asset value and are considered to be Level 1 in the fair value hierarchy. Securities for which quotations are not available are stated at fair value as determined by the Pricing Committee of the Adviser appointed by the Board of Trustees. The Pricing Committee provides oversight of the Funds’ valuation policies and procedures, which are approved by the Funds’ Board of Trustees. Among other things, these procedures allow the Funds to utilize independent pricing services, |
38 |
quotations from securities dealers, and other market sources to determine fair value. The Pricing Committee convenes regularly to review the fair value of financial instruments for which market prices are not readily available. The Pricing Committee employs various methods for calibrating the valuation approaches utilized to determine fair value, including a regular review of key inputs and assumptions, transactional back-testing and disposition analysis. | |
Certain factors such as economic conditions, political events, market trends, the nature of and duration of any restrictions on disposition, trading in similar securities of the issuer or comparable issuers and other security specific information are used to determine the fair value of these securities. Depending on the relative significance of valuation inputs, these securities may be classified either as Level 2 or Level 3 in the fair value hierarchy. The price which the Funds may realize upon sale of an investment may differ materially from the value presented in the Schedules of Investments. | |
The Funds utilize various methods to measure the fair value of its investments on a recurring basis which includes a hierarchy that prioritizes inputs to valuation methods used to measure fair value. The fair value hierarchy gives highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The transfers between levels of the fair value hierarchy assume the financial instruments were transferred at the beginning of the reporting period. The three levels of the fair value hierarchy are described below: | |
Level 1 — Quoted prices in active markets for identical securities. | |
Level 2 — Significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). | |
Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments). | |
A summary of the inputs, the levels used to value the Funds’ investments, and transfers between levels are located in the Schedules of Investments. Additionally, tables that reconcile the valuation of the Funds’ Level 3 investments and that present additional information about valuation methodologies and unobservable inputs, if applicable, are located in the Schedules of Investments. |
B. | Federal Income Taxes—It is each Fund’s policy to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Therefore, no federal income tax provision is required. |
C. | Dividends and Distributions to Shareholders—Dividends to shareholders from net investment income and distributions from net realized capital gains, if any, are declared and paid annually by each Fund (except for dividends from net investment income on the Pharmaceutical ETF, which are declared and paid quarterly). Distributions from net realized capital gains, if any, are declared and paid annually by each Fund. Income dividends and capital gain distributions are determined in accordance with U.S. income tax regulations, which may differ from such amounts determined in accordance with GAAP. |
D. | Currency Translation—Assets and liabilities denominated in foreign currencies and commitments under foreign currency contracts are translated into U.S. dollars at the closing prices of such currencies each business day. Purchases and sales of investments are translated at the exchange rates prevailing when such investments are acquired or sold. Foreign denominated income and expenses are translated at the exchange rates prevailing when accrued. The portion of realized and unrealized gains and losses on investments that result from fluctuations in foreign currency exchange rates is not separately disclosed in the financial statements. Recognized gains or losses attributable to foreign currency fluctuations on foreign currency denominated assets, other than investments, and liabilities are recorded as net realized gain (loss) on foreign currency transactions and foreign denominated assets and liabilities in the Statements of Operations. |
E. | Restricted Securities—The Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and |
39 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
prompt sale at an acceptable price may be difficult. Information regarding restricted securities, if any, is included at the end of each Fund’s Schedule of Investments. | |
F. | Repurchase Agreements—The Funds may enter into repurchase agreements with financial institutions, deemed to be creditworthy by the Adviser, to generate income from their excess cash balances and to invest securities lending cash collateral. A repurchase agreement is an agreement under which a Fund acquires securities from a seller, subject to resale to the seller at an agreed upon price and date. A Fund, through its custodian/securities lending agent, takes possession of securities collateralizing the repurchase agreement. Pursuant to the terms of the repurchase agreement, such securities must have an aggregate market value greater than or equal to the terms of the repurchase price plus accrued interest at all times. If the value of the underlying securities falls below the value of the repurchase price plus accrued interest, the Funds will require the seller to deposit additional collateral by the next business day. If the request for additional collateral is not met, or the seller defaults on its repurchase obligation, the Funds maintain their right to sell the underlying securities at market value and may claim any resulting loss against the seller. Repurchase agreements held as of September 30, 2015 are reflected in the Schedules of Investments. |
G. | Use of Derivative Instruments—The Funds may invest in derivative instruments, including, but not limited to, options, futures, swaps and other derivatives relating to foreign currency transactions. A derivative is an instrument whose value is derived from underlying assets, indices, reference rates or a combination of these factors. Derivative instruments may be privately negotiated contracts (often referred to as over-the-counter (“OTC”) derivatives) or they may be listed and traded on an exchange. Derivative contracts may involve future commitments to purchase or sell financial instruments at specified terms on a specified date, or to exchange interest payment streams or currencies based on a notional or contractual amount. Derivative instruments may involve a high degree of financial risk. The use of derivative instruments also involves the risk of loss if the Adviser is incorrect in its expectation of the timing or level of fluctuations in securities prices, interest rates or currency prices. Investments in derivative instruments also include the risk of default by the counterparty, the risk that the investment may not be liquid and the risk that a small movement in the price of the underlying security or benchmark may result in a disproportionately large movement, unfavorable or favorable, in the price of the derivative instruments. The Funds held no derivative instruments during the year ended September 30, 2015. |
H. | Offsetting Assets and Liabilities—In the ordinary course of business, the Funds enter into transactions subject to enforceable master netting or other similar agreements. Generally, the right of setoff in those agreements allows the Funds to set off any exposure to a specific counterparty with any collateral received or delivered to that counterparty based on the terms of the agreements. The Funds may pledge or receive cash and/or securities as collateral for derivative instruments, securities lending and repurchase agreements. For financial reporting purposes, the Funds present securities lending and repurchase agreement assets and liabilities on a gross basis in the Statements of Assets and Liabilities. Collateral held at September 30, 2015 is presented in the Schedules of Investments. Also, refer to related disclosures in Note 2F (Repurchase Agreements) and Note 9 (Securities Lending). |
I. | Other—Security transactions are accounted for on trade date. Transactions in certain securities may take longer than the customary settlement cycle to be completed. The counterparty is required to collateralize such trades with cash in excess of the market value of the transaction, which is held at the custodian and marked to market daily. Realized gains and losses are calculated on the identified cost basis. Dividend income is recorded on the ex-dividend date except that certain dividends from foreign securities are recognized upon notification of the ex-dividend date/rate. Interest income, including amortization of premiums and discounts, is accrued as earned. |
In the normal course of business, the Funds enter into contracts that contain a variety of general indemnifications. The Funds’ maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. However, the Adviser believes the risk of loss under these arrangements to be remote. |
Note 3—Investment Management and Other Agreements—The Adviser is the investment adviser to the Funds. The Adviser receives a management fee, calculated daily and payable monthly based on an annual rate of 0.35% of each Fund’s average daily net assets (except for Environmental Services ETF and Gaming ETF). The management fee rates for Environmental Services ETF and Gaming ETF are 0.50% of each Fund’s average daily net assets. The Adviser has agreed, at least until February 1, 2016, to voluntarily waive or limit its fees and to assume as its own expense certain expenses otherwise payable by the Funds so that each Fund’s total annual operating expenses does not exceed the
40 |
expense limitations (excluding acquired fund fees and expenses, interest expense, trading expenses, offering costs, taxes and extraordinary expenses) listed in the table below.
The current expense limitations and the amounts waived/assumed by the Adviser for the year ended September 30, 2015, are as follows:
Fund | Expense Limitations | Waiver of Management Fees | Expenses Assumed by the Adviser | |||||||||
Biotech ETF | 0.35 | % | $330,219 | $ | — | |||||||
Environmental Services ETF | 0.55 | 79,554 | 14,702 | |||||||||
Gaming ETF | 0.65 | 114,837 | — | |||||||||
Pharmaceutical ETF | 0.35 | 212,209 | — | |||||||||
Retail ETF | 0.35 | 146,310 | — | |||||||||
Semiconductor ETF | 0.35 | 215,794 | — |
In addition, Van Eck Securities Corporation, an affiliate and wholly owned subsidiary of the Adviser, acts as the Funds’ distributor (the “Distributor”). Certain officers and a Trustee of the Trust are officers, directors or stockholders of the Adviser and Distributor.
Note 4—Investments—For the year ended September 30, 2015, the cost of purchases and proceeds from sales of investments other than U.S. government obligations and short-term obligations (excluding in-kind transactions described in Note 6) were as follows:
Fund | Cost of Investments Purchased | Proceeds from Investments Sold | |||||||
Biotech ETF | $ | 260,629,958 | $ | 82,435,970 | |||||
Environmental Services ETF | 4,763,462 | 3,019,591 | |||||||
Gaming ETF | 9,164,264 | 10,697,122 | |||||||
Pharmaceutical ETF | 99,694,174 | 44,328,109 | |||||||
Retail ETF | 28,692,904 | 10,574,272 | |||||||
Semiconductor ETF | 75,594,376 | 73,808,119 |
Note 5—Income Taxes—As of September 30, 2015, for Federal income tax purposes, the identified cost of investments owned, net unrealized appreciation (depreciation), gross unrealized appreciation, and gross unrealized depreciation of investments were as follows:
Fund | Cost of Investments | Gross Unrealized Appreciation | Gross Unrealized Depreciation | Net Unrealized Appreciation (Depreciation) | ||||||||||||
Biotech ETF | $ | 728,718,653 | $7,928,087 | $ | (77,270,677 | ) | $(69,342,590 | ) | ||||||||
Environmental Services ETF | 15,189,450 | 1,701,530 | (1,688,127 | ) | 13,403 | |||||||||||
Gaming ETF | 36,540,157 | 2,293,886 | (14,567,810 | ) | (12,273,924 | ) | ||||||||||
Pharmaceutical ETF | 354,140,626 | 2,415,260 | (42,309,650 | ) | (39,894,390 | ) | ||||||||||
Retail ETF | 212,071,508 | 7,819,501 | (15,899,687 | ) | (8,080,186 | ) | ||||||||||
Semiconductor ETF | 209,463,868 | 281,350 | (18,503,302 | ) | (18,221,952 | ) |
At September 30, 2015, the components of accumulated earnings (deficit) on a tax basis, for each Fund, were as follows:
Fund | Undistributed Ordinary Income | Undistributed Long-Term Capital Gains | Accumulated Capital Losses | Other Temporary Differences | Unrealized Appreciation (Depreciation) | Total | |||||||||||||||
Biotech ETF | $1,294,236 | $— | $ | (4,602,069 | ) | $(22,957 | ) | $(69,342,590 | ) | $(72,673,380 | ) | ||||||||||
Environmental Services ETF | 132,036 | — | (15,151,434 | ) | (1,735 | ) | 13,403 | (15,007,730 | ) | ||||||||||||
Gaming ETF | 844,816 | — | (2,340,952 | ) | (4,537 | ) | (12,275,479 | ) | (13,776,152 | ) | |||||||||||
Pharmaceutical ETF | 1,438,437 | — | — | (14,699 | ) | (39,894,390 | ) | (38,470,652 | ) | ||||||||||||
Retail ETF | 2,976,177 | — | (1,019,343 | ) | (2,912 | ) | (8,080,186 | ) | (6,126,264 | ) | |||||||||||
Semiconductor ETF | 4,466,754 | — | (1,047,505 | ) | (17,272 | ) | (18,221,952 | ) | (14,819,975 | ) |
41 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
The tax character of dividends paid to shareholders during the years ended September 30, 2015 and September 30, 2014 was as follows:
September 30, 2015 | September 30, 2014 | |||||||
Fund | Ordinary Income | Ordinary Income | ||||||
Biotech ETF | $ | — | $ | 16,340 | ||||
Environmental Services ETF | 263,000 | 225,000 | ||||||
Gaming ETF | 1,789,800 | 802,900 | ||||||
Pharmaceutical ETF | 6,396,063 | 5,483,238 | ||||||
Retail ETF | 690,116 | 408,291 | ||||||
Semiconductor ETF | 6,554,432 | 4,956,298 |
At September 30, 2015, the Funds had capital loss carryforwards available to offset future capital gains, as follows:
Post-Effective– No Expiration Short-Term | Post-Effective– No Expiration Long-Term | Amount Expiring in the Year Ended September 30, |
||||||||||||||||||
Fund | Capital Losses | Capital Losses | 2018 | 2017 | 2016 | |||||||||||||||
Biotech ETF | $1,053,288 | $3,548,781 | $ | — | $ | — | $ | — | ||||||||||||
Environmental Services ETF | 534,238 | 5,581,983 | 479,375 | 6,445,705 | 2,110,133 | |||||||||||||||
Gaming ETF | 2,252,454 | 88,498 | — | — | — | |||||||||||||||
Retail ETF | 963,801 | 55,542 | — | — | — | |||||||||||||||
Semiconductor ETF | 663,985 | 383,520 | — | — | — |
During the year ended September 30, 2015, as a result of permanent book to tax differences, primarily due to foreign currency gains and losses, net operating losses, deemed distribution on shareholder redemptions and tax treatment of in-kind redemptions, the Funds’ incurred differences that affected undistributed (accumulated) net investment income (loss), accumulated net realized gain (loss) on investments and aggregate paid in capital by the amounts in the table below. Net assets were not affected by these reclassifications.
Fund | Increase (Decrease) in Accumulated Net Investment Income (Loss) | Increase (Decrease) in Accumulated Net Realized Gain (Loss) | Increase (Decrease) in Aggregate Paid in Capital | |||||||||
Biotech ETF | $ | — | $ | (186,132,147 | ) | $ | 186,132,147 | |||||
Environmental Services ETF | (848 | ) | (1,160,079 | ) | 1,160,927 | |||||||
Gaming ETF | (53,103 | ) | (952,133 | ) | 1,005,236 | |||||||
Pharmaceutical ETF | — | (70,586,983 | ) | 70,586,983 | ||||||||
Retail ETF | 66 | (25,311,345 | ) | 25,311,279 | ||||||||
Semiconductor ETF | (856,319 | ) | 40,766,690 | (39,910,371 | ) |
The Funds recognize the tax benefits of uncertain tax positions only where the position is “more-likely-than-not” to be sustained assuming examination by applicable tax authorities. Management has analyzed the Funds’ tax positions, and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on return filings for all open tax years. The Funds do not have exposure for additional years that might still be open in certain foreign jurisdictions. Therefore, no provision for income tax is required in the Funds’ financial statements. However, the Funds are subject to foreign taxes on the appreciation in value of certain investments. The Funds provide for such taxes on both realized and unrealized appreciation.
The Funds recognize interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statements of Operations. During the year ended September 30, 2015, the Funds did not incur any interest or penalties.
Note 6—Capital Share Transactions—As of September 30, 2015, there were an unlimited number of capital shares of beneficial interest authorized by the Trust with no par value. Shares are issued and redeemed by the Funds only in Creation Units, consisting of 50,000 shares, or multiples thereof. The consideration for the purchase or redemption of Creation Units of the Funds generally consists of the in-kind contribution or distribution of securities constituting the Funds’ underlying index plus a small amount of cash. For the year ended September 30, 2015, the Trust had in-kind contributions and redemptions as follows:
42 |
Fund | In-Kind Contributions | In-Kind Redemptions | ||||||
Biotech ETF | $ | 456,375,825 | $ | 555,745,243 | ||||
Environmental Services ETF | 1,740,113 | 3,540,054 | ||||||
Gaming ETF | 5,272,791 | 11,486,733 | ||||||
Pharmaceutical ETF | 259,587,570 | 401,035,688 | ||||||
Retail ETF | 317,554,573 | 214,395,928 | ||||||
Semiconductor ETF | 7,511,031,798 | 7,691,722,323 |
The in-kind contributions and in-kind redemptions in this table represent the accumulation of each Fund’s daily net shareholder transactions including rebalancing activity, while the Statements of Changes in Net Assets reflect shareholder transactions including any cash component of the transactions.
Note 7—Concentration of Risk—The investment objective of each Fund is to seek investment results that correspond generally to the price and yield performance, before fees and expenses, of its underlying index, as indicated in the name of each Fund. The Adviser uses a “passive” or index approach to achieve each Fund’s investment objective by investing in a portfolio of securities that generally replicates the Fund’s index. Each of the Funds is classified as a non-diversified fund under the 1940 Act. Non-diversified funds generally hold securities of fewer issuers than diversified funds and may be more susceptible to the risks associated with these particular issuers, or to a single economic, political or regulatory occurrence affecting these issuers. The Funds may purchase securities on foreign exchanges. Securities of foreign issuers involve special risks and considerations not typically associated with investing in U.S. issuers. These risks include devaluation of currencies, currency controls, less reliable information about issuers, different securities transaction clearance and settlement practices, future adverse political and economic developments and local/regional conflicts. These risks are heightened for investments in emerging market countries. Moreover, securities of many foreign issuers and their markets may be less liquid and their prices more volatile than those of comparable U.S. issuers.
Note 8—Trustee Deferred Compensation Plan—The Trust has a Deferred Compensation Plan (the “Plan”) for Trustees under which the Trustees can elect to defer receipt of their trustee fees until retirement, disability or termination from the Board of Trustees. The fees otherwise payable to the participating Trustees are deemed invested in shares of the Funds as directed by the Trustees.
The expense for the Plan is included in “Trustees’ fees and expenses” in the Statements of Operations. The liability for the Plan is shown as “Deferred Trustee fees” in the Statements of Assets and Liabilities.
Note 9—Securities Lending—To generate additional income, each of the Funds may lend its securities pursuant to a securities lending agreement with The Bank of New York Mellon, the securities lending agent and also the Funds’ custodian. Each Fund may lend up to 33% of its investments requiring that the loan be continuously collateralized by cash, U.S. government or U.S. government agency securities, shares of an investment trust or mutual fund, or any combination of cash and such securities at all times equal to at least 102% (105% for foreign securities) of the market value plus accrued interest on the securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled on the next business day. During the term of the loan, the Funds will continue to receive any dividends, interest or amounts equivalent thereto, on the securities loaned while receiving a fee from the borrower and/or earning interest on the investment of the cash collateral. Such fees and interest are shared with the securities lending agent under the terms of the securities lending agreement. The Funds may pay reasonable finders’, administrative and custodial fees in connection with a loan of its securities. Securities lending income is disclosed as such in the Statements of Operations. The collateral for securities loaned is recognized in the Schedules of Investments and the Statements of Assets and Liabilities. The cash collateral is maintained on the Funds’ behalf by the lending agent and is invested in repurchase agreements collateralized by obligations of the U.S. Treasury and/or Government Agencies. Loans are subject to termination at the option of the borrower or the Funds. Upon termination of the loan, the borrower will return to the lender securities identical to the securities loaned. The Funds bear the risk of delay in recovery of, or even loss of rights in, the securities loaned should the borrower of the securities fail financially. The value of loaned securities and related collateral outstanding at September 30, 2015 are presented on a gross basis in the Schedules of Investments and Statements of Assets and Liabilities.
43 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
Note 10—Share Split—On January 27, 2012, the Board of Trustees of the Market Vectors ETF Trust approved a split of the shares for Biotech ETF, Pharmaceutical ETF, and Retail ETF. The share splits took place for shareholders of record as of the close of business on February 10, 2012, and were paid on February 13, 2012. Each Fund’s shares began trading on a split-adjusted basis on February 14, 2012. Biotech ETF and Retail ETF split its shares three-for-one. Pharmaceutical ETF split its shares two-for-one.
Note 11—Bank Line of Credit—The Funds may participate in a $200 million committed credit facility (the “Facility”) to be utilized for temporary financing until the settlement of sales or purchases of portfolio securities, the repurchase or redemption of shares of the Funds at the request of the shareholders and other temporary or emergency purposes. The Funds have agreed to pay commitment fees, pro rata, based on the unused but available balance. Interest is charged to the Funds at rates based on prevailing market rates in effect at the time of borrowings. During the year ended September 30, 2015, the following Funds borrowed under this Facility:
Fund | Days Outstanding | Average Daily Loan Balance | Average Interest Rate | Outstanding Loan Balance as of September 30, 2015 | ||||||||||||
Biotech ETF | 160 | $ | 1,557,165 | 1.52 | % | $ | 754,759 | |||||||||
Environmental Services ETF | 12 | 372,374 | 1.51 | — | ||||||||||||
Gaming ETF | 127 | 157,111 | 1.52 | 118,050 | ||||||||||||
Pharmaceutical ETF | 326 | 1,387,089 | 1.52 | 666,793 | ||||||||||||
Retail ETF | 193 | 365,350 | 1.52 | 108,233 | ||||||||||||
Semiconductor ETF | 213 | 841,199 | 1.52 | — |
Note 12—Custodian Fees—The Funds have entered into an expense offset agreement with the custodian wherein they receive a credit toward the reduction of custodian fees whenever there are uninvested cash balances. The Funds could have invested their cash balances elsewhere if they had not agreed to a reduction in fees under the expense offset agreement with the custodian. For the year ended September 30, 2015, there were no offsets to custodian fees.
Note 13—Subsequent Events—The Funds have evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued.
The following dividend from net investment income was declared and paid subsequent to September 30, 2015:
Fund | Ex-Date | Record Date | Payable Date | Per Share | ||||||||
Pharmaceutical ETF | 10/1/15 | 10/5/15 | 10/7/15 | $ | 0.284 |
44 |
MARKET VECTORS ETF TRUST
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Trustees and Shareholders of Market Vectors ETF Trust
We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Biotech ETF, Environmental Services ETF, Gaming ETF, Pharmaceutical ETF, Retail ETF and Semiconductor ETF (six of the series constituting Market Vectors ETF Trust) (the “Funds”) as of September 30, 2015, and the related statements of operations, the statements of changes in net assets and the financial highlights for the periods indicated therein. These financial statements and financial highlights are the responsibility of the Funds’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. We were not engaged to perform an audit of the Funds’ internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and financial highlights, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2015, by correspondence with the custodian and brokers or by other appropriate auditing procedures where replies from brokers were not received. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of Biotech ETF, Environmental Services ETF, Gaming ETF, Pharmaceutical ETF, Retail ETF and Semiconductor ETF (six of the series constituting Market Vectors ETF Trust) at September 30, 2015, the results of their operations, the changes in their net assets and the financial highlights for the periods indicated therein, in conformity with U.S. generally accepted accounting principles.
New York, New York
November 24, 2015
45 |
MARKET VECTORS ETF TRUST
(unaudited)
The information set forth below is for each Fund’s fiscal year as required by federal laws. Shareholders, however, must report dividends on a calendar year basis for income tax purposes, which may include dividends for portions of two fiscal years of a Fund.
Accordingly, the information needed by shareholders for calendar year 2015 income tax purposes will be sent to them in early 2016. Please consult your tax advisor for proper treatment of this information.
The Fund listed below intends to pass through foreign tax credits in the maximum amounts shown. The gross foreign source income earned during the period ended September 30, 2015 by the Fund was as shown below.
Fund | Foreign Tax Credits | Gross Foreign Source Income | ||||||
Gaming ETF | $ | 25,179 | $ | 949,196 |
Corporate Dividends Received Deduction
The Funds listed below had the following percentage of ordinary income dividends paid that qualified for the Corporate Received Deduction for fiscal-year 2015.
Environmental Services ETF | 81.19 | % | ||
Gaming ETF | 13.16 | % | ||
Pharmaceutical ETF | 66.93 | % | ||
Retail ETF | 100.00 | % | ||
Semiconductor ETF | 77.26 | % |
46 |
MARKET VECTORS ETF TRUST
BOARD OF TRUSTEES AND OFFICERS
September 30, 2015 (unaudited)
Name, Address1 and Year of Birth |
Position(s) Held with the Trust |
Term of Office2 and Length of Time Served |
Principal Occupation(s) During Past Five Years |
Number of Portfolios in Fund Complex3 Overseen |
Other Directorships Held By Trustee During Past Five Years | |||||
Independent Trustees: | ||||||||||
David H. Chow, 1957*† |
Chairman Trustee | Since 2008 Since 2006 |
Founder and CEO, DanCourt Management LLC (financial/strategy consulting firm and Registered Investment Adviser), March 1999 to present. | 58 | Director, Forward Management LLC and Audit Committee Chairman, January 2008 to present; Trustee, Berea College of Kentucky and Vice Chairman of the Investment Committee, May 2009 to present; Member of the Governing Council of the Independent Directors Council, October 2012 to present; President, July 2013 to present; Secretary and Board Member of the CFA Society of Stamford, July 2009 to present; Advisory Board member, MainStay Fund Complex4, June 2015 to present. | |||||
R. Alastair Short, 1953*† |
Trustee | Since 2006 | President, Apex Capital Corporation (personal investment vehicle), January 1988 to present; Vice Chairman, W.P. Stewart & Co., Inc. (asset management firm), September 2007 to September 2008; and Managing Director, The GlenRock Group, LLC (private equity investment firm), May 2004 to September 2007. | 69 | Chairman and Independent Director, EULAV Asset Management, January 2011 to present; Independent Director, Tremont offshore funds, June 2009 to present; Director, Kenyon Review. | |||||
Peter J. Sidebottom, 1962*† |
Trustee | Since 2012 | Partner, PWC/Strategy & Financial Services Advisory, February 2015 to present; Founder and Board Member, AspenWoods Risk Solutions, September 2013 to present; Independent consultant, June 2013 to February 2015; Partner, Bain & Company (management consulting firm), April 2012 to December 2013; Executive Vice President and Senior Operating Committee Member, TD Ameritrade (on-line brokerage firm), February 2009 to January 2012. | 58 | Board Member, Special Olympics, New Jersey, November 2011 to September 2013; Director, The Charlotte Research Institute, December 2000 to present; Board Member, Social Capital Institute, University of North Carolina Charlotte, November 2004 to January 2012; Board Member, NJ-CAN, July 2014 to present. | |||||
Richard D. Stamberger, 1959*† | Trustee | Since 2006 | Director, President and CEO, SmartBrief, Inc. (media company). | 69 | Director, Food and Friends, Inc., 2013 to present. | |||||
Interested Trustee: | ||||||||||
Jan F. van Eck, 19635 | Trustee, President and Chief Executive Officer | Trustee (Since 2006); President and Chief Executive Officer (Since 2009) |
Director, President and Owner of the Adviser, Van Eck Associates Corporation; Director and President, Van Eck Securities Corporation (“VESC”); Director and President, Van Eck Absolute Return Advisers Corp. (“VEARA”). | 58 | Director, National Committee on US-China Relations. |
1 | The address for each Trustee and officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Each Trustee serves until resignation, death, retirement or removal. Officers are elected yearly by the Trustees. |
3 | The Fund Complex consists of the Van Eck Funds, Van Eck VIP Trust and the Trust. |
4 | The MainStay Fund Complex consists of MainStay Funds Trust, MainStay Funds, MainStay VP Funds Trust, Private Advisors Alternative Strategies Master Fund, Private Advisors Alternative Strategies Fund and MainStay DefinedTerm Municipal Opportunities Fund. |
5 | “Interested person” of the Trust within the meaning of the 1940 Act. Mr. van Eck is an officer of the Adviser. |
* | Member of the Audit Committee. |
† | Member of the Nominating and Corporate Governance Committee. |
47 |
MARKET VECTORS ETF TRUST
BOARD OF TRUSTEES AND OFFICERS
September 30, 2015 (unaudited) (continued)
Officer’s Name, Address1 and Year of Birth |
Position(s) Held with the Trust |
Term of Office2 and Length of Time Served |
Principal Occupation(s) During The Past Five Years | |||
Officers: | ||||||
Russell G. Brennan, 1964 |
Assistant Vice President and Assistant Treasurer | Since 2008 | Assistant Vice President and Assistant Treasurer of the Adviser (since 2008); Manager (Portfolio Administration) of the Adviser, September 2005 to October 2008; Officer of other investment companies advised by the Adviser. | |||
Charles T. Cameron, 1960 |
Vice President | Since 2006 | Director of Trading (since 1995) and Portfolio Manager (since 1997) for the Adviser; Officer of other investment companies advised by the Adviser. | |||
Simon Chen, 1971 |
Assistant Vice President | Since 2012 | Greater China Director of the Adviser (Since January 2012); General Manager, SinoMarkets Ltd. (June 2007 to December 2011). | |||
John J. Crimmins, 1957 |
Vice President, Treasurer, Chief Financial Officer and Principal Accounting Officer | Vice President, Chief Financial Officer and Principal Accounting Officer (Since 2012); Treasurer (Since 2009) | Vice President of Portfolio Administration of the Adviser, June 2009 to present; Vice President of VESC and VEARA, June 2009 to present; Chief Financial, Operating and Compliance Officer, Kern Capital Management LLC, September 1997 to February 2009; Officer of other investment companies advised by the Adviser. | |||
Eduardo Escario, 1975 |
Vice President | Since 2012 | Regional Director, Business Development/Sales for Southern Europe and South America of the Adviser (since July 2008); Regional Director (Spain, Portugal, South America and Africa) of Dow Jones Indexes and STOXX Ltd. (May 2001 – July 2008). | |||
Lars Hamich, 1968 |
Vice President | Since 2012 | Managing Director and Chief Executive Officer of Van Eck Global (Europe) GmbH (since 2009); Chief Executive Officer of Market Vectors Index Solutions GmbH (“MVIS”) (since June 2011); Managing Director of STOXX Limited (until 2008). | |||
Wu-Kwan Kit, 1981 |
Assistant Vice President and Assistant Secretary | Since 2011 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2011); Associate, Schulte Roth & Zabel (September 2007 – 2011); University of Pennsylvania Law School (August 2004 – May 2007). | |||
Susan C. Lashley, 1955 |
Vice President | Since 2006 | Vice President of the Adviser and VESC; Officer of other investment companies advised by the Adviser. | |||
Laura I. Martínez, 1980 |
Assistant Vice President and Assistant Secretary | Since 2008 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2008); Associate, Davis Polk & Wardwell (October 2005 – June 2008); Officer of other investment companies advised by the Adviser. | |||
Ferat Oeztuerk, 1983 |
Assistant Vice President | Since 2012 | Sales Associate, Van Eck Global (Europe) GmbH (since November 2011); Account Manager, Vodafone Global Enterprise Limited (January 2011 to October 2011). | |||
James Parker, 1969 |
Assistant Treasurer | Since June 2014 | Manager (Portfolio Administration) of the Adviser (Since June 2010); Vice President of JPMorgan Chase & Co. (April 1999 to January 2010). | |||
Jonathan R. Simon, 1974 |
Vice President, Secretary and Chief Legal Officer | Vice President (Since 2006) and Secretary and Chief Legal Officer (Since 2014) | Vice President (since 2006), General Counsel and Secretary (since 2014) of the Adviser, VESC and VEARA; Officer of other investment companies advised by the Adviser. | |||
Bruce J. Smith, 1955 |
Senior Vice President | Since 2006 | Senior Vice President, Chief Financial Officer, Treasurer and Controller of the Adviser, VESC and VEARA (since 1997); Director of the Adviser, VESC and VEARA (since October 2010); Officer of other investment companies advised by the Adviser. | |||
Janet Squitieri, 1961 |
Chief Compliance Officer | Since September 2013 | Vice President, Global Head of Compliance of the Adviser, VESC and VEARA (since September 2013); Chief Compliance Officer and Senior Vice President North America of HSBC Global Asset Management NA (August 2010 – September 2013); Chief Compliance Officer North America of Babcock & Brown LP (July 2008 – June 2010). |
1 | The address for each Officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Officers are elected yearly by the Trustees. |
48 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited)
At a meeting held on December 4, 2014 (the “December Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), considered and approved an investment management agreement between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “December Investment Management Agreement”) with respect to the Market Vectors Morningstar International Wide Moat ETF (the “New December Fund”). In addition, at a meeting held on March 2, 2015 (the “March Meeting”), the Board, including all of the Independent Trustees, considered and approved investment management agreements (the “March Investment Management Agreement”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Market Vectors Australia Equal Weight ETF, Market Vectors Australia Hedged Equal Weight ETF, Market Vectors Brazil Equal Weight ETF, Market Vectors China Equal Weight ETF, Market Vectors Europe Equal Weight ETF, Market Vectors Europe Hedged Equal Weight ETF, Market Vectors Germany Equal Weight ETF, Market Vectors Global Spin-Off ETF, Market Vectors Hong Kong Equal Weight ETF, Market Vectors India Equal Weight ETF, Market Vectors Italy Equal Weight ETF, Market Vectors Japan Equal Weight ETF, Market Vectors Japan Hedged Equal Weight ETF, Market Vectors Mexico Equal Weight ETF, Market Vectors Russia Equal Weight ETF, Market Vectors South Africa Equal Weight ETF, Market Vectors South Korea Equal Weight ETF, Market Vectors Spain Equal Weight ETF, Market Vectors Taiwan Equal Weight ETF and Market Vectors United Kingdom Equal Weight ETF (the “New March Funds”). In addition, at a meeting held on September 3, 2015 (the “September Meeting”), the Board, including all of the Independent Trustees, considered and approved an investment management agreement (the “September Investment Management Agreement”) with respect to the Market Vectors Generic Drugs ETF (and collectively, with the New December Fund and the New March Funds, the “Funds”). The December Investment Management Agreement, the March Investment Management Agreement and the September Investment Management Agreement are collectively referred to as the “Investment Management Agreements.”
The Board’s approval of each Investment Management Agreement was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In advance of the relevant meeting, the Trustees received materials from the Adviser, including expense information for other funds. The Adviser provided the Trustees with information regarding, among other things, the various aspects of each Fund’s proposed investment program, fee arrangements and service provider arrangements. The Independent Trustees’ consideration of each Investment Management Agreement was based, in part, on information obtained through discussions with the Adviser at the December Meeting, March Meeting and September Meeting (as applicable) regarding the management of the Funds, information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others proposed to be involved in the management and administration of the Funds. The Trustees also considered the terms and scope of services that the Adviser would provide under each Investment Management Agreement, including the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of at least one year following the effective date of each Fund’s respective registration statement.
The Trustees considered the benefits, other than the fees under the Investment Management Agreements, that the Adviser would receive from serving as adviser to each Fund, including any benefits it may receive from serving as administrator to each Fund and from an affiliate of the Adviser serving as distributor to each Fund. The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability of each of the Funds to the Adviser because the Funds had not yet commenced operations. In addition, because the Funds had not yet commenced operations, the Trustees could not consider the historical performance or the quality of services previously provided to each of the Funds by the Adviser, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the December Meeting, the March Meeting and September Meeting (as applicable) as part of their consideration of the Investment Management Agreements.
49 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited) (continued)
In voting to approve the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of the Investment Management Agreements are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
* * *
At a meeting held on June 9, 2015 (the “Renewal Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), approved the continuation of the investment management agreements between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “Investment Management Agreements”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Biotech ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Environmental Services ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Gaming ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Morningstar Wide Moat ETF, MSCI International Quality Dividend ETF, MSCI International Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI Emerging Markets Quality ETF, Pharmaceutical ETF, Retail ETF, Russia Equal Weight ETF, Semiconductor ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF (collectively, the “Funds”).
The Board’s approval of the Investment Management Agreements was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In preparation for the Renewal Meeting, the Trustees held a meeting on May 15, 2015. At that meeting, the Trustees discussed the information the Adviser and Lipper Inc. (“Lipper”), an independent third party data provider, had provided to them in advance. The information provided to the Trustees included, among other things, information about the performance (for those Funds which had begun operations) and expenses of the Funds and the Funds’ peer funds (other index-based exchange-traded funds (“ETFs”)), information about the advisory services provided to the Funds and the personnel providing those services, and the profitability and other benefits enjoyed by the Adviser and its affiliates as a result of the Adviser’s relationship with the Funds. In reviewing performance information for the Funds against their peer groups, the Trustees considered that each Fund generally invests in a different group of issuers than the funds in its designated peer group. In addition, the Trustees reviewed certain performance information for each Fund that was not provided by Lipper. For these and other reasons, the Trustees noted that the peer group information did not necessarily provide meaningful direct comparisons to the Funds.
The Independent Trustees’ consideration of the Investment Management Agreements was based, in part, on their review of information obtained through discussions with the Adviser at the Renewal Meeting and the May 15, 2015 meeting regarding the management of the Funds and information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others involved in the management and administration of the Funds. The Trustees also considered the terms of, and scope of services that the Adviser provides under, the Investment Management Agreements, including, where applicable, the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of time.
The Trustees concluded that the Adviser has the requisite expertise and skill to manage the Funds’ portfolios. In evaluating the performance over relevant periods of each of the Funds that had commenced operations prior to the date of the Renewal Meeting (the “Operating Funds”), the Trustees reviewed various performance metrics but relied principally on a comparison of the “gross” performance of each Operating Fund (i.e., measured without regard to the impact of fees and expenses) to the performance of its benchmark index, in each case incorporating any fair value adjustments to the underlying securities. Based on the foregoing, the Trustees concluded that the investment performance of the Operating Funds was satisfactory.
50 |
The Trustees also considered information relating to the financial condition of the Adviser and the current status, as they understood it, of the Adviser’s compliance environment.
As noted above, the Trustees were also provided various data from Lipper comparing the Operating Funds’ expenses and performance to that of other ETFs. The Trustees noted that the information provided showed that each Operating Fund had a total expense ratio (after the effect of any applicable expense limitation) below or equal to the average and/or median of its respective peer group of funds, except for each of Market Vectors Gaming ETF and Morningstar Wide Moat ETF, which had a total expense ratio (after the effect of any applicable expense limitation) greater than the average and median of its peer group of funds. With respect to these Operating Funds, the Trustees reviewed the amount by which these Operating Funds’ total expense ratios (after the effect of any applicable expense limitation) exceeded the average and median of their respective peer groups. The Trustees concluded, in light of this information and the other information available to them, that the fees paid by the Operating Funds were reasonable in light of the performance of the Operating Funds and the quality of services received.
The Trustees also considered the benefits, other than fees under the Investment Management Agreements, received by the Adviser from serving as adviser to the Funds, including any benefits it may receive from serving as administrator to the Funds and from an affiliate of the Adviser serving as distributor for the Funds.
The Trustees also considered information provided by the Adviser about the overall profitability of the Adviser and its profitability or loss in respect of each Operating Fund. The Trustees reviewed each Fund’s asset size, expense ratio and expense cap and noted that the Investment Management Agreements do not include breakpoints in the advisory fee rates as asset levels in a Fund increase. The Trustees considered the potential variability in net assets of these Funds and the sustainability of any potential economies of scale which may exist. The Trustees also evaluated the extent to which management fees for the Operating Funds effectively incorporate the benefits of economies of scale. The Trustees noted that the Adviser has capped expenses on each Operating Fund since its inception. Based on the foregoing and the other information available to them, the Trustees determined that the advisory fee rate for each Fund is reasonable and appropriate in relation to the current asset size of each Fund and the other factors discussed above and currently reflects an appropriate sharing of any economies of scale which may exist with shareholders. The Trustees also determined that the profits earned by the Adviser in respect of the Funds that were profitable to the Adviser were reasonable in light of the nature and quality of the services received by such Funds.
The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability to the Adviser of Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Russia Equal Weight ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF to the Adviser because the Funds had not yet commenced operations at the time of the Renewal Meeting. The Trustees also could not consider the historical performance or the quality of services previously provided to each of these Funds, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the Renewal Meeting and at their May 15, 2015 meeting as part of their consideration of the Investment Management Agreements.
In voting to approve the continuation of the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of each Investment Management Agreement are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
51 |
This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by a Market Vectors ETF Trust (the “Trust”) Prospectus and Summary Prospectus, which includes more complete information. An investor should consider the investment objective, risks, and charges and expenses of the Funds carefully before investing. The prospectus and summary prospectus contains this and other information about the investment company. Please read the prospectus and summary prospectus carefully before investing.
Additional information about the Trust’s Board of Trustees/Officers and a description of the policies and procedures the Trust uses to determine how to vote proxies relating to portfolio securities are provided in the Statement of Additional Information. The Statement of Additional Information and information regarding how the Trust voted proxies relating to portfolio securities during the most recent twelve month period ending June 30 is available, without charge, by calling 1.800.826.2333, or by visiting www.vaneck.com, or on the Securities and Exchange Commission’s website at http://www.sec.gov.
The Trust files its complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarters of each fiscal year on Form N-Q. The Trust’s Form N-Qs are available on the Commission’s website at http://www.sec.gov and may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1.202.942.8090. The Funds’ complete schedules of portfolio holdings are also available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Investment Adviser: Van Eck Associates Corporation
Distributor: Van Eck Securities Corporation 666 Third Avenue New York, NY 10017 vaneck.com
Account Assistance: 1.800.826.2333 www.vaneck.com |
MVINDUSAR
ANNUAL REPORT S E P T E M B E R 3 0 , 2 0 1 5 |
MARKET VECTORS®
STRATEGIC EQUITY ETFs
Global Spin-Off ETF | SPUN |
Morningstar International Moat ETF | MOTI |
Morningstar Wide Moat ETF | MOAT® |
800.826.2333
vaneck.com
The information contained in the management discussion represents the opinions of Market Vectors ETF Trust and may differ from other persons. This information is not intended to be a forecast of future events, a guarantee of future results or investment advice. The information contained herein regarding each index has been provided by the relevant index provider. Also, unless otherwise specifically noted, any discussion of the Funds’ holdings and the Funds’ performance, and the views of Market Vectors ETF Trust are as of September 30, 2015, and are subject to change.
MARKET VECTORS STRATEGIC EQUITY ETFs
(unaudited)
In the last six months, two additional ETFs have joined Market Vectors Morningstar Wide Moat ETF (NYSE Arca: MOAT), as such, we are pleased to present this report for the three Strategic Equity exchange-traded funds (ETFs) of the Market Vectors ETF Trust for the 12-month period ended September 30, 2015.
Sustainable Competitive Advantages
As I mentioned in my last letter, MOAT seeks to track companies Morningstar believes possess sustainable competitive advantages and exhibit attractive valuations. We continue to believe that investors looking to make long-term allocations to broad asset classes, such as U.S. equity or international markets, may find that this strategic approach offers an attractive way to enhance exposure to core asset classes.
In the context of a long-term allocation to the U.S. equity market, the Morningstar® Wide Moat Focus IndexSM 1 the index MOAT seeks to replicate—continues to feature an impressive batting average measured against the S&P 500® Index,2 particularly over long-term holding periods. As of September 30, illustrating the success of Morningstar’s process of identifying attractively priced companies with sustainable competitive advantages, the Wide Moat Focus Index had outperformed the S&P 500 Index 62% of the time if held for a year.
Batting Average Shows the Percent of Time
Morningstar Wide Moat Focus Index
Outperformed the S&P 500 Index
Monthly Frequency: 3/2007 – 9/2015
Total Periods | 103 | 98 | 92 | 68 | 44 | ||
Total Outperformed | 50 | 57 | 57 | 59 | 40 | ||
Batting Average | 49% | 58% | 62% | 87% | 91% |
Source: Morningstar, FactSet. Batting Average is measured by dividing the number of periods a portfolio or investment strategy outperforms a benchmark by the total number of periods.
Not intended to be a forecast of future events, a guarantee of future results or investment advice. Current market conditions may not continue. Past performance is no guarantee of future results; current performance may be lower or higher than the performance data quoted. Index performance is not illustrative of fund performance. Investors cannot invest directly in an Index.
International Companies with a Competitive Advantage and an Established Event Driven Strategy
Building on the success of Morningstar’s process of identifying attractively priced companies in the U.S. with sustainable competitive advantages, we decided to create a fund that would, instead, focus on such companies elsewhere around the world.
Launched on July 13, Market Vectors Morningstar International Moat ETF (NYSE Arca: MOTI) joins MOAT in providing exposure to Morningstar’s research on companies with sustainable competitive advantages: “moats”. However, rather than focusing solely on the U.S., the Morningstar® Global ex-US Moat Focus Index,SM 3 which MOTI seeks to replicate, targets a select group of companies in developed and emerging markets outside the United States that Morningstar equity analysts believe have long-term sustainable competitive advantages and are attractively priced at each quarterly rebalance. The index contains 50 stocks weighted equally each quarter.
1 |
MARKET VECTORS STRATEGIC EQUITY ETFs
(unaudited)
Launched on June 9, just over a month before MOTI, Market Vector Global Spin-Off ETF (NYSE Arca: SPUN) offers global exposure to companies spun off from their parents. Employing an established event-driven strategy, SPUN seeks to benefit from the long-term potential of corporate spin-offs to unlock shareholder value.
Spin-offs are generally the result of large companies divesting smaller subsidiaries in a way that may not trigger traditional Wall Street analyst coverage. Historically, this has resulted in short-term valuation disconnects.
The index that SPUN seeks to replicate is the Horizon Kinetics Global Spin-Off Index.4 It is distinguished from others in the market both by its global developed markets exposure and its unique eligibility methodology. Unlike other similar indices, spin-offs are eligible to enter the index early in their life cycle and remain in the index for five years following their addition. The index is rebalanced quarterly, at which point constituents are weighted equally.
Please stay in touch with us through our website (www.vaneck.com) on which we offer videos, email subscriptions, blogs and educational literature. Should you have any questions, please contact us at 1.800.826.2333 or visit www.vaneck.com.
Thank you for participating in the Market Vectors ETF Trust. On the following pages, you will find the performance record of each of the funds for the 12-month period ending September 30, 2015. You will also find their financial statements. We value your continuing confidence in us and look forward to helping you meet your investment goals in the future.
Jan F. van Eck
Trustee and President
Market Vectors ETF Trust
October 22, 2015
Represents the opinions of the investment adviser. Past performance is no guarantee of future results. Not intended to be a forecast of future events, a guarantee of future results or investment advice. Current market conditions may not continue.
All indices are unmanaged and include the reinvestment of all dividends, but do not reflect the payment of transaction costs, advisory fees or expenses that are associated with an investment in a fund. An index’s performance is not illustrative of a fund’s performance. Indices are not securities in which investments can be made. Results reflect past performance and do not guarantee future results.
1 | Morningstar® Wide Moat Focus IndexSM (MWMFTR) is a rules-based, equal-weighted index that is intended to offer exposure to companies that have sustainable competitive advantages according to Morningstar analysts. |
2 | S&P 500® Index consists of 500 widely held common stocks covering the leading industries in the U.S. economy. |
3 | Morningstar® Global ex-US Moat Focus IndexSM (MGEUMFUN) is a rules-based, equal-weighted index intended to offer exposure to 50 attractively priced companies outside the U.S. with sustainable competitive advantages according to Morningstar’s equity research team. |
4 | Horizon Kinetics Global Spin-Off Index (GSPIN) is a rules-based, equal-weighted index intended to track the performance of listed, publicly held spin-offs that are domiciled and trade in the U.S. or developed markets of Western Europe and Asia. |
2 |
Management Discussion (unaudited)
Among the Market Vectors Strategic Equity ETFs, only Market Vectors Morningstar Wide Moat ETF (MOAT) traded for the 12-month period. Neither Market Vectors Morningstar International Moat ETF (MOTI), nor Market Vectors Global Spin-Off ETF (SPUN) traded for the full period, having been launched on July 13, 2015 and June 9, 2015, respectively.
Morningstar Wide Moat
For the 12-month period, Market Vectors Morningstar Wide Moat ETF returned -9.41%* and underperformed the S&P 500® Index1 by 6.76%. The primary driver of underperformance was the Fund’s concentration in the energy sector. Within the energy sector, the Fund’s separate exposures to the two sub-sectors of energy equipment and services, and oil, gas and consumable fuels detracted approximately equally from Fund performance. Consumer discretionary companies also detracted from the Fund’s performance. Top contributing sectors for the period included consumer staples and health care. Within consumer staples, household products and tobacco companies provided the largest positive contributions to return.
Morningstar International Moat
Market Vectors Morningstar International Moat ETF traded for less than three months and has returned -12.23%. During this period, Australia, Canada, and India were the largest detractors from performance. The financials and materials sectors were the two largest negative contributors to the Fund’s total returns.
Global Spin-Off
Market Vectors Global Spin-Off ETF traded for less than four months and has posted a return of -14.16%. During this period, U.S. companies were, by far, the largest detractors from the Fund’s total returns. The financials and energy sectors were the two largest negative contributors to the Fund’s performance.
* | Returns based on NAV. The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Funds reflects temporary waivers of expenses and/or fees. Had the Funds incurred all expenses, investment returns would have been reduced. Investment return and value of the shares of the Funds will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Current performance may be lower or higher than performance data quoted. |
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. | |
1 | S&P 500® Index consists of 500 widely held common stocks covering the industrial, utility, financial, and transportation sectors. |
3 |
September 30, 2015 (unaudited)
Total Return | Share Price1 | NAV | GSPIN2 | ||||||||
Life* (cumulative) | (13.80 | )% | (14.16 | )% | (14.12)% | ||||||
* since 6/9/15 |
Commencement date for the Market Vectors Global Spin-Off ETF was 6/9/15.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (6/9/15) to the first day of secondary market trading in shares of the Fund (6/10/15), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 6.24% / Net Expense Ratio 0.55%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.55% of the Fund’s average daily net assets per year until at least February 1, 2017. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | Horizon Kinetics Global Spin-Off Index (GSPIN) is a rules-based, equal-weighted index intended to track the performance of listed, publicly-held spin-offs that are domiciled and trade in the U.S. or developed markets of Western Europe and Asia. |
Horizon Kinetics Global Spin-Off Index was created and is maintained by Horizon Kinetics LLC. Horizon Kinetics LLC does not sponsor, endorse, issue, sell, or promote the Market Vectors Global Spin-Off ETF and bears no liability with respect to that ETF or any security.
4 |
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Global Spin-Off ETF (SPUN)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for SPUN is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
June 10, 2015* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 1 | 1.3 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 1 | 1.3 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 2 | 2.5 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 6 | 7.6 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 10 | 12.7 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 20 | 25.2 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 22 | 27.8 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 10 | 12.7 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 3 | 3.8 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 3 | 3.8 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 1 | 1.3 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
79 | 100.0 | % |
* | First Day of secondary market trading. |
5 |
MORNINGSTAR INTERNATIONAL MOAT ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Total Return | Share Price1 | NAV | MGEUMFUN2 | |||||||||
Life* (cumulative) | (12.26 | )% | (12.23 | )% | (12.13 | )% | ||||||
* since 7/13/15 |
Commencement date for the Market Vectors Morningstar International Moat ETF was 7/13/15.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (7/13/15) to the first day of secondary market trading in shares of the Fund (7/14/15), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 2.49% / Net Expense Ratio 0.56%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.56% of the Fund’s average daily net assets per year until at least February 1, 2017. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | Morningstar® Global ex-US Moat Focus IndexSM (MGEUMFUN) is a rules-based, equal-weighted index intended to offer exposure to companies that Morningstar, Inc. determines have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors (“wide and narrow moat companies”). |
The Morningstar® Global ex-US Moat Focus IndexSM was created and is maintained by Morningstar, Inc. Morningstar, Inc. does not sponsor, endorse, issue, sell, or promote the Market Vectors Morningstar International Moat ETF and bears no liability with respect to that ETF or any security. Morningstar® is a registered trademark of Morningstar, Inc. Morningstar® Global ex-US Moat Focus IndexSM is a service mark of Morningstar, Inc.
6 |
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Morningstar International Moat ETF (MOTI)
Closing
Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for MOTI is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
July 14, 2015* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 1 | 1.8 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 3 | 5.4 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 4 | 7.1 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 5 | 8.9 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 21 | 37.4 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 16 | 28.6 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 2 | 3.6 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 3 | 5.4 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 1 | 1.8 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
56 | 100.0 | % |
* | First day of secondary market trading. |
7 |
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Hypothetical Growth of $10,000 (Since Inception) | ||
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark. |
Total Return | Share Price1 | NAV | MWMFTR2 | |||
One Year | (9.62)% | (9.41)% | (8.90)% | |||
Life* (annualized) | 10.84% | 10.88% | 11.39% | |||
Life* (cumulative) | 42.42% | 42.58% | 44.87% | |||
* since 4/24/12 |
Commencement date for the Market Vectors Morningstar Wide Moat ETF was 4/24/12.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (4/24/12) to the first day of secondary market trading in shares of the Fund (4/25/12), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting marketvectorsetfs.com.
Gross Expense Ratio 0.50% / Net Expense Ratio 0.49%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.49% of the Fund’s average daily net assets per year until at least February 1, 2016. During such time, the expense limitation is expected to continue until the Fund’s Board of Trustees acts to discontinue all or a portion of such expense limitation.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
8 |
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | Morningstar® Wide Moat Focus IndexSM (MWMFTR) is a rules-based, equal-weighted index intended to offer exposure to companies that Morningstar, Inc. determines have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors (“wide moat companies”). |
The Morningstar® Wide Moat Focus IndexSM was created and is maintained by Morningstar, Inc. Morningstar, Inc. does not sponsor, endorse, issue, sell, or promote the Market Vectors Morningstar Wide Moat ETF and bears no liability with respect to that ETF or any security. Morningstar® is a registered trademark of Morningstar, Inc. Morningstar® Wide Moat Focus IndexSM is a service mark of Morningstar, Inc.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors Morningstar Wide Moat ETF (MOAT)
Closing Price vs.
NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for MOAT is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
April 25, 2012* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 0 | 0.0 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 2 | 0.2 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 658 | 76.1 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 201 | 23.3 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 3 | 0.4 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
864 | 100.0 | % |
* | First Day of secondary market trading. |
9 |
MARKET VECTORS ETF TRUST
(unaudited)
Hypothetical $1,000 investment at beginning of period
As a shareholder of a Fund, you incur operating expenses, including management fees and other Fund expenses. This disclosure is intended to help you understand the ongoing costs (in dollars) of investing in your Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The disclosure is based on an investment of $1,000 invested at the beginning of the period and held for the entire period, April 1, 2015 to September 30, 2015.
Actual Expenses
The first line in the table below provides information about account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Period.”
Hypothetical Example for Comparison Purposes
The second line in the table below provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as program fees. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
Beginning Account Value April 1, 2015 | Ending Account Value September 30, 2015 | Annualized Expense Ratio During Period | Expenses
Paid During the Period | |||||||||||||
Global Spin-Off ETF# | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 858.40 | 0.55 | % | $ | 1.58 | ||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,013.78 | 0.55 | % | $ | 1.71 | ||||||||
Morningstar International Moat ETF## | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 877.70 | 0.56 | % | $ | 1.14 | ||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,009.61 | 0.56 | % | $ | 1.22 | ||||||||
Morningstar Wide Moat ETF* | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 922.20 | 0.50 | % | $ | 2.41 | ||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.56 | 0.50 | % | $ | 2.54 |
* | Expenses are equal to the Fund’s annualized expense ratio (for the six months ended September 30, 2015) multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half year divided by the number of days in the fiscal year (to reflect the one-half year period). |
# | Expenses are equal to the Fund’s annualized expense ratio (for the period from June 9, 2015 (commencement of operations) to September 30, 2015) multiplied by the average account value over the period, multiplied by the number of days since commencement of operations divided by the number of days in the fiscal year. |
## | Expenses are equal to the Fund’s annualized expense ratio (for the period from July 13, 2015 (commencement of operations) to September 30, 2015) multiplied by the average account value over the period, multiplied by the number of days since commencement of operations divided by the number of days in the fiscal year. |
** | Assumes annual return of 5% before expenses for the six months ended September 30, 2015, or for the period from commencement of operations to September 30, 2015. |
10 |
September 30, 2015
Number | ||||||||
of Shares | Value | |||||||
COMMON STOCKS: 86.3% | ||||||||
Australia: 5.8% | ||||||||
2,929 | DuluxGroup Ltd. # | $ | 11,071 | |||||
10,224 | Echo Entertainment Group Ltd. # | 35,002 | ||||||
21,517 | Orora Ltd. # | 35,134 | ||||||
29,006 | South32 Ltd. * # | 28,051 | ||||||
8,146 | Treasury Wine Estates Ltd. # | 37,765 | ||||||
147,023 | ||||||||
China / Hong Kong: 2.6% | ||||||||
4,500 | Cheung Kong Property Holdings Ltd. # | 32,968 | ||||||
156,000 | Global Brands Group Holding Ltd. * # | 32,294 | ||||||
65,262 | ||||||||
Finland: 2.6% | ||||||||
3,532 | Caverion Corp. # | 35,280 | ||||||
3,279 | Valmet OYJ # | 31,749 | ||||||
67,029 | ||||||||
France: 1.6% | ||||||||
520 | Edenred # | 8,506 | ||||||
571 | Groupe Fnac SA * # | 32,629 | ||||||
41,135 | ||||||||
Germany: 1.4% | ||||||||
674 | OSRAM Licht AG # | 34,883 | ||||||
Ireland: 2.4% | ||||||||
564 | Allegion Plc (USD) | 32,520 | ||||||
617 | Prothena Corp. Plc (USD) * | 27,975 | ||||||
60,495 | ||||||||
Italy: 0.5% | ||||||||
1,150 | World Duty Free SpA * # | 13,138 | ||||||
Luxembourg: 1.1% | ||||||||
1,068 | Aperam SA * # | 28,850 | ||||||
New Zealand: 1.3% | ||||||||
19,113 | Chorus Ltd. * # | 32,726 | ||||||
Norway: 1.1% | ||||||||
7,833 | Aker Solutions ASA # Reg S | 27,055 | ||||||
Singapore: 0.4% | ||||||||
9,800 | Frasers Centrepoint Ltd. # | 10,238 | ||||||
Spain: 1.2% | ||||||||
5,237 | Distribuidora Internacional de Alimentacion SA * # | 31,670 | ||||||
Switzerland: 1.2% | ||||||||
177 | Autoneum Holding AG * # | 32,119 | ||||||
United Kingdom: 3.3% | ||||||||
2,267 | Alent Plc # | 16,685 | ||||||
2,822 | Concentric AB (SEK) # | 32,731 | ||||||
9,828 | Indivior Plc # | 33,801 | ||||||
83,217 | ||||||||
United States: 59.8% | ||||||||
556 | AbbVie, Inc. | 30,252 | ||||||
1,052 | ADT Corp. | 31,455 | ||||||
920 | Alexander & Baldwin, Inc. | 31,584 | ||||||
444 | AMC Networks, Inc. * | 32,487 | ||||||
1,457 | Babcock & Wilcox Enterprises, Inc. * | 24,478 | ||||||
1,681 | Barnes and Noble Education, Inc. * | 21,365 | ||||||
604 | Baxalta, Inc. | 19,032 |
Number | ||||||||
of Shares | Value | |||||||
United States: (continued) | ||||||||
398 | BWX Technologies, Inc. | $ | 10,491 | |||||
49 | Cable One Inc * | 20,552 | ||||||
8,554 | California Resources Corp. | 22,240 | ||||||
655 | CDK Global, Inc. | 31,296 | ||||||
2,448 | Chemours Co. | 15,839 | ||||||
1,017 | Columbia Pipeline Group, Inc. | 18,601 | ||||||
933 | CST Brands, Inc. | 31,405 | ||||||
506 | Energizer Holdings, Inc. | 19,587 | ||||||
1,280 | Engility Holdings, Inc. | 32,998 | ||||||
672 | Enova International, Inc. * | 6,868 | ||||||
690 | Fiesta Restaurant Group, Inc. * | 31,305 | ||||||
703 | Fortune Brands Home & Security, Inc. | 33,371 | ||||||
1,188 | FTD Cos, Inc. * | 35,402 | ||||||
1,600 | Gannett Co., Inc. | 23,568 | ||||||
996 | Halyard Health, Inc. * | 28,326 | ||||||
265 | Howard Hughes Corp. * | 30,406 | ||||||
306 | Huntington Ingalls Industries, Inc. | 32,788 | ||||||
538 | Hyster-Yale Materials Handling, Inc. | 31,113 | ||||||
1,057 | Keysight Technologies, Inc. * | 32,598 | ||||||
867 | KLX, Inc. * | 30,987 | ||||||
1,954 | Knowles Corp. * | 36,012 | ||||||
1,337 | Lands’ End, Inc. * | 36,112 | ||||||
631 | Liberty Broadband Corp. * | 32,459 | ||||||
1,278 | Liberty TripAdvisor Holdings, Inc. * | 28,333 | ||||||
1,265 | Lumentum Holdings, Inc. * | 21,442 | ||||||
398 | Mallinckrodt Plc * | 25,448 | ||||||
716 | Marathon Petroleum Corp. | 33,172 | ||||||
456 | Marriott Vacations Worldwide Corp. | 31,072 | ||||||
620 | Murphy USA, Inc. * | 34,069 | ||||||
2,405 | Navient Corp. | 27,032 | ||||||
2,052 | New Media Investment Group, Inc. | 31,724 | ||||||
2,537 | News Corp. | 32,017 | ||||||
1,950 | NorthStar Asset Management Group, Inc. | 28,002 | ||||||
1,922 | NOW, Inc. * | 28,446 | ||||||
793 | ONE Gas, Inc. | 35,947 | ||||||
638 | PayPal Holdings, Inc. * | 19,803 | ||||||
437 | Phillips 66 | 33,579 | ||||||
568 | Post Holdings, Inc. * | 33,569 | ||||||
700 | QEP Resources, Inc. | 8,771 | ||||||
821 | Rayonier Advanced Materials, Inc. | 5,024 | ||||||
752 | Science Applications International Corp. | 30,238 | ||||||
837 | Starz * | 31,254 | ||||||
1,664 | Time, Inc. | 31,699 | ||||||
2,303 | TimkenSteel Corp. | 23,306 | ||||||
675 | TopBuild Corp. * | 20,905 | ||||||
758 | Vista Outdoor, Inc. * | 33,678 | ||||||
3,811 | WPX Energy, Inc. * | 25,229 | ||||||
948 | Xura, Inc. * | 21,216 | ||||||
1,011 | Xylem, Inc. | 33,211 | ||||||
1,523,163 | ||||||||
Total Common Stocks (Cost: $2,406,546) |
2,198,003 |
See Notes to Financial Statements
11 |
GLOBAL SPIN-OFF ETF
SCHEDULE OF INVESTMENTS
(continued)
Number | ||||||||
of Shares | Value | |||||||
REAL ESTATE INVESTMENT TRUSTS: 13.6% | ||||||||
United States: 12.5% | ||||||||
656 | Care Capital Properties, Inc. | $ | 21,602 | |||||
1,829 | CareTrust REIT, Inc. | 20,759 | ||||||
1,513 | Communications Sales & Leasing, Inc. * | 27,083 | ||||||
1,052 | Gaming and Leisure Properties, Inc. | 31,244 | ||||||
2,279 | New Residential Investment Corp. | 29,855 | ||||||
2,676 | New Senior Investment Group, Inc. | 27,991 | ||||||
2,162 | Rouse Properties, Inc. | 33,684 | ||||||
1,338 | Starwood Waypoint Residential Trust | 31,884 | ||||||
1,586 | Urban Edge Properties | 34,242 | ||||||
2,706 | WP GLIMCHER, Inc. | 31,552 | ||||||
1,716 | Xenia Hotels & Resorts, Inc. | 29,961 | ||||||
319,857 |
Number | ||||||||
of Shares | Value | |||||||
Virgin Islands (US): 1.1% | ||||||||
2,017 | Altisource Residential Corp. | $ | 28,077 | |||||
Total Real Estate Investment Trusts (Cost: $387,235) |
347,934 | |||||||
MONEY MARKET FUND: 1.0% (Cost: $24,494) |
||||||||
24,494 | Dreyfus Government Cash Management Fund | 24,494 | ||||||
Total Investments: 100.9% (Cost: $2,818,275) |
2,570,431 | |||||||
Liabilities in excess of other assets: (0.9)% | (23,558 | ) | ||||||
NET ASSETS: 100.0% | $ | 2,546,873 |
SEK | Swedish Krona |
USD | United States Dollar |
* | Non-income producing |
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $614,345 which represents 24.1% of net assets. |
Reg S | Security was purchased pursuant to Regulation S under the Securities Act of 1933, which exempts from registration securities offered and sold outside of the United States. Such a security cannot be sold in the United States without either an effective registration statement filed pursuant to the Securities Act of 1933, or pursuant to an exemption from registration. |
Summary of Investments | ||||||||
by Sector (unaudited) | % of Investments | Value | ||||||
Consumer Discretionary | 26.6 | % | $ | 684,588 | ||||
Consumer Staples | 4.8 | 122,591 | ||||||
Energy | 6.5 | 168,647 | ||||||
Financials | 20.0 | 515,032 | ||||||
Health Care | 6.4 | 164,834 | ||||||
Industrials | 18.1 | 465,007 | ||||||
Information Technology | 7.5 | 192,605 | ||||||
Materials | 6.4 | 163,960 | ||||||
Telecommunication Services | 1.3 | 32,726 | ||||||
Utilities | 1.4 | 35,947 | ||||||
Money Market Fund | 1.0 | 24,494 | ||||||
100.0 | % | $ | 2,570,431 |
See Notes to Financial Statements
12 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices |
Level 2 Significant Observable Inputs |
Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks | |||||||||||||||||
Australia | $ | — | $ | 147,023 | $ | — | $ | 147,023 | |||||||||
China / Hong Kong | — | 65,262 | — | 65,262 | |||||||||||||
Finland | — | 67,029 | — | 67,029 | |||||||||||||
France | — | 41,135 | — | 41,135 | |||||||||||||
Germany | — | 34,883 | — | 34,883 | |||||||||||||
Ireland | 60,495 | — | — | 60,495 | |||||||||||||
Italy | — | 13,138 | — | 13,138 | |||||||||||||
Luxembourg | — | 28,850 | — | 28,850 | |||||||||||||
New Zealand | — | 32,726 | — | 32,726 | |||||||||||||
Norway | — | 27,055 | — | 27,055 | |||||||||||||
Singapore | — | 10,238 | — | 10,238 | |||||||||||||
Spain | — | 31,670 | — | 31,670 | |||||||||||||
Switzerland | — | 32,119 | — | 32,119 | |||||||||||||
United Kingdom | — | 83,217 | — | 83,217 | |||||||||||||
United States | 1,523,163 | — | — | 1,523,163 | |||||||||||||
Real Estate Investment Trusts* | 347,934 | — | — | 347,934 | |||||||||||||
Money Market Fund | 24,494 | — | — | 24,494 | |||||||||||||
Total | $ | 1,956,086 | $ | 614,345 | $ | — | $ | 2,570,431 |
* See Schedule of Investments for security type and geographic sector breakouts.
There were no transfers between levels during the period ended September 30, 2015.
See Notes to Financial Statements
13 |
MORNINGSTAR INTERNATIONAL MOAT ETF
SCHEDULE OF INVESTMENTS
September 30, 2015
Number | ||||||||
of Shares | Value | |||||||
COMMON STOCKS: 94.1% | ||||||||
Australia: 12.2% | ||||||||
31,710 | Brambles Ltd. # | $ | 217,940 | |||||
4,133 | Commonwealth Bank of Australia # | 212,247 | ||||||
34,693 | IOOF Holdings Ltd. # | 209,468 | ||||||
45,890 | Platinum Asset Management Ltd. # | 219,356 | ||||||
23,682 | QBE Insurance Group Ltd. # | 215,775 | ||||||
417,232 | Sigma Pharmaceuticals Ltd. # | 219,588 | ||||||
1,294,374 | ||||||||
Canada: 14.0% | ||||||||
4,254 | Bank of Montreal | 230,929 | ||||||
3,111 | Canadian Imperial Bank of Commerce | 222,483 | ||||||
15,813 | Comeco Corp. | 191,898 | ||||||
8,695 | Potash Corp. of Saskatchewan, Inc. | 177,895 | ||||||
10,586 | Power Corp. of Canada | 218,479 | ||||||
9,347 | Power Financial Corp. | 213,335 | ||||||
5,660 | Toronto-Dominion Bank | 222,060 | ||||||
1,477,079 | ||||||||
Chile: 4.1% | ||||||||
4,773,871 | Banco Santander | 215,815 | ||||||
184,153 | Empresa Nacional de Electricidad SA | 216,250 | ||||||
432,065 | ||||||||
China / Hong Kong: 16.1% | ||||||||
550,000 | Agricultural Bank of China Ltd. # | 208,887 | ||||||
476,000 | Bank of China Ltd. # | 205,267 | ||||||
68,000 | BOC Hong Kong Holdings Ltd. # | 200,551 | ||||||
314,000 | China Construction Bank Corp. # | 209,542 | ||||||
160,000 | China State Construction International Holdings Ltd. # | 229,606 | ||||||
366,000 | Industrial and Commercial Bank of China Ltd. # | 211,440 | ||||||
17,000 | Sun Hung Kai Properties Ltd # | 221,736 | ||||||
39,000 | Wharf Holdings Ltd. # | 220,054 | ||||||
1,707,083 | ||||||||
France: 9.5% | ||||||||
6,985 | Carrefour SA # | 206,797 | ||||||
16,832 | Credit Agricole SA # | 193,583 | ||||||
11,278 | Edenred # | 184,483 | ||||||
1,351 | Kering # | 220,923 | ||||||
3,538 | Schneider Electric SE # | 197,921 | ||||||
1,003,707 | ||||||||
India: 8.7% | ||||||||
69,612 | Ambuja Cements Ltd. # | 218,714 | ||||||
55,974 | ICICI Bank Ltd. # | 231,334 | ||||||
47,102 | ITC Ltd. # | 236,182 | ||||||
63,915 | State Bank of India # | 231,858 | ||||||
918,088 |
Number | ||||||||
of Shares | Value | |||||||
Luxembourg: 2.0% | ||||||||
3,410 | Millicom International Cellular SA (SEK) # | $ | 212,818 | |||||
Mexico: 1.9% | ||||||||
38,400 | Grupo Televisa SAB | 199,854 | ||||||
Netherlands: 1.9% | ||||||||
8,571 | Koninklijke Philips NV # | 201,441 | ||||||
Singapore: 5.9% | ||||||||
110,200 | CapitaLand Ltd. # | 208,250 | ||||||
34,450 | Oversea-Chinese Banking Corp Ltd. # | 213,496 | ||||||
15,900 | United Overseas Bank Ltd. # | 207,776 | ||||||
629,522 | ||||||||
Spain: 2.0% | ||||||||
24,860 | Banco Bilbao Vizcaya Argentaria SA # | 209,996 | ||||||
Sweden: 2.0% | ||||||||
14,605 | Svenska Handelsbanken AB # | 209,079 | ||||||
Switzerland: 1.8% | ||||||||
3,729 | LafargeHolcim Ltd. # | 194,974 | ||||||
United Kingdom: 12.0% | ||||||||
10,374 | Burberry Group Plc # | 215,323 | ||||||
60,861 | Centrica Plc # | 211,712 | ||||||
27,950 | HSBC Holdings Plc # | 211,126 | ||||||
5,374 | Johnson Matthey Plc # | 199,509 | ||||||
188,352 | Lloyds Banking Group Plc # | 214,715 | ||||||
5,577 | Unilever NV (LDR) # | 223,324 | ||||||
1,275,709 | ||||||||
Total Common Stocks (Cost: $11,095,620) |
9,965,789 | |||||||
REAL ESTATE INVESTMENT TRUSTS: 6.2% | ||||||||
Australia: 2.0% | ||||||||
52,849 | Goodman Group # | 218,561 | ||||||
Singapore: 4.2% | ||||||||
233,500 | CapitaLand Commercial Trust Ltd. # | 220,637 | ||||||
165,100 | CapitaLand Mall Trust # | 220,945 | ||||||
441,582 | ||||||||
Total Real Estate Investment Trusts (Cost: $726,251) |
660,143 | |||||||
Total Investments: 100.3% (Cost: $11,821,871) |
10,625,932 | |||||||
Liabilities in excess of other assets: (0.3)% | (34,540 | ) | ||||||
NET ASSETS: 100.0% | $ | 10,591,392 |
LDR | Local Depositary Receipt |
SEK | Swedish Krona |
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $8,516,934 which represents 80.4% of net assets. |
See Notes to Financial Statements
14 |
Summary of Investments | ||||||||
by Sector (unaudited) | % of Investments | Value | ||||||
Consumer Discretionary | 6.0 | % | $ | 636,100 | ||||
Consumer Staples | 6.3 | 666,303 | ||||||
Energy | 1.8 | 191,898 | ||||||
Financials | 60.7 | 6,448,780 | ||||||
Health Care | 2.1 | 219,588 | ||||||
Industrials | 9.7 | 1,031,391 | ||||||
Materials | 7.4 | 791,092 | ||||||
Telecommunication Services | 2.0 | 212,818 | ||||||
Utilities | 4.0 | 427,962 | ||||||
100.0 | % | $ | 10,625,932 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices | Level 2 Significant Observable Inputs |
Level 3 Significant Unobservable Inputs | Value | ||||||||||||||
Common Stocks | |||||||||||||||||
Australia | $ | — | $ | 1,294,374 | $ | — | $ | 1,294,374 | |||||||||
Canada | 1,477,079 | — | — | 1,477,079 | |||||||||||||
Chile | 432,065 | — | — | 432,065 | |||||||||||||
China / Hong Kong | — | 1,707,083 | — | 1,707,083 | |||||||||||||
France | — | 1,003,707 | — | 1,003,707 | |||||||||||||
India | — | 918,088 | — | 918,088 | |||||||||||||
Luxembourg | — | 212,818 | — | 212,818 | |||||||||||||
Mexico | 199,854 | — | — | 199,854 | |||||||||||||
Netherlands | — | 201,441 | — | 201,441 | |||||||||||||
Singapore | — | 629,522 | — | 629,522 | |||||||||||||
Spain | — | 209,996 | — | 209,996 | |||||||||||||
Sweden | — | 209,079 | — | 209,079 | |||||||||||||
Switzerland | — | 194,974 | — | 194,974 | |||||||||||||
United Kingdom | — | 1,275,709 | — | 1,275,709 | |||||||||||||
Real Estate Investment Trusts* | — | 660,143 | — | 660,143 | |||||||||||||
Total | $ | 2,108,998 | $ | 8,516,934 | $ | — | $ | 10,625,932 |
* See Schedule of Investments for security type and geographic sector breakouts.
There were no transfers between levels during the period ended September 30, 2015.
See Notes to Financial Statements
15 |
SCHEDULE OF INVESTMENTS
September 30, 2015
Number | ||||||||
of Shares | Value | |||||||
COMMON STOCKS: 99.7% | ||||||||
Capital Goods: 9.8% | ||||||||
812,481 | Emerson Electric Co. | $ | 35,887,286 | |||||
411,504 | United Technologies Corp. | 36,619,741 | ||||||
72,507,027 | ||||||||
Consumer Durables & Apparel: 4.8% | ||||||||
296,050 | Polaris Industries, Inc. | 35,487,513 | ||||||
Diversified Financials: 9.9% | ||||||||
289,429 | Berkshire Hathaway, Inc. | 37,741,542 | ||||||
953,016 | Franklin Resources, Inc. | 35,509,376 | ||||||
73,250,918 | ||||||||
Household & Personal Products: 5.4% | ||||||||
551,936 | The Procter and Gamble Co. | 39,706,276 | ||||||
Materials: 4.7% | ||||||||
405,368 | Monsanto Co. | 34,594,105 | ||||||
Media: 20.2% | ||||||||
1,409,270 | Discovery Communications, Inc. * † | 36,683,298 | ||||||
539,105 | Time Warner, Inc. | 37,063,469 | ||||||
1,427,363 | Twenty-First Century Fox, Inc. | 38,510,254 | ||||||
370,881 | Walt Disney Co. | 37,904,038 | ||||||
150,161,059 | ||||||||
Pharmaceuticals, Biotechnology: 4.8% | ||||||||
727,838 | Merck and Co., Inc. | 35,947,919 | ||||||
Semiconductor: 4.8% | ||||||||
2,444,798 | Applied Materials, Inc. | 35,914,083 | ||||||
Software & Services: 5.1% | ||||||||
2,073,318 | The Western Union Co. | 38,066,118 | ||||||
Technology: 4.9% | ||||||||
818,817 | Autodesk, Inc. | 36,142,582 | ||||||
Technology Hardware & Equipment: 5.0% | ||||||||
695,812 | Qualcomm, Inc. | 37,385,979 | ||||||
Transportation: 15.0% | ||||||||
1,359,100 | CSX Corp. | 36,559,790 | ||||||
478,800 | Norfolk Southern Corp. | 36,580,320 | ||||||
434,694 | Union Pacific Corp. | 38,431,297 | ||||||
111,571,407 | ||||||||
Utilities: 5.3% | ||||||||
1,175,633 | ITC Holdings Corp. | 39,195,604 | ||||||
Total Common Stocks (Cost: $800,172,904) |
739,930,590 |
Principal | ||||||||
Amount | Value | |||||||
SHORT-TERM INVESTMENTS HELD AS COLLATERAL FOR SECURITIES LOANED: 0.6% | ||||||||
Repurchase Agreements: 0.6% | ||||||||
$ | 1,130,211 | Repurchase agreement dated 9/30/15 with BNP Paribas Securities Corp., 0.11%, due 10/1/15, proceeds $1,130,214; (collateralized by various U.S. government and agency obligations, 0.25% to 7.50%, due 8/1/16 to 10/1/45, valued at $1,152,817 including accrued interest) | $ | 1,130,211 | ||||
1,130,211 | Repurchase agreement dated 9/30/15 with Citigroup Global Markets, Inc., 0.12%, due 10/1/15, proceeds $1,130,215; (collateralized by various U.S. government and agency obligations, 0.00% to 7.00%, due 5/15/18 to 10/1/45, valued at $1,152,815 including accrued interest) | 1,130,211 | ||||||
1,130,211 | Repurchase agreement dated 9/30/15 with HSBC Securities USA, Inc., 0.10%, due 10/1/15, proceeds $1,130,214; (collateralized by various U.S. government and agency obligations, 0.00% to 7.25%, due 11/15/15 to 7/15/37, valued at $1,152,816 including accrued interest) | 1,130,211 | ||||||
1,130,211 | Repurchase agreement dated 9/30/15 with Mizuho Securities USA, Inc., 0.14%, due 10/1/15, proceeds $1,130,215; (collateralized by various U.S. government and agency obligations, 0.00% to 4.50%, due 10/9/19 to 10/1/45, valued at $1,152,815 including accrued interest) | 1,130,211 | ||||||
237,928 | Repurchase agreement dated 9/30/15 with Royal Bank of Scotland Plc, 0.09%, due 10/1/15, proceeds $237,929; (collateralized by various U.S. government and agency obligations, 0.09% to 3.63%, due 1/31/16 to 2/15/44, valued at $242,687 including accrued interest) | 237,928 | ||||||
Total Short-Term Investments Held as Collateral for Securities Loaned | ||||||||
(Cost: $4,758,772) | 4,758,772 | |||||||
Total Investments: 100.3% (Cost: $804,931,676) |
744,689,362 | |||||||
Liabilities in excess of other assets: (0.3)% | (2,325,831 | ) | ||||||
NET ASSETS: 100.0% | $ | 742,363,531 |
* | Non-income producing |
† | Security fully or partially on loan. Total market value of securities on loan is $4,587,605. |
See Notes to Financial Statements
16 |
Summary of Investments by Sector Excluding | ||||||||
Collateral for Securities Loaned (unaudited) | % of Investments | Value | ||||||
Consumer Discretionary | 25.1 | % | $ | 185,648,572 | ||||
Consumer Staples | 5.4 | 39,706,276 | ||||||
Financials | 9.9 | 73,250,918 | ||||||
Health Care | 4.8 | 35,947,919 | ||||||
Industrials | 24.9 | 184,078,434 | ||||||
Information Technology | 19.9 | 147,508,762 | ||||||
Materials | 4.7 | 34,594,105 | ||||||
Utilities | 5.3 | 39,195,604 | ||||||
100.0 | % | $ | 739,930,590 |
The summary of inputs used to value the Fund's investments as of September 30, 2015 is as follows:
Level 1 Quoted Prices |
Level 2 Significant Observable Inputs |
Level 3 Significant Unobservable Inputs |
Value | ||||||||||||||
Common Stocks* | $ | 739,930,590 | $ | — | $ | — | $ | 739,930,590 | |||||||||
Repurchase Agreements | — | 4,758,772 | — | 4,758,772 | |||||||||||||
Total | $ | 739,930,590 | $ | 4,758,772 | $ | — | $ | 744,689,362 |
* See Schedule of Investments for security type and industry sector breakouts.
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
17 |
MARKET VECTORS ETF TRUST
STATEMENTS OF ASSETS AND LIABILITIES
September 30, 2015
Global Spin-Off ETF |
Morningstar International Moat ETF |
Morningstar Wide Moat ETF |
||||||||||
Assets: | ||||||||||||
Investments, at value (1) (2) | $ | 2,570,431 | $ | 10,625,932 | $ | 739,930,590 | ||||||
Short-term investments held as collateral for securities loaned (3) | — | — | 4,758,772 | |||||||||
Cash | — | — | 2,149,602 | |||||||||
Cash denominated in foreign currency, at value (4) | 621 | 6,056 | — | |||||||||
Receivables: | ||||||||||||
Investment securities sold | 497,795 | 5,987 | — | |||||||||
Shares sold | 389 | — | 32 | |||||||||
Due from Adviser | 8,108 | 11,539 | — | |||||||||
Dividends | 3,408 | 43,882 | 646,696 | |||||||||
Prepaid expenses | 104 | — | 10,956 | |||||||||
Total assets | 3,080,856 | 10,693,396 | 747,496,648 | |||||||||
Liabilities: | ||||||||||||
Payables: | ||||||||||||
Investment securities purchased | 503,587 | 6,016 | — | |||||||||
Collateral for securities loaned | — | — | 4,758,772 | |||||||||
Shares redeemed | — | — | — | |||||||||
Due to Adviser | — | — | 243,224 | |||||||||
Due to custodian | — | 55,184 | — | |||||||||
Deferred Trustee fees | — | — | 19,818 | |||||||||
Accrued expenses | 30,396 | 40,804 | 111,303 | |||||||||
Total liabilities | 533,983 | 102,004 | 5,133,117 | |||||||||
NET ASSETS | $ | 2,546,873 | $ | 10,591,392 | $ | 742,363,531 | ||||||
Shares outstanding | 150,000 | 400,000 | 26,550,000 | |||||||||
Net asset value, redemption and offering price per share | $ | 16.98 | $ | 26.48 | $ | 27.96 | ||||||
Net assets consist of: | ||||||||||||
Aggregate paid in capital | $ | 2,826,978 | $ | 12,090,894 | $ | 935,151,755 | ||||||
Net unrealized depreciation | (247,853 | ) | (1,196,479 | ) | (60,242,314 | ) | ||||||
Undistributed net investment income | 7,096 | 54,293 | 12,363,462 | |||||||||
Accumulated net realized loss | (39,348 | ) | (357,316 | ) | (144,909,372 | ) | ||||||
$ | 2,546,873 | $ | 10,591,392 | $ | 742,363,531 | |||||||
(1) Value of securities on loan | $ | — | $ | — | $ | 4,587,605 | ||||||
(2) Cost of investments | $ | 2,818,275 | $ | 11,821,871 | $ | 800,172,904 | ||||||
(3) Cost of short-term investments held as collateral for securities loaned | $ | — | $ | — | $ | 4,758,772 | ||||||
(4) Cost of cash denominated in foreign currency | $ | 606 | $ | 6,034 | $ | — |
See Notes to Financial Statements
18 |
MARKET VECTORS ETF TRUST
For the Year Ended September 30, 2015
Global Spin-Off ETF(a) | Morningstar International Moat ETF(b) | Morningstar Wide Moat ETF | ||||||||||
Income: | ||||||||||||
Dividends | $ | 10,439 | $ | 88,177 | $ | 21,324,617 | ||||||
Securities lending income | — | — | 52,606 | |||||||||
Foreign taxes withheld | — | (5,414 | ) | (90,364 | ) | |||||||
Total income | 10,439 | 82,763 | 21,286,859 | |||||||||
Expenses: | ||||||||||||
Management fees | 2,912 | 10,805 | 4,030,669 | |||||||||
Professional fees | 12,726 | 24,146 | 117,095 | |||||||||
Insurance | 7 | — | 12,750 | |||||||||
Trustees’ fees and expenses | 140 | 24 | 32,091 | |||||||||
Reports to shareholders | 5,596 | 7,669 | 92,376 | |||||||||
Indicative optimized portfolio value fee | 819 | 1,500 | 2,128 | |||||||||
Custodian fees | 9,183 | 6,000 | 23,987 | |||||||||
Registration fees | 2,729 | 2,441 | 25,034 | |||||||||
Transfer agent fees | 328 | 150 | 1,880 | |||||||||
Fund accounting fees | 1,751 | 916 | 47,021 | |||||||||
Interest | — | — | 24,161 | |||||||||
Other | 273 | 300 | 43,650 | |||||||||
Total expenses | 36,464 | 53,951 | 4,452,842 | |||||||||
Waiver of management fees | (2,912 | ) | (10,805 | ) | (39,730 | ) | ||||||
Expenses assumed by the Adviser | (30,345 | ) | (31,045 | ) | — | |||||||
Net expenses | 3,207 | 12,101 | 4,413,112 | |||||||||
Net investment income | 7,232 | 70,662 | 16,873,747 | |||||||||
Net realized gain (loss) on: | ||||||||||||
Investments | (39,348 | ) | (357,316 | ) | (126,099,813 | ) | ||||||
In-kind redemption | — | — | 87,726,557 | |||||||||
Foreign currency transactions and foreign denominated assets and liabilities | (136 | ) | (16,369 | ) | — | |||||||
Net realized loss | (39,484 | ) | (373,685 | ) | (38,373,256 | ) | ||||||
Net change in unrealized appreciation (depreciation) on: | ||||||||||||
Investments | (247,844 | ) | (1,195,941 | ) | (58,131,508 | ) | ||||||
Foreign currency transactions and foreign denominated assets and liabilities | (9 | ) | (538 | ) | — | |||||||
Net change in unrealized appreciation (depreciation) | (247,853 | ) | (1,196,479 | ) | (58,131,508 | ) | ||||||
Net Decrease in Net Assets Resulting from Operations | $ | (280,105 | ) | $ | (1,499,502 | ) | $ | (79,631,017 | ) |
(a) | For the period June 9, 2015 (commencement of operations) through September 30, 2015. |
(b) | For the period July 13, 2015 (commencement of operations) through September 30, 2015. |
See Notes to Financial Statements
19 |
MARKET VECTORS ETF TRUST
STATEMENTS OF CHANGES IN NET ASSETS
Global Spin-Off ETF | Morningstar International Moat ETF | Morningstar Wide Moat ETF | ||||||||||||||
For the Period June 9, 2015* through September 30, 2015 | For the Period July 13, 2015* through September 30, 2015 | For the Year Ended September 30, 2015 | For the Year Ended September 30, 2014 | |||||||||||||
Operations: | ||||||||||||||||
Net investment income | $ | 7,232 | $ | 70,662 | $ | 16,873,747 | $ | 10,392,816 | ||||||||
Net realized gain (loss) | (39,484 | ) | (373,685 | ) | (38,373,256 | ) | 86,785,912 | |||||||||
Net change in unrealized appreciation (depreciation) | (247,853 | ) | (1,196,479 | ) | (58,131,508 | ) | (5,881,068 | ) | ||||||||
Net increase (decrease) in net assets resulting from operations | (280,105 | ) | (1,499,502 | ) | (79,631,017 | ) | 91,297,660 | |||||||||
Dividends to shareholders: | ||||||||||||||||
Dividends from net investment income | — | — | (13,000,000 | ) | (4,225,050 | ) | ||||||||||
Share transactions:** | ||||||||||||||||
Proceeds from sale of shares | 2,826,978 | 12,090,894 | 159,367,725 | 415,642,323 | ||||||||||||
Cost of shares redeemed | — | — | (177,988,761 | ) | (13,494,178 | ) | ||||||||||
Increase (decrease) in net assets resulting from share transactions | 2,826,978 | 12,090,894 | (18,621,036 | ) | 402,148,145 | |||||||||||
Total increase (decrease) in net assets. | 2,546,873 | 10,591,392 | (111,252,053 | ) | 489,220,755 | |||||||||||
Net Assets, beginning of period | — | — | 853,615,584 | 364,394,829 | ||||||||||||
Net Assets, end of period† | $ | 2,546,873 | $ | 10,591,392 | $ | 742,363,531 | $ | 853,615,584 | ||||||||
† Including undistributed net investment income | $ | 7,096 | $ | 54,293 | $ | 12,363,462 | $ | 8,489,715 | ||||||||
** Shares of Common Stock Issued (no par value) | ||||||||||||||||
Shares sold | 150,000 | 400,000 | 5,100,000 | 14,300,000 | ||||||||||||
Shares redeemed | — | — | (5,850,000 | ) | (450,000 | ) | ||||||||||
Net increase (decrease) | 150,000 | 400,000 | (750,000 | ) | 13,850,000 |
* Commencement of operations
See Notes to Financial Statements
20 |
MARKET VECTORS ETF TRUST
For a share outstanding throughout each period:
(a) | Commencement of operations. |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Not Annualized |
(d) | Annualized |
See Notes to Financial Statements
21 |
MARKET VECTORS ETF TRUST
FINANCIAL HIGHLIGHTS
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Not Annualized |
(d) | Annualized |
See Notes to Financial Statements
22 |
MARKET VECTORS ETF TRUST
September 30, 2015
Note 1—Fund Organization—Market Vectors ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended, as an open-end management investment company. The Trust was incorporated in Delaware as a statutory trust on March 15, 2001. The Trust operates as a series fund, and as of September 30, 2015, offers fifty-eight investment portfolios, each of which represents a separate series of the Trust.
These financial statements relate only to the following investment portfolios: Global Spin-Off ETF, Morningstar International Moat ETF and Morningstar Wide Moat ETF (each a “Fund” and, together, the “Funds”). Each Fund’s investment objective is to replicate as closely as possible, before fees and expenses, the price and yield performance of its index. Each Fund, using a “passive” or indexing investment approach, attempts to approximate the investment performance of its index by investing in a portfolio of securities that generally replicates the index.
The Funds’ commencement of operations dates and their respective indices are presented below:
Commencement | ||||
Fund | of Operations | Index | ||
Global Spin-Off ETF | June 9, 2015 | Horizon Kinetics Global Spin-Off Index (1) | ||
Morningstar International Moat ETF | July 13, 2015 | Morningstar® Global ex-US Moat Focus Index SM(2) | ||
Morningstar Wide Moat ETF | April 24, 2012 | Morningstar® Wide Moat Focus Index SM(2) |
(1) | Published by Horizon Kinetics, LLC |
(2) | Published by Morningstar, Inc. |
Note 2—Significant Accounting Policies—The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.
The Funds are investment companies and are following accounting and reporting requirements of Accounting Standards Codification (“ASC”) 946 Financial Services—Investment Companies.
The following is a summary of significant accounting policies followed by the Funds.
A. | Security Valuation—The Funds value their investments in securities and other assets and liabilities carried at fair value daily. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Securities traded on national exchanges or traded on the NASDAQ National Market System are valued at the last sales price as reported at the close of each business day. Securities traded on the NASDAQ Stock Market are valued at the NASDAQ official closing price. Over-the-counter securities not included in the NASDAQ National Market System and listed securities for which no sale was reported are valued at the mean of the bid and ask prices. To the extent these securities are actively traded they are categorized as Level 1 in the fair value hierarchy (described below). Certain foreign securities, whose values may be affected by market direction or events occurring before the Funds’ pricing time (4:00 p.m. Eastern Standard Time) but after the last close of the securities’ primary market, are fair valued using a pricing service and are categorized as Level 2 in the fair value hierarchy. The pricing service, using methods approved by the Board of Trustees, considers the correlation of the trading patterns of the foreign security to intraday trading in the U.S. markets, based on indices of domestic securities and other appropriate indicators such as prices of relevant ADR’s and futures contracts. The Funds may also fair value securities in other situations, such as, when a particular foreign market is closed but the Fund is open. Short-term obligations with sixty days or less to maturity are valued at amortized cost, which with accrued interest approximates fair value. Money market fund investments are valued at net asset value and are considered to be Level 1 in the fair value hierarchy. Securities for which quotations are not available are stated at fair value as determined by the Pricing Committee of Van Eck Associates Corporation (the “Adviser”) appointed by the Board of Trustees. The Pricing Committee provides oversight of the Funds’ valuation policies and procedures, which are approved by the Funds’ Board of Trustees. Among other things, these procedures allow the Funds to utilize independent pricing services, quotations from securities dealers, and other market sources to determine fair value. The Pricing Committee convenes regularly to review the fair value of financial instruments for which market prices are not readily available. The Pricing Committee employs various methods for calibrating the valuation approaches utilized to determine fair value, including a regular review of key inputs and assumptions, transactional back-testing and disposition analysis. |
23 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
Certain factors such as economic conditions, political events, market trends, the nature of and duration of any restrictions on disposition, trading in similar securities of the issuer or comparable issuers and other security specific information are used to determine the fair value of these securities. Depending on the relative significance of valuation inputs, these securities may be classified either as Level 2 or Level 3 in the fair value hierarchy. The price which the Funds may realize upon sale of an investment may differ materially from the value presented in the Schedules of Investments. | |
The Funds utilize various methods to measure the fair value of its investments on a recurring basis which includes a hierarchy that prioritizes inputs to valuation methods used to measure fair value. The fair value hierarchy gives highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The transfers between levels of the fair value hierarchy assume the financial instruments were transferred at the beginning of the reporting period. The three levels of the fair value hierarchy are described below: | |
Level 1 — Quoted prices in active markets for identical securities. | |
Level 2 — Significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). | |
Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments). | |
A summary of the inputs, the levels used to value the Funds’ investments, and transfers between levels are located in the Schedules of Investments. Additionally, tables that reconcile the valuation of the Funds’ Level 3 investments and that present additional information about valuation methodologies and unobservable inputs, if applicable, are located in the Schedules of Investments. | |
B. | Federal Income Taxes—It is each Fund’s policy to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Therefore, no federal income tax provision is required. |
C. | Dividends and Distributions to Shareholders—Dividends to shareholders from net investment income and distributions from net realized capital gains, if any, are declared and paid annually by each Fund. Income dividends and capital gain distributions are determined in accordance with U.S. income tax regulations, which may differ from such amounts determined in accordance with GAAP. |
D. | Currency Translation—Assets and liabilities denominated in foreign currencies and commitments under foreign currency contracts are translated into U.S. dollars at the closing prices of such currencies each business day. Purchases and sales of investments are translated at the exchange rates prevailing when such investments are acquired or sold. Foreign denominated income and expenses are translated at the exchange rates prevailing when accrued. The portion of realized and unrealized gains and losses on investments that result from fluctuations in foreign currency exchange rates is not separately disclosed in the financial statements. Recognized gains or losses attributable to foreign currency fluctuations on foreign currency denominated assets, other than investments, and liabilities are recorded as net realized gain (loss) on foreign currency transactions and foreign denominated assets and liabilities in the Statements of Operations. |
E. | Restricted Securities—The Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities, if any, is included at the end of each Fund’s Schedule of Investments. |
F. | Use of Derivative Instruments—The Funds may invest in derivative instruments, including, but not limited to, options, futures, swaps and other derivatives relating to foreign currency transactions. A derivative is an instrument whose value is derived from underlying assets, indices, reference rates or a combination of these factors. Derivative instruments may be privately negotiated contracts (often referred to as over-the-counter (“OTC”) derivatives) or they may be listed and traded on an exchange. Derivative contracts may involve future commitments to purchase or sell |
24 |
financial instruments at specified terms on a specified date, or to exchange interest payment streams or currencies based on a notional or contractual amount. Derivative instruments may involve a high degree of financial risk. The use of derivative instruments also involves the risk of loss if the Adviser is incorrect in its expectation of the timing or level of fluctuations in securities prices, interest rates or currency prices. Investments in derivative instruments also include the risk of default by the counterparty, the risk that the investment may not be liquid and the risk that a small movement in the price of the underlying security or benchmark may result in a disproportionately large movement, unfavorable or favorable, in the price of the derivative instruments. The Funds held no derivative instruments during the year ended September 30, 2015. | |
G. | Repurchase Agreements—The Funds may enter into repurchase agreements with financial institutions, deemed to be creditworthy by the Adviser, to generate income from their excess cash balances and to invest securities lending cash collateral. A repurchase agreement is an agreement under which a Fund acquires securities from a seller, subject to resale to the seller at an agreed upon price and date. A Fund, through its custodian/securities lending agent, takes possession of securities collateralizing the repurchase agreement. Pursuant to the terms of the repurchase agreement, such securities must have an aggregate market value greater than or equal to the terms of the repurchase price plus accrued interest at all times. If the value of the underlying securities falls below the value of the repurchase price plus accrued interest, the Funds will require the seller to deposit additional collateral by the next business day. If the request for additional collateral is not met, or the seller defaults on its repurchase obligation, the Funds maintain their right to sell the underlying securities at market value and may claim any resulting loss against the seller. Repurchase agreements held as of September 30, 2015 are reflected in the Schedules of Investments. |
H. | Offsetting Assets and Liabilities—In the ordinary course of business, the Funds enter into transactions subject to enforceable master netting or other similar agreements. Generally, the right of setoff in those agreements allows the Funds to set off any exposure to a specific counterparty with any collateral received or delivered to that counterparty based on the terms of the agreements. The Funds may pledge or receive cash and/or securities as collateral for derivative instruments, securities lending and repurchase agreements. For financial reporting purposes, the Funds present securities lending and repurchase agreement assets and liabilities on a gross basis in the Statements of Assets and Liabilities. Collateral held at September 30, 2015 is presented in the Schedules of Investments. Also, refer to related disclosures in Note 2G (Repurchase Agreements) and Note 9 (Securities Lending). |
I. | Other—Security transactions are accounted for on trade date. Transactions in certain securities may take longer than the customary settlement cycle to be completed. The counterparty is required to collateralize such trades with cash in excess of the market value of the transaction, which is held at the custodian and marked to market daily. Realized gains and losses are calculated on the identified cost basis. Dividend income is recorded on the ex-dividend date except that certain dividends from foreign securities are recognized upon notification of the ex-dividend date/rate. Interest income, including amortization of premiums and discounts, is accrued as earned. |
In the normal course of business, the Funds enter into contracts that contain a variety of general indemnifications. The Funds’ maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. However, the Adviser believes the risk of loss under these arrangements to be remote. |
Note 3—Investment Management and Other Agreements—The Adviser is the investment adviser to the Funds. The Adviser receives a management fee, calculated daily and payable monthly based on an annual rate of each Fund’s average daily net assets. The Adviser has agreed, at least until February 1, 2017, (for Morningstar Wide Moat ETF until February 1, 2016) to voluntarily waive or limit its fees and to assume as its own expense certain expenses otherwise payable by the Funds so that each Fund’s total annual operating expenses does not exceed the expense caps (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) listed in the table below.
25 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
The current management fee rate, expense limitations and the amounts waived/assumed by the Adviser for the year ended September 30, 2015, are as follows:
Management | Expense | Waiver of | Expenses Assumed | |||||||||||||
Fund | Fee Rate | Limitations | Management Fees | by the Adviser | ||||||||||||
Global Spin-Off ETF* | 0.50 | % | 0.55 | % | $ 2,912 | $30,345 | ||||||||||
Morningstar International Moat ETF** | 0.50 | 0.56 | 10,805 | 31,045 | ||||||||||||
Morningstar Wide Moat ETF | 0.45 | 0.49 | 39,730 | — |
* | For the period June 9, 2015 (commencement of operations) through September 30, 2015. |
** | For the period July 13, 2015 (commencement of operations) through September 30, 2015. |
In addition, Van Eck Securities Corporation, an affiliate of the Adviser, acts as the Funds’ distributor (the “Distributor”). Certain officers and a Trustee of the Trust are officers, directors or stockholders of the Adviser and Distributor.
Note 4—Investments—For the year ended September 30, 2015, the cost of purchases and proceeds from sales of investments other than U.S. government obligations and short-term obligations (excluding in-kind transactions described in Note 6) were as follows:
Cost of Investments | Proceeds from | |||||||
Fund | Purchased | Investments Sold | ||||||
Global Spin-Off ETF | $ | 661,795 | $ | 623,645 | ||||
Morningstar International Moat ETF | 10,577,550 | 5,709,853 | ||||||
Morningstar Wide Moat ETF | 121,971,184 | 817,827,000 |
Note 5—Income Taxes—As of September 30, 2015, for Federal income tax purposes, the identified cost of investments owned, net unrealized depreciation, gross unrealized appreciation, and gross unrealized depreciation of investments were as follows:
Net Unrealized | ||||||||||||||||
Gross Unrealized | Gross Unrealized | Appreciation | ||||||||||||||
Fund | Cost of Investments | Appreciation | Depreciation | (Depreciation) | ||||||||||||
Global Spin-Off ETF | $ | 2,818,315 | $ | 16,511 | $ | (264,395 | ) | $ | (247,884 | ) | ||||||
Morningstar International Moat ETF | 11,830,775 | 9,115 | (1,213,958 | ) | (1,204,843 | ) | ||||||||||
Morningstar Wide Moat ETF | 804,931,676 | 1,377,730 | (61,620,044 | ) | (60,242,314 | ) |
At September 30, 2015, the components of accumulated earnings (deficit) on a tax basis, for each Fund, were as follows:
Undistributed | Undistributed | Accumulated | Qualified | Other | Unrealized | |||||||||||||||||||||||
Ordinary | Long-Term | Capital | Late Year | Temporary | Appreciation | |||||||||||||||||||||||
Fund | Income | Capital Gains | Losses | Losses | Difference | (Depreciation) | Total | |||||||||||||||||||||
Global Spin-Off ETF | $ | 7,097 | $ | — | $ | (39,308 | ) | $ | — | $ | — | $ | (247,894 | ) | $ | (280,105 | ) | |||||||||||
Morningstar International Moat ETF | 54,312 | — | (348,431 | ) | — | — | (1,205,383 | ) | (1,499,502 | ) | ||||||||||||||||||
Morningstar Wide Moat ETF | 12,383,280 | — | (144,909,372 | ) | — | (19,818 | ) | (60,242,314 | ) | (192,788,224 | ) |
The tax character of dividends paid to shareholders during the years ended September 30, 2015 and September 30, 2014 was as follows:
2015 Dividends | 2014 Dividends | |||||||
Fund | Ordinary Income | Ordinary Income | ||||||
Morningstar Wide Moat ETF | $ | 13,000,000 | $ | 4,225,050 |
Global Spin-Off ETF and Morningstar International Moat ETF commenced operations on June 9, 2015 and July 13, 2015, respectively, and had no distributions during the period ended September 30, 2015.
26 |
At September 30, 2015, the Funds had capital loss carryforwards available to offset future capital gains, as follows:
Post-Effective- | Post-Effective- | |||||||
No Expiration | No Expiration | |||||||
Short-Term | Long-Term | |||||||
Fund | Capital Losses | Capital Losses | ||||||
Global Spin-Off ETF | $ | 39,308 | $ | — | ||||
Morningstar International Moat ETF | 348,431 | — | ||||||
Morningstar Wide Moat ETF | 121,644,701 | 23,264,671 |
During the year ended September 30, 2015, as a result of permanent book to tax differences, primarily due to investments in Passive Foreign Investment Companies, foreign currency gains and losses and tax treatment of in-kind redemptions, the Funds’ incurred differences that affected undistributed net investment income (loss), accumulated net realized gain (loss) on investments and aggregate paid in capital by the amounts in the table below. Net assets were not affected by these reclassifications.
Increase (Decrease) | Increase (Decrease) | Increase( Decrease) | ||||||||||
in Accumulated Net | in Accumulated | in Aggregate | ||||||||||
Fund | Investment Income (Loss) | Net Realized Gain (Loss) | Paid in Capital | |||||||||
Global Spin-Off ETF | $ | (136 | ) | $ | 136 | $ | — | |||||
Morningstar International Moat ETF | (16,369 | ) | 16,369 | — | ||||||||
Morningstar Wide Moat ETF | — | (87,722,525 | ) | 87,722,525 |
The Funds recognize the tax benefits of uncertain tax positions only where the position is “more-likely-than-not” to be sustained assuming examination by applicable tax authorities. Management has analyzed the Funds’ tax positions, and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on return filings for all open tax years, or expected to be taken in the Funds’ current tax year. The Funds do not have exposure for additional years that might still be open in certain foreign jurisdictions. Therefore, no provision for income tax is required in the Funds’ financial statements.
The Funds recognize interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statements of Operations. During the year ended September 30, 2015, the Funds did not incur any interest or penalties.
Note 6—Capital Share Transactions—As of September 30, 2015, there were an unlimited number of capital shares of beneficial interest authorized by the Trust with no par value. Shares are issued and redeemed by the Funds only in Creation Units, consisting of 50,000 shares, or multiples thereof. The consideration for the purchase or redemption of Creation Units of the Funds generally consists of the in-kind contribution or distribution of securities constituting the Funds’ underlying index plus a small amount of cash. For the year ended September 30, 2015, the Funds had in-kind contributions and redemptions as follow:
Fund | In-Kind Contributions | In-Kind Redemptions | ||||||
Global Spin-Off ETF | $ | 2,794,979 | $ | — | ||||
Morningstar International Moat ETF | 7,311,490 | — | ||||||
Morningstar Wide Moat ETF | 1,781,077,395 | 1,103,135,491 |
The in-kind contributions and in-kind redemptions in this table represent the accumulation of each Fund’s daily net shareholder transactions including rebalancing activity, while the Statements of Changes in Net Assets reflect shareholder transactions including any cash component of the transactions.
Note 7—Concentration of Risk—The investment objective of each Fund is to seek investment results that correspond generally to the price and yield performance, before fees and expenses, of its underlying index, as indicated in the name of each Fund. The Adviser uses a “passive” or index approach to achieve each Fund’s investment objective by investing in a portfolio of securities that generally replicates the Funds’ index. Each of the Funds is classified as a non-diversified fund under the 1940 Act. Non-diversified funds generally hold securities of fewer issuers than diversified funds and may be more susceptible to the risks associated with these particular issuers, or to a single economic, political or regulatory occurrence affecting these issuers. The Funds may purchase securities on foreign exchanges. Securities of foreign issuers involve special risks and considerations not typically associated with investing in U.S. issuers. These risks include devaluation of currencies, currency controls, less reliable information about issuers, different
27 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
(continued)
securities transaction clearance and settlement practices, future adverse political and economic developments and local/regional conflicts. These risks are heightened for investments in emerging market countries. Moreover, securities of many foreign issuers and their markets may be less liquid and their prices more volatile than those of comparable U.S. issuers.
Global Spin-Off ETF may invest in spun-off companies that have been spun-off from a parent company for a number of reasons, including but not limited to low growth prospects, high capital requirements or an unfavorable capitalization structure. Investments in spun-off companies are subject to the risk that any of these characteristics will adversely affect the value of investments in the spun-off companies. There can be no assurance that a spun-off company will be financially independent or profitable, especially where the company represented a non-core or non-competitive business line of the parent company at the time of the spin-off.
Global Spin-Off ETF may invest directly in real estate investment trusts (“REITs”) and is exposed to the risk of owning real estate directly, as well as to risks that relate specifically to the way in which REITs are organized and operated. REITs generally invest directly in real estate, in mortgages or in some combination of the two. The Fund indirectly bears management expenses along with the direct expenses of the Fund. Individual REITs may own a limited number of properties and may concentrate in a particular region or property type. REITs may also be subject to heavy cash flow dependency, default by borrowers and self-liquidation.
Note 8—Trustee Deferred Compensation Plan—The Trust has a Deferred Compensation Plan (the “Plan”) for Trustees under which the Trustees can elect to defer receipt of their trustee fees until retirement, disability or termination from the Board of Trustees. The fees otherwise payable to the participating Trustees are deemed invested in shares of the Funds as directed by the Trustees.
The expense for the Plan is included in “Trustees’ fees and expenses” in the Statements of Operations. The liability for the Plan is shown as “Deferred Trustee fees” in the Statements of Assets and Liabilities.
Note 9—Securities Lending—To generate additional income, each of the Funds may lend its securities pursuant to a securities lending agreement with The Bank of New York Mellon, the securities lending agent and also the Funds’ custodian. Each Fund may lend up to 33% of its investments requiring that the loan be continuously collateralized by cash, U.S. government or U.S. government agency securities, shares of an investment trust or mutual fund, or any combination of cash and such securities at all times equal to at least 102% (105% for foreign securities) of the market value plus accrued interest on the securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled on the next business day. During the term of the loan, the Funds will continue to receive any dividends, interest or amounts equivalent thereto, on the securities loaned while receiving a fee from the borrower and/or earning interest on the investment of the cash collateral. Such fees and interest are shared with the securities lending agent under the terms of the securities lending agreement. The Funds may pay reasonable finders’, administrative and custodial fees in connection with a loan of its securities. Securities lending income is disclosed as such in the Statements of Operations. The collateral for securities loaned is recognized in the Schedules of Investments and the Statements of Assets and Liabilities. The cash collateral is maintained on the Funds’ behalf by the lending agent and is invested in repurchase agreements collateralized by obligations of the U.S. Treasury and/or Government Agencies. Loans are subject to termination at the option of the borrower or the Funds. Upon termination of the loan, the borrower will return to the lender securities identical to the securities loaned. The Funds bear the risk of delay in recovery of, or even loss of rights in, the securities loaned should the borrower of the securities fail financially. The value of loaned securities and related collateral outstanding at September 30, 2015 are presented on a gross basis in the Schedules of Investments and Statements of Assets and Liabilities.
28 |
Note 10—Bank Line of Credit—Certain Funds may participate in a $200 million committed credit facility (the “Facility”) to be utilized for temporary financing until the settlement of sales or purchases of portfolio securities, the repurchase or redemption of shares of the Funds at the request of the shareholders and other temporary or emergency purposes. Participating Funds have agreed to pay commitment fees, pro rata, based on the unused but available balance. Interest is charged to the Funds at rates based on prevailing market rates in effect at the time of borrowings. During the year ended September 30, 2015, the following Fund borrowed under this Facility:
Outstanding Loan | ||||||||
Days | Average Daily | Average | Balance as of | |||||
Fund | Outstanding | Loan Balance | Interest Rate | September 30, 2015 | ||||
Morningstar Wide Moat ETF | 323 | $1,773,981 | 1.52% | $— |
Note 11—Custodian Fees—The Funds have entered into an expense offset agreement with the custodian wherein they receive a credit toward the reduction of custodian fees whenever there are uninvested cash balances. The Funds could have invested their cash balances elsewhere if they had not agreed to a reduction in fees under the expense offset agreement with the custodian. For the year ended September 30, 2015, there were no offsets to custodian fees.
Note 12—Subsequent Event Review—The Funds have evaluated subsequent events and transactions for potential recognition or disclosure through the date the financial statements were issued.
29 |
MARKET VECTORS ETF TRUST
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Trustees and Shareholders of Market Vectors ETF Trust
We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of Global Spin-Off ETF, Morningstar International Moat ETF and Morningstar Wide Moat ETF (three of the series constituting Market Vectors ETF Trust) (the “Funds”) as of September 30, 2015, and the related statements of operations, the statements of changes in net assets and the financial highlights for the periods indicated therein. These financial statements and financial highlights are the responsibility of the Funds’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. We were not engaged to perform an audit of the Funds’ internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and financial highlights, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2015, by correspondence with the custodian and brokers or by other appropriate auditing procedures where replies from brokers were not received. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of Global Spin-Off ETF, Morningstar International Moat ETF and Morningstar Wide Moat ETF (three of the series constituting Market Vectors ETF Trust) at September 30, 2015, the results of their operations, the changes in their net assets and the financial highlights for the periods indicated therein, in conformity with U.S. generally accepted accounting principles.
New York, New York
November 24, 2015
30 |
(unaudited)
The information set forth below is for each Fund’s fiscal year as required by federal laws. Shareholders, however, must report dividends on a calendar year basis for income tax purposes, which may include dividends for portions of two fiscal years of a Fund.
Accordingly, the information needed by shareholders for calendar year 2015 income tax purposes will be sent to them in early 2016. Please consult your tax advisor for proper treatment of this information.
The Fund listed below intends to pass through foreign tax credits in the maximum amounts shown. The gross foreign source income earned during the period ended September 30, 2015 by the Fund was as shown below.
Fund | Foreign Tax Credits | Gross Foreign Source Income | ||||||
Morningstar International Moat ETF | $4,404 | $ | 88,319 |
Corporate Dividends Received Deduction
The Funds listed below had the following percentage of ordinary income dividends paid that qualified for the Corporate Received Deduction for fiscal-year 2015.
Morningstar Wide Moat ETF | 100.00% |
31 |
MARKET VECTORS ETF TRUST
September 30, 2015 (unaudited)
Independent Trustees:
Name, Address1 and Year of Birth | Position(s) Held with the Trust | Term of Office2 and Length of Time Served | Principal Occupation(s) During Past Five Years | Number of Portfolios in Fund Complex3 Overseen | Other
Directorships Held By Trustee During Past Five Years | |||||
David H. Chow, 1957*† | Chairman Trustee | Since 2008 Since 2006 | Founder and CEO, DanCourt Management LLC (financial/strategy consulting firm and Registered Investment Adviser), March 1999 to present. | 58 | Director, Forward Management LLC and Audit Committee Chairman, January 2008 to present; Trustee, Berea College of Kentucky and Vice-Chairman of the Investment Committee, May 2009 to present; Member of the Governing Council of the Independent Directors Council, October 2012 to present; President, July 2013 to present; Secretary and Board Member of the CFA Society of Stamford, July 2009 to present; Advisory Board member, MainStay Fund Complex4, June 2015 to present. | |||||
R. Alastair Short, 1953*† | Trustee | Since 2006 | President, Apex Capital Corporation (personal investment vehicle), January 1988 to present; Vice Chairman, W.P. Stewart & Co., Inc. (asset management firm), September 2007 to September 2008; and Managing Director, The GlenRock Group, LLC (private equity investment firm), May 2004 to September 2007. | 69 | Chairman and Independent Director, EULAV Asset Management, January 2011 to present; Independent Director, Tremont offshore funds, June 2009 to present; Director, Kenyon Review. | |||||
Peter J. Sidebottom, 1962*† | Trustee | Since 2012 | Partner, PWC/Strategy & Financial Services Advisory, February 2015 to present; Founder and Board Member, AspenWoods Risk Solutions, September 2013 to present; Independent consultant, June 2013 to February 2015; Partner, Bain & Company (management consulting firm), April 2012 to December 2013; Executive Vice President and Senior Operating Committee Member, TD Ameritrade (on-line brokerage firm), February 2009 to January 2012. | 58 | Board Member, Special Olympics, New Jersey, November 2011 to September 2013; Director, The Charlotte Research Institute, December 2000 to present; Board Member, Social Capital Institute, University of North Carolina Charlotte, November 2004 to January 2012; Board Member, NJ-CAN, July 2014 to present. | |||||
Richard D. Stamberger, 1959*† | Trustee | Since 2006 | Director, President and CEO, SmartBrief, Inc. (media company). | 69 | Director, Food and Friends, Inc., 2013 to present. | |||||
Interested Trustee: | ||||||||||
Jan F. van Eck, 19635 | Trustee, President and Chief Executive Officer | Trustee (Since 2006); President and Chief Executive Officer (Since 2009) | Director, President and Owner of the Adviser, Van Eck Associates Corporation; Director and President, Van Eck Securities Corporation (“VESC”); Director and President, Van Eck Absolute Return Advisers Corp. (“VEARA”). | 58 | Director, National Committee on US-China Relations. |
1 | The address for each Trustee and officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Each Trustee serves until resignation, death, retirement or removal. Officers are elected yearly by the Trustees. |
3 | The Fund Complex consists of the Van Eck Funds, Van Eck VIP Trust and the Trust. |
4 | The MainStay Fund Complex consists of MainStay Funds Trust, MainStay Funds, MainStay VP Funds Trust, Private Advisors Alternative Strategies Master Fund, Private Advisors Alternative Strategies Fund and MainStay DefinedTerm Municipal Opportunities Fund. |
5 | “Interested person” of the Trust within the meaning of the 1940 Act. Mr. van Eck is an officer of the Adviser. |
* | Member of the Audit Committee. |
† | Member of the Nominating and Corporate Governance Committee. |
32 |
Officers: | ||||||
Officer’s Name, Address1 and Year of Birth | Position(s) Held with the Trust | Term of Office2 and Length of Time Served | Principal Occupation(s) During The Past Five Years | |||
Russell G. Brennan, 1964 | Assistant Vice President and Assistant Treasurer | Since 2008 | Assistant Vice President and Assistant Treasurer of the Adviser (since 2008); Manager (Portfolio Administration) of the Adviser, September 2005 to October 2008; Officer of other investment companies advised by the Adviser. | |||
Charles T. Cameron, 1960 | Vice President | Since 2006 | Director of Trading (since 1995) and Portfolio Manager (since 1997) for the Adviser; Officer of other investment companies advised by the Adviser. | |||
Simon Chen, 1971 | Assistant Vice President | Since 2012 | Greater China Director of the Adviser (Since January 2012); General Manager, SinoMarkets Ltd. (June 2007 to December 2011). | |||
John J. Crimmins, 1957 | Vice President, Treasurer, Chief Financial Officer and Principal Accounting Officer | Vice President, Chief Financial Officer and Principal Accounting Officer (Since 2012); Treasurer
(Since 2009) | Vice President of Portfolio Administration of the Adviser, June 2009 to present; Vice President of VESC and VEARA, June 2009 to present; Chief Financial, Operating and Compliance Officer, Kern Capital Management LLC, September 1997 to February 2009; Officer of other investment companies advised by the Adviser. | |||
Eduardo Escario, 1975 | Vice President | Since 2012 | Regional Director, Business Development/Sales for Southern Europe and South America of the Adviser (since July 2008); Regional Director (Spain, Portugal, South America and Africa) of Dow Jones Indexes and STOXX Ltd. (May 2001 – July 2008). | |||
Lars Hamich, 1968 | Vice President | Since 2012 | Managing Director and Chief Executive Officer of Van Eck Global (Europe) GmbH (since 2009); Chief Executive Officer of Market Vectors Index Solutions GmbH (“MVIS”) (since June 2011); Managing Director of STOXX Limited (until 2008). | |||
Wu-Kwan Kit, 1981 | Assistant Vice President and Assistant Secretary | Since 2011 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2011); Associate, Schulte Roth & Zabel (September 2007-2011); University of Pennsylvania Law School (August 2004 – May 2007). | |||
Susan C. Lashley, 1955 | Vice President | Since 2006 | Vice President of the Adviser and VESC; Officer of other investment companies advised by the Adviser. | |||
Laura I. Martínez, 1980 | Assistant Vice President and Assistant Secretary | Since 2008 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2008); Associate, Davis Polk & Wardwell (October 2005 – June 2008); Officer of other investment companies advised by the Adviser. | |||
Ferat Oeztuerk, 1983 | Assistant Vice President | Since 2012 | Sales Associate, Van Eck Global (Europe) GmbH (since November 2011); Account Manager, Vodafone Global Enterprise Limited (January 2011 to October 2011). | |||
James Parker, 1969 | Assistant Treasurer | Since June 2014 | Manager (Portfolio Administration) of the Adviser (Since June 2010); Vice President of JPMorgan Chase & Co. (April 1999 to January 2010). | |||
Jonathan R. Simon, 1974 | Vice President, Secretary and Chief Legal Officer | Vice President (Since 2006) and Secretary and Chief Legal Officer (Since 2014) | Vice President (since 2006), General Counsel and Secretary (since 2014) of the Adviser, VESC and VEARA; Officer of other investment companies advised by the Adviser. | |||
Bruce J. Smith, 1955 | Senior Vice President | Since 2006 | Senior Vice President, Chief Financial Officer, Treasurer and Controller of the Adviser, VESC and VEARA (since 1997); Director of the Adviser, VESC and VEARA (since October 2010); Officer of other investment companies advised by the Adviser. | |||
Janet Squitieri, 1961 | Chief Compliance Officer | Since September 2013 | Vice President, Global Head of Compliance of the Adviser, VESC and VEARA (since September 2013); Chief Compliance Officer and Senior Vice President North America of HSBC Global Asset Management NA (August 2010 – September 2013); Chief Compliance Officer North America of Babcock & Brown LP (July 2008 – June 2010). |
1 | The address for each Officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Officers are elected yearly by the Trustees. |
33 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited)
At a meeting held on December 4, 2014 (the “December Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), considered and approved an investment management agreement between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “December Investment Management Agreement”) with respect to the Market Vectors Morningstar International Wide Moat ETF (the “New December Fund”). In addition, at a meeting held on March 2, 2015 (the “March Meeting”), the Board, including all of the Independent Trustees, considered and approved investment management agreements (the “March Investment Management Agreement”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Market Vectors Australia Equal Weight ETF, Market Vectors Australia Hedged Equal Weight ETF, Market Vectors Brazil Equal Weight ETF, Market Vectors China Equal Weight ETF, Market Vectors Europe Equal Weight ETF, Market Vectors Europe Hedged Equal Weight ETF, Market Vectors Germany Equal Weight ETF, Market Vectors Global Spin-Off ETF, Market Vectors Hong Kong Equal Weight ETF, Market Vectors India Equal Weight ETF, Market Vectors Italy Equal Weight ETF, Market Vectors Japan Equal Weight ETF, Market Vectors Japan Hedged Equal Weight ETF, Market Vectors Mexico Equal Weight ETF, Market Vectors Russia Equal Weight ETF, Market Vectors South Africa Equal Weight ETF, Market Vectors South Korea Equal Weight ETF, Market Vectors Spain Equal Weight ETF, Market Vectors Taiwan Equal Weight ETF and Market Vectors United Kingdom Equal Weight ETF (the “New March Funds”). In addition, at a meeting held on September 3, 2015 (the “September Meeting”), the Board, including all of the Independent Trustees, considered and approved an investment management agreement (the “September Investment Management Agreement”) with respect to the Market Vectors Generic Drugs ETF (and collectively, with the New December Fund and the New March Funds, the “Funds”). The December Investment Management Agreement, the March Investment Management Agreement and the September Investment Management Agreement are collectively referred to as the “Investment Management Agreements.”
The Board’s approval of each Investment Management Agreement was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In advance of the relevant meeting, the Trustees received materials from the Adviser, including expense information for other funds. The Adviser provided the Trustees with information regarding, among other things, the various aspects of each Fund’s proposed investment program, fee arrangements and service provider arrangements. The Independent Trustees’ consideration of each Investment Management Agreement was based, in part, on information obtained through discussions with the Adviser at the December Meeting, March Meeting and September Meeting (as applicable) regarding the management of the Funds, information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others proposed to be involved in the management and administration of the Funds. The Trustees also considered the terms and scope of services that the Adviser would provide under each Investment Management Agreement, including the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of at least one year following the effective date of each Fund’s respective registration statement.
The Trustees considered the benefits, other than the fees under the Investment Management Agreements, that the Adviser would receive from serving as adviser to each Fund, including any benefits it may receive from serving as administrator to each Fund and from an affiliate of the Adviser serving as distributor to each Fund. The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability of each of the Funds to the Adviser because the Funds had not yet commenced operations. In addition, because the Funds had not yet commenced operations, the Trustees could not consider the historical performance or the quality of services previously provided to each of the Funds by the Adviser, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the December Meeting, the March Meeting and September Meeting (as applicable) as part of their consideration of the Investment Management Agreements.
34 |
In voting to approve the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of the Investment Management Agreements are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
* * *
At a meeting held on June 9, 2015 (the “Renewal Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), approved the continuation of the investment management agreements between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “Investment Management Agreements”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Biotech ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Environmental Services ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Gaming ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Morningstar Wide Moat ETF, MSCI International Quality Dividend ETF, MSCI International Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI Emerging Markets Quality ETF, Pharmaceutical ETF, Retail ETF, Russia Equal Weight ETF, Semiconductor ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF (collectively, the “Funds”).
The Board’s approval of the Investment Management Agreements was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In preparation for the Renewal Meeting, the Trustees held a meeting on May 15, 2015. At that meeting, the Trustees discussed the information the Adviser and Lipper Inc. (“Lipper”), an independent third party data provider, had provided to them in advance. The information provided to the Trustees included, among other things, information about the performance (for those Funds which had begun operations) and expenses of the Funds and the Funds’ peer funds (other index-based exchange-traded funds (“ETFs”)), information about the advisory services provided to the Funds and the personnel providing those services, and the profitability and other benefits enjoyed by the Adviser and its affiliates as a result of the Adviser’s relationship with the Funds. In reviewing performance information for the Funds against their peer groups, the Trustees considered that each Fund generally invests in a different group of issuers than the funds in its designated peer group. In addition, the Trustees reviewed certain performance information for each Fund that was not provided by Lipper. For these and other reasons, the Trustees noted that the peer group information did not necessarily provide meaningful direct comparisons to the Funds.
The Independent Trustees’ consideration of the Investment Management Agreements was based, in part, on their review of information obtained through discussions with the Adviser at the Renewal Meeting and the May 15, 2015 meeting regarding the management of the Funds and information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others involved in the management and administration of the Funds. The Trustees also considered the terms of, and scope of services that the Adviser provides under, the Investment Management Agreements, including, where applicable, the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of time.
The Trustees concluded that the Adviser has the requisite expertise and skill to manage the Funds’ portfolios. In evaluating the performance over relevant periods of each of the Funds that had commenced operations prior to the date of the Renewal Meeting (the “Operating Funds”), the Trustees reviewed various performance metrics but relied principally on a comparison of the “gross” performance of each Operating Fund (i.e., measured without regard to the impact of fees and expenses) to the performance of its benchmark index, in each case incorporating any fair value adjustments to the underlying securities. Based on the foregoing, the Trustees concluded that the investment performance of the Operating Funds was satisfactory.
35 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited) (continued)
The Trustees also considered information relating to the financial condition of the Adviser and the current status, as they understood it, of the Adviser’s compliance environment.
As noted above, the Trustees were also provided various data from Lipper comparing the Operating Funds’ expenses and performance to that of other ETFs. The Trustees noted that the information provided showed that each Operating Fund had a total expense ratio (after the effect of any applicable expense limitation) below or equal to the average and/or median of its respective peer group of funds, except for each of Market Vectors Gaming ETF and Morningstar Wide Moat ETF, which had a total expense ratio (after the effect of any applicable expense limitation) greater than the average and median of its peer group of funds. With respect to these Operating Funds, the Trustees reviewed the amount by which these Operating Funds’ total expense ratios (after the effect of any applicable expense limitation) exceeded the average and median of their respective peer groups. The Trustees concluded, in light of this information and the other information available to them, that the fees paid by the Operating Funds were reasonable in light of the performance of the Operating Funds and the quality of services received.
The Trustees also considered the benefits, other than fees under the Investment Management Agreements, received by the Adviser from serving as adviser to the Funds, including any benefits it may receive from serving as administrator to the Funds and from an affiliate of the Adviser serving as distributor for the Funds.
The Trustees also considered information provided by the Adviser about the overall profitability of the Adviser and its profitability or loss in respect of each Operating Fund. The Trustees reviewed each Fund’s asset size, expense ratio and expense cap and noted that the Investment Management Agreements do not include breakpoints in the advisory fee rates as asset levels in a Fund increase. The Trustees considered the potential variability in net assets of these Funds and the sustainability of any potential economies of scale which may exist. The Trustees also evaluated the extent to which management fees for the Operating Funds effectively incorporate the benefits of economies of scale. The Trustees noted that the Adviser has capped expenses on each Operating Fund since its inception. Based on the foregoing and the other information available to them, the Trustees determined that the advisory fee rate for each Fund is reasonable and appropriate in relation to the current asset size of each Fund and the other factors discussed above and currently reflects an appropriate sharing of any economies of scale which may exist with shareholders. The Trustees also determined that the profits earned by the Adviser in respect of the Funds that were profitable to the Adviser were reasonable in light of the nature and quality of the services received by such Funds.
The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability to the Adviser of Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Russia Equal Weight ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF to the Adviser because the Funds had not yet commenced operations at the time of the Renewal Meeting. The Trustees also could not consider the historical performance or the quality of services previously provided to each of these Funds, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the Renewal Meeting and at their May 15, 2015 meeting as part of their consideration of the Investment Management Agreements.
In voting to approve the continuation of the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of each Investment Management Agreement are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
36 |
This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by a Market Vectors ETF Trust (the “Trust”) Prospectus and Summary Prospectus, which includes more complete information. An investor should consider the investment objective, risks, and charges and expenses of the Funds carefully before investing. The prospectus and summary prospectus contains this and other information about the investment company. Please read the prospectus and summary prospectus carefully before investing.
Additional information about the Trust’s Board of Trustees/Officers and a description of the policies and procedures the Trust uses to determine how to vote proxies relating to portfolio securities are provided in the Statement of Additional Information. The Statement of Additional Information and information regarding how the Trust voted proxies relating to portfolio securities during the most recent twelve month period ending June 30 is available, without charge, by calling 1.800.826.2333, or by visiting www.vaneck.com, or on the Securities and Exchange Commission’s website at http://www.sec.gov.
The Trust files its complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarters of each fiscal year on Form N-Q. The Trust’s Form N-Qs are available on the Commission’s website at http://www.sec.gov and may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1.202.942.8090. The Funds’ complete schedules of portfolio holdings are also available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Investment Adviser: Van Eck Associates Corporation
Distributor: Van Eck Securities Corporation
Account Assistance: 1.800.826.2333 |
MVSTRATAR
ANNUAL
REPORT S E P T E M B E R 3 0 , 2 0 1 5 |
MARKET VECTORS® | |
QUALITY ETFs | |
MSCI Emerging Markets Quality ETF | QEM® |
MSCI Emerging Markets Quality Dividend ETF | QDEM® |
MSCI International Quality ETF | QXUS® |
MSCI International Quality Dividend ETF | QDXU® |
800.826.2333 | |
vaneck.com |
The information contained in the management discussion represents the opinions of Market Vectors ETF Trust and may differ from other persons. This information is not intended to be a forecast of future events, a guarantee of future results or investment advice. The information contained herein regarding each index has been provided by the relevant index provider. Also, unless otherwise specifically noted, any discussion of the Funds’ holdings and the Funds’ performance, and the views of Market Vectors ETF Trust are as of September 30, 2015, and are subject to change.
(unaudited)
On September 3, 2015, the Board of Trustees of Market Vectors ETF Trust approved the termination and liquidation of the following funds (“Funds”): Market Vectors MSCI Emerging Markets Quality ETF (QEM); Market Vectors MSCI Emerging Markets Quality Dividend ETF (QDEM); Market Vectors MSCI International Quality ETF (QXUS); and Market Vectors MSCI International Quality Dividend ETF (QDXU).
The Funds ceased trading their shares on NYSE Arca, Inc. after the close of business on Friday, September 18, 2015. The Funds liquidated and distributed their remaining proceeds or assets to shareholders (“Liquidating Distributions”) on October 16, 2015.
Shareholders who held shares of the Funds on the Funds’ liquidation date received Liquidating Distributions with values equal to their respective proportionate ownership interests in the Funds on that date.
Shareholders who received Liquidating Distributions generally will have recognized capital gains or losses equal to the amount received for their shares over their adjusted basis in such shares. Please consult your personal tax advisor about the potential tax consequences.
Shareholders should call the Funds’ distributor, Van Eck Securities Corporation, at 1.800.826.2333 for additional information.
Thank you for your participation in the Market Vectors ETF Trust. On the following pages, you will find the performance record of each of the four funds for the 12-month period ending September 30, 2015 as well as their financial statements.
Jan F. van Eck
Trustee and President
Market Vectors ETF Trust
October 21, 2015
Represents the opinions of the investment adviser. Past performance is no guarantee of future results. Not intended to be a forecast of future events, a guarantee of future results or investment advice. Current market conditions may not continue.
1 |
MARKET VECTORS QUALITY ETFs
Management Discussion (unaudited)
MSCI Emerging Markets Quality
Sweden was the largest positive contributor to the Fund’s total returns. Exposures to Brazil and South Africa were the two largest negative contributors to the Fund’s total returns, followed by exposure to Indonesia. All sectors detracted from the Fund’s performance, with the financials and energy sectors being the largest detractors.
MSCI Emerging Markets Quality Dividend
Not one sector or country contributed positively to overall performance. As with the MSCI Emerging Markets Quality ETF, exposures to Brazil and South Africa were the two largest negative contributors to the Fund’s total returns. China was also a major detractor from performance. Energy companies were the most significant detractors from the Fund’s total returns, followed by financial companies.
MSCI International Quality
Exposures to Denmark and Spain were the two largest positive contributors to the Fund’s total returns. Exposures to the U.K. and Australia were the two largest detractors from performance. On a sector basis, industrials and materials companies provided the greatest negative contributions, followed by those in the energy and information technology sectors.
MSCI International Quality Dividend
Exposure to the U.K. was the largest negative contributor to the Fund’s total returns, followed by exposures to Canada and Australia. On a sector basis, energy and financial companies provided the greatest negative contributions to overall performance, followed by materials companies.
2 |
MSCI EMERGING MARKETS QUALITY ETF
September 30, 2015 (unaudited)
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark.
Hypothetical Growth of $10,000 (Since Inception)
Total Return | Share Price1 | NAV | M1EFQU2 | |||||||||
One Year | (17.42 | )% | (14.72 | )% | (14.96 | )% | ||||||
Life* (annualized) | (6.47 | )% | (4.79 | )% | (4.60 | )% | ||||||
Life* (cumulative) | (10.69 | )% | (7.96 | )% | (7.66 | )% | ||||||
* since 1/21/2014 |
Commencement date for the Market Vectors MSCI Emerging Markets Quality ETF was 1/21/14.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (1/21/14) to the first day of secondary market trading in shares of the Fund (1/23/14), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 2.85% / Net Expense Ratio 0.50%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.50% of the Fund’s average daily net assets per year until at least February 1, 2016. The expense limitation continued until the Fund liquidated on October 16, 2015.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
3 |
MSCI EMERGING MARKETS QUALITY ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
2 | MSCI Emerging Markets Quality Index (M1EFQU) is modified capitalization weighted and aims to capture the performance of quality growth stocks selected from the Parent Index (MSCI Emerging Markets Index), by identifying stocks with high quality scores based on three main fundamental variables: high return on equity, stable year-over-year earnings growth and low financial leverage. The Index reweights the selected quality growth stocks from the parent index to emphasize stocks with high quality scores. |
MSCI Emerging Markets Quality Index (the “Index”) is the exclusive property and a trademark of MSCI and has been licensed for use for certain purposes by Van Eck Associates Corporation for Market Vectors Emerging Markets Quality ETF (the “Fund”) based on the Index. The Fund is not sponsored, endorsed, sold or promoted by MSCI, and MSCI makes no representation regarding the advisability of trading in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors MSCI Emerging Markets Quality
ETF (QEM)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for QEM is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
January 23, 2014* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 14 | 3.3 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 4 | 0.9 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 3 | 0.7 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 5 | 1.2 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 5 | 1.2 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 5 | 1.2 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 6 | 1.4 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 9 | 2.1 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 14 | 3.3 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 31 | 7.3 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 55 | 12.9 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 84 | 19.6 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 56 | 13.2 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 36 | 8.5 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 15 | 3.5 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 11 | 2.6 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 17 | 4.0 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 17 | 4.0 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 7 | 1.6 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 8 | 1.9 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 1 | 0.2 | % | |||||
Less Than -5.0% | 23 | 5.4 | % | |||||
426 | 100.0 | % |
* | First Day of secondary market trading. |
4 |
MSCI EMERGING MARKETS QUALITY DIVIDEND ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark.
Hypothetical Growth of $10,000 (Since Inception)
Total Return | Share Price1 | NAV | M1EFDY2 | |||||||||
One Year | (20.37 | )% | (20.14 | )% | (22.50 | )% | ||||||
Life* (annualized) | (10.17 | )% | (9.58 | )% | (10.94 | )% | ||||||
Life* (cumulative) | (16.58 | )% | (15.65 | )% | (17.78 | )% | ||||||
* since 1/21/2014 |
Commencement date for the Market Vectors MSCI Emerging Markets Quality Dividend ETF was 1/21/14.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (1/21/14) to the first day of secondary market trading in shares of the Fund (1/23/14), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 3.34% / Net Expense Ratio 0.50%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.50% of the Fund’s average daily net assets per year until at least February 1, 2016. The expense limitation continued until the Fund liquidated on October 16, 2015.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
5 |
MSCI EMERGING MARKETS QUALITY DIVIDEND ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | MSCI Emerging Markets High Dividend Yield Index (M1EFDY) is modified capitalization weighted and is designed to reflect the performance of equities in the Parent Index (MSCI Emerging Markets Index) with dividend yields that are higher than average dividend yield of the Parent Index that are deemed by the Index Provider (MSCI) to be both sustainable and persistent. |
MSCI Emerging Markets High Dividend Yield Index (the “Index”) is the exclusive property and a trademark of MSCI and has been licensed for use for certain purposes by Van Eck Associates Corporation for Market Vectors Emerging Markets Quality Dividend ETF (the “Fund”) based on the Index. The Fund is not sponsored, endorsed, sold or promoted by MSCI, and MSCI makes no representation regarding the advisability of trading in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors MSCI Emerging Markets Quality
Dividend ETF (QDEM)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for QDEM is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
January 23, 2014* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 19 | 4.5 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 4 | 0.9 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 4 | 0.9 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 4 | 0.9 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 9 | 2.1 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 9 | 2.1 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 16 | 3.8 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 28 | 6.6 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 25 | 5.9 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 35 | 8.2 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 65 | 15.3 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 99 | 23.1 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 51 | 12.0 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 22 | 5.2 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 12 | 2.8 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 5 | 1.2 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 5 | 1.2 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 5 | 1.2 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 2 | 0.5 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 1 | 0.2 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 6 | 1.4 | % | |||||
426 | 100.0 | % |
* | First Day of secondary market trading. |
6 |
MSCI INTERNATIONAL QUALITY ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark.
Hypothetical Growth of $10,000 (Since Inception)
Total Return | Share Price1 | NAV | M1WDUQU2 | |||||||||
One Year | (7.16 | )% | (6.78 | )% | (8.30 | )% | ||||||
Life* (annualized) | (2.92 | )% | (2.82 | )% | (3.29 | )% | ||||||
Life* (cumulative) | (4.89 | )% | (4.72 | )% | (5.50 | )% | ||||||
* since 1/21/2014 |
Commencement date for the Market Vectors MSCI International Quality ETF was 1/21/14.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (1/21/14) to the first day of secondary market trading in shares of the Fund (1/23/14), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 4.88% / Net Expense Ratio 0.45%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.45% of the Fund’s average daily net assets per year until at least February 1, 2016. The expense limitation continued until the Fund liquidated on October 16, 2015.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
7 |
MSCI INTERNATIONAL QUALITY ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | MSCI ACWI ex USA Quality Index (M1WDUQU) is modified capitalization and aims to capture the performance of quality growth stocks selected from the Parent Index (MSCI ASWI ex USA Quality Index) by identifying stocks with high quality scores based on three main fundamental variables: high return on equity, stable year-over-year earnings growth and low financial leverage. The Index reweights the selected quality growth stocks from the parent index to emphasize stocks with high quality scores. |
MSCI ACWI ex USA Quality Index (the “Index”) is the exclusive property and a trademark of MSCI and has been licensed for use for certain purposes by Van Eck Associates Corporation for Market Vectors International Quality ETF (the “Fund”) based on the Index. The Fund is not sponsored, endorsed, sold or promoted by MSCI, and MSCI makes no representation regarding the advisability of trading in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors MSCI International Quality
ETF (QXUS)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for QXUS is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
January 23, 2014* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 11 | 2.6 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 2 | 0.5 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 4 | 0.9 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 6 | 1.4 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 8 | 1.9 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 8 | 1.9 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 11 | 2.6 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 19 | 4.5 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 15 | 3.5 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 35 | 8.2 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 60 | 14.0 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 109 | 25.5 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 65 | 15.2 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 20 | 4.7 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 25 | 5.9 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 13 | 3.1 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 10 | 2.4 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 5 | 1.2 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 0 | 0.0 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
426 | 100.0 | % |
* | First Day of secondary market trading. |
8 |
MSCI INTERNATIONAL QUALITY DIVIDEND ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
This chart shows the value of a hypothetical $10,000 investment in the Fund at NAV and at Share Price over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The result is compared with the Fund’s benchmark.
Hypothetical Growth of $10,000 (Since Inception)
Total Return | Share Price1 | NAV | M1WDUDY2 | |||||||||
One Year | (16.97 | )% | (14.50 | )% | (17.05 | )% | ||||||
Life* (annualized) | (9.48 | )% | (7.66 | )% | (9.03 | )% | ||||||
Life* (cumulative) | (15.49 | )% | (12.60 | )% | (14.78 | )% | ||||||
* since 1/21/2014 |
Commencement date for the Market Vectors MSCI International Quality Dividend ETF was 1/21/14.
1 | The price used to calculate market return (Share Price) is determined by using the closing price listed on NYSE Arca. Since the shares of the Fund did not trade in the secondary market until several days after the Fund’s commencement, for the period from commencement (1/21/14) to the first day of secondary market trading in shares of the Fund (1/23/14), the NAV of the Fund is used as a proxy for the secondary market trading price to calculate market returns. |
The performance data quoted represents past performance. Past performance is not a guarantee of future results. Performance information for the Fund reflects temporary waivers of expenses and/or fees. Had the Fund incurred all expenses, investment returns would have been reduced. These returns do not reflect the deduction of taxes that a shareholder would pay on Fund dividends and distributions or the sale of Fund shares.
Investment return and value of the shares of the Fund will fluctuate so that an investor’s shares, when sold, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Performance current to the most recent month-end is available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Gross Expense Ratio 4.23% / Net Expense Ratio 0.45%
Van Eck Associates Corporation (the “Adviser”) has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.45% of the Fund’s average daily net assets per year until at least February 1, 2016. The expense limitation continued until the Fund liquidated on October 16, 2015.
Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called “creation units” and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
The “Net Asset Value” (NAV) of a Market Vectors exchange-traded fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF’s intraday trading value. Market Vectors ETF investors should not expect to buy or sell shares at NAV.
9 |
MSCI INTERNATIONAL QUALITY DIVIDEND ETF
PERFORMANCE COMPARISON
September 30, 2015 (unaudited)
Index returns assume the reinvestment of all income and do not reflect any management fees or brokerage expenses associated with Fund returns. Investors cannot invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses.
2 | MSCI ACWI ex USA High Dividend Yield Index (M1WDUDY) is modified capitalization and is designed to reflect the performance of equities in the Parent Index (MSCI ACWI ex USA Index) with dividend yields that are higher than average dividend yield of the Parent Index that are deemed by the Index Provider (MSCI) to be both sustainable and persistent. |
MSCI ACWI ex USA High Dividend Yield Index (the “Index”) is the exclusive property and a trademark of MSCI and has been licensed for use for certain purposes by Van Eck Associates Corporation for Market Vectors International Quality Dividend ETF (the “Fund”) based on the Index. The Fund is not sponsored, endorsed, sold or promoted by MSCI, and MSCI makes no representation regarding the advisability of trading in the Fund.
FREQUENCY DISTRIBUTION OF PREMIUMS AND DISCOUNTS
(unaudited)
Market Vectors MSCI International Quality
Dividend ETF (QDXU)
Closing Price vs. NAV
The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price for QDXU is at a premium or discount to its daily net asset value (NAV). The chart is for comparative purposes only and represents the period noted.
January 23, 2014* through September 30, 2015 | ||||||||
Premium/Discount Range | Number of Days | Percentage of Total Days | ||||||
Greater than or Equal to 5.0% | 1 | 0.2 | % | |||||
Greater than or Equal to 4.5% And Less Than 5.0% | 2 | 0.5 | % | |||||
Greater than or Equal to 4.0% And Less Than 4.5% | 2 | 0.5 | % | |||||
Greater than or Equal to 3.5% And Less Than 4.0% | 0 | 0.0 | % | |||||
Greater than or Equal to 3.0% And Less Than 3.5% | 3 | 0.7 | % | |||||
Greater than or Equal to 2.5% And Less Than 3.0% | 2 | 0.5 | % | |||||
Greater than or Equal to 2.0% And Less Than 2.5% | 7 | 1.6 | % | |||||
Greater than or Equal to 1.5% And Less Than 2.0% | 2 | 0.5 | % | |||||
Greater than or Equal to 1.0% And Less Than 1.5% | 7 | 1.6 | % | |||||
Greater than or Equal to 0.5% And Less Than 1.0% | 36 | 8.5 | % | |||||
Greater than or Equal to 0.0% And Less Than 0.5% | 117 | 27.4 | % | |||||
Greater than or Equal to -0.5% And Less Than 0.0% | 146 | 34.3 | % | |||||
Greater than or Equal to -1.0% And Less Than -0.5% | 50 | 11.7 | % | |||||
Greater than or Equal to -1.5% And Less Than -1.0% | 19 | 4.5 | % | |||||
Greater than or Equal to -2.0% And Less Than -1.5% | 6 | 1.4 | % | |||||
Greater than or Equal to -2.5% And Less Than -2.0% | 4 | 0.9 | % | |||||
Greater than or Equal to -3.0% And Less Than -2.5% | 7 | 1.6 | % | |||||
Greater than or Equal to -3.5% And Less Than -3.0% | 11 | 2.6 | % | |||||
Greater than or Equal to -4.0% And Less Than -3.5% | 2 | 0.5 | % | |||||
Greater than or Equal to -4.5% And Less Than -4.0% | 2 | 0.5 | % | |||||
Greater than or Equal to -5.0% And Less Than -4.5% | 0 | 0.0 | % | |||||
Less Than -5.0% | 0 | 0.0 | % | |||||
426 | 100.0 | % |
* | First Day of secondary market trading. |
10 |
MARKET VECTORS ETF TRUST
(unaudited)
Hypothetical $1,000 investment at beginning of period
As a shareholder of a Fund, you incur operating expenses, including management fees and other Fund expenses. This disclosure is intended to help you understand the ongoing costs (in dollars) of investing in your Fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The disclosure is based on an investment of $1,000 invested at the beginning of the period and held for the entire period, April 1, 2015 to September 30, 2015.
Actual Expenses
The first line in the table below provides information about account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Period.”
Hypothetical Example for Comparison Purposes
The second line in the table below provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as program fees. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.
Beginning | Ending | Annualized | Expenses Paid | |||||||||||||
Account | Account | Expense | During the Period* | |||||||||||||
Value | Value | Ratio | April 1, 2015- | |||||||||||||
April 1, 2015 | September 30, 2015 | During Period | September 30, 2015 | |||||||||||||
MSCI Emerging Markets Quality ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 844.20 | 0.50 | % | $2.31 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.56 | 0.50 | % | $2.54 | |||||||||
MSCI Emerging Markets Quality Dividend ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 839.50 | 0.50 | % | $2.31 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.56 | 0.50 | % | $2.54 | |||||||||
MSCI International Quality ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 925.50 | 0.45 | % | $2.17 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.81 | 0.45 | % | $2.28 | |||||||||
MSCI International Quality Dividend ETF | ||||||||||||||||
Actual | $ | 1,000.00 | $ | 903.90 | 0.45 | % | $2.15 | |||||||||
Hypothetical** | $ | 1,000.00 | $ | 1,022.81 | 0.45 | % | $2.28 |
* | Expenses are equal to the Fund’s annualized expense ratio (for the six months ended September 30, 2015) multiplied by the average account value over the period, multiplied by the number of days in the most recent fiscal half year divided by the number of days in the fiscal year (to reflect the one-half year period). |
** | Assumes annual return of 5% before expenses |
11 |
MSCI EMERGING MARKETS QUALITY DIVIDEND ETF
September 30, 2015
Number of Shares | Value | |||||
COMMON STOCKS: 3.4% | ||||||
Qatar: 3.4% | ||||||
588 | Barwa Real Estate Co. QSC # | $ | 6,917 | |||
281 | Gulf International Services QSC # | 5,032 | ||||
914 | Industries Qatar QSC # | 30,941 | ||||
2,220 | Masraf Al Rayan QSC # | 26,263 | ||||
166 | Qatar Electricity and Water Co. QSC | 9,544 | ||||
1,057 | Qatar National Bank SAQ # | 54,478 | ||||
133,175 | ||||||
Taiwan: 0.0% | ||||||
1,363 | Yuanta Financial Holding Co. Ltd. # | 507 | ||||
Total Common Stocks: 3.4% (Cost: $158,721) | 133,682 | |||||
Other assets less liabilities: 96.6% | 3,829,582 | |||||
NET ASSETS: 100.0% | $ | 3,963,264 | ||||
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $124,138 which represents 3.1% of net assets. |
Summary of Investments by | |||||||||
Sector (unaudited) | % of Investments | Value | |||||||
Energy | 3.8 | % | $ | 5,032 | |||||
Financials | 66.0 | 88,165 | |||||||
Industrials | 23.1 | 30,941 | |||||||
Utilities | 7.1 | 9,544 | |||||||
100.0 | % | $ | 133,682 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 2 | Level 3 | |||||||||||||||||
Level 1 | Significant | Significant | ||||||||||||||||
Quoted | Observable | Unobservable | ||||||||||||||||
Prices | Inputs | Inputs | Value | |||||||||||||||
Common Stocks | ||||||||||||||||||
Qatar | $ | 9,544 | $ | 123,631 | $ | — | $ | 133,175 | ||||||||||
Taiwan | — | 507 | — | 507 | ||||||||||||||
Total | $ | 9,544 | $ | 124,138 | $ | — | $ | 133,682 |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
12 |
MSCI INTERNATIONAL QUALITY ETF
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||
COMMON STOCKS: 0.5% | ||||||
Qatar: 0.5% | ||||||
55 | Gulf International Services QSC # | $ | 985 | |||
171 | Industries Qatar QSC # | 5,789 | ||||
365 | Masraf Al Rayan QSC # | 4,318 | ||||
31 | Qatar Electricity and Water Co. QSC | 1,782 | ||||
96 | Qatar Insurance Co. SAQ | 2,454 | ||||
162 | Qatar National Bank SAQ # | 8,350 | ||||
Total Common Stocks: 0.5% (Cost: $28,767) | 23,678 | |||||
Other assets less liabilities: 99.5% | 4,444,834 | |||||
NET ASSETS: 100.0% | $ | 4,468,512 |
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $19,442 which represents 0.4% of net assets. |
Summary of Investments | |||||||||
by Sector (unaudited) | % of Investments | Value | |||||||
Energy | 4.2 | % | $ | 985 | |||||
Financials | 63.9 | 15,122 | |||||||
Industrials | 24.4 | 5,789 | |||||||
Utilities | 7.5 | 1,782 | |||||||
100.0 | % | $ | 23,678 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 2 | Level 3 | |||||||||||||||||
Level 1 | Significant | Significant | ||||||||||||||||
Quoted | Observable | Unobservable | ||||||||||||||||
Prices | Inputs | Inputs | Value | |||||||||||||||
Common Stocks | ||||||||||||||||||
Qatar | $ | 4,236 | $ | 19,442 | $ | — | $ | 23,678 |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
13 |
MSCI INTERNATIONAL QUALITY DIVIDEND ETF
SCHEDULE OF INVESTMENTS
September 30, 2015
Number of Shares | Value | |||||
COMMON STOCKS: 0.7% | ||||||
Qatar: 0.7% | ||||||
117 | Barwa Real Estate Co. QSC # | $ | 1,376 | |||
56 | Gulf International Services QSC # | 1,003 | ||||
181 | Industries Qatar QSC # | 6,127 | ||||
441 | Masraf Al Rayan QSC # | 5,217 | ||||
33 | Qatar Electricity & Water Co. QSC | 1,897 | ||||
210 | Qatar National Bank SAQ # | 10,824 | ||||
26,444 | ||||||
Taiwan: 0.0% | ||||||
262 | Yuanta Financial Holding Co. Ltd. # | 98 | ||||
Total Common Stocks: 0.7% (Cost: $30,051) | 26,542 | |||||
Other assets less liabilities: 99.3% | 4,006,683 | |||||
NET ASSETS: 100.0% | $ | 4,033,225 |
# | Indicates a fair valued security which has been valued in good faith pursuant to guidelines established by the Board of Trustees. The aggregate value of fair valued securities is $24,645 which represents 0.6% of net assets. |
Summary of Investments | |||||||||
by Sector (unaudited) | % of Investments | Value | |||||||
Energy | 3.8 | % | $ | 1,003 | |||||
Financials | 66.0 | 17,515 | |||||||
Industrials | 23.1 | 6,127 | |||||||
Utilities | 7.1 | 1,897 | |||||||
100.0 | % | $ | 26,542 |
The summary of inputs used to value the Fund’s investments as of September 30, 2015 is as follows:
Level 2 | Level 3 | |||||||||||||||||
Level 1 | Significant | Significant | ||||||||||||||||
Quoted | Observable | Unobservable | ||||||||||||||||
Prices | Inputs | Inputs | Value | |||||||||||||||
Common Stocks | ||||||||||||||||||
Qatar | $ | 1,897 | $ | 24,547 | $ | — | $ | 26,444 | ||||||||||
Taiwan | — | 98 | — | 98 | ||||||||||||||
Total | $ | 1,897 | $ | 24,645 | $ | — | $ | 26,542 |
There were no transfers between levels during the year ended September 30, 2015.
See Notes to Financial Statements
14 |
MARKET VECTORS ETF TRUST
STATEMENTS OF ASSETS AND LIABILITIES
September 30, 2015
MSCI | MSCI | MSCI | MSCI | |||||||||||||||||
Emerging | Emerging | International | International | |||||||||||||||||
Markets Quality | Markets Quality | Quality | Quality Dividend | |||||||||||||||||
ETF | Dividend ETF | ETF | ETF | |||||||||||||||||
Assets: | ||||||||||||||||||||
Investments, at value (1) | $ | — | $ | 133,682 | $ | 23,678 | $ | 26,542 | ||||||||||||
Cash | 4,432,389 | 3,830,495 | 4,462,498 | 4,020,563 | ||||||||||||||||
Cash denominated in foreign currency, at value (2) | 51,366 | 26,798 | 19,444 | 16,810 | ||||||||||||||||
Receivables: | ||||||||||||||||||||
Investment securities sold | 3,742 | 4,101 | 3,198 | 5,681 | ||||||||||||||||
Due from Adviser | 15,123 | 12,390 | 14,367 | 8,996 | ||||||||||||||||
Dividends | 1,946 | 6,483 | 14,662 | 14,299 | ||||||||||||||||
Prepaid expenses | — | 76 | 73 | 71 | ||||||||||||||||
Total assets | 4,504,566 | 4,014,025 | 4,537,920 | 4,092,962 | ||||||||||||||||
Liabilities: | ||||||||||||||||||||
Payables: | ||||||||||||||||||||
Investment securities purchased | 3,743 | 2,280 | 3,199 | 5,335 | ||||||||||||||||
Deferred Trustee fees | 22 | 17 | 19 | 17 | ||||||||||||||||
Accrued expenses | 60,601 | 48,464 | 66,190 | 54,385 | ||||||||||||||||
Total liabilities | 64,366 | 50,761 | 69,408 | 59,737 | ||||||||||||||||
NET ASSETS | $ | 4,440,200 | $ | 3,963,264 | $ | 4,468,512 | $ | 4,033,225 | ||||||||||||
Shares outstanding. | 100,000 | 100,000 | 100,000 | 100,000 | ||||||||||||||||
Net asset value, redemption and offering price per share | $ | 44.40 | $ | 39.63 | $ | 44.69 | $ | 40.33 | ||||||||||||
Net assets consist of: | ||||||||||||||||||||
Aggregate paid in capital | $ | 5,537,879 | $ | 5,026,356 | $ | 4,939,388 | $ | 5,039,718 | ||||||||||||
Net unrealized appreciation (depreciation) | 689 | (24,127 | ) | (5,609 | ) | (4,001 | ) | |||||||||||||
Undistributed (accumulated) net investment income (loss) | (33,241 | ) | 39,485 | (11,239 | ) | 33,884 | ||||||||||||||
Accumulated net realized loss | (1,065,127 | ) | (1,078,450 | ) | (454,028 | ) | (1,036,376 | ) | ||||||||||||
$ | 4,440,200 | $ | 3,963,264 | $ | 4,468,512 | $ | 4,033,225 | |||||||||||||
(1) Cost of investments | $ | — | $ | 158,721 | $ | 28,767 | $ | 30,051 | ||||||||||||
(2) Cost of cash denominated in foreign currency | $ | 50,371 | $ | 25,696 | $ | 19,113 | $ | 16,615 |
See Notes to Financial Statements
15 |
MARKET VECTORS ETF TRUST
For the Year Ended September 30, 2015
MSCI | MSCI | MSCI | MSCI | |||||||||||||||||
Emerging | Emerging | International | International | |||||||||||||||||
Markets Quality | Markets Quality | Quality | Quality Dividend | |||||||||||||||||
ETF | Dividend ETF | ETF | ETF | |||||||||||||||||
Income: | ||||||||||||||||||||
Dividends | $ | 210,984 | $ | 223,506 | $ | 141,253 | $ | 229,050 | ||||||||||||
Securities lending income | 1,963 | 279 | 1,050 | 2,063 | ||||||||||||||||
Foreign taxes withheld | (25,690 | ) | (29,975 | ) | (12,128 | ) | (16,742 | ) | ||||||||||||
Total income | 187,257 | 193,810 | 130,175 | 214,371 | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Management fees | 36,009 | 24,012 | 21,972 | 20,734 | ||||||||||||||||
Professional fees | 50,139 | 41,031 | 49,707 | 40,850 | ||||||||||||||||
Insurance | 242 | 90 | 88 | 87 | ||||||||||||||||
Trustees’ fees and expenses | 1,130 | 1,600 | 1,498 | 1,370 | ||||||||||||||||
Reports to shareholders | 13,933 | 13,553 | 13,430 | 13,221 | ||||||||||||||||
Indicative optimized portfolio value fee | 7,969 | 7,898 | 7,314 | 7,873 | ||||||||||||||||
Custodian fees | 55,517 | 36,838 | 77,119 | 56,835 | ||||||||||||||||
Registration fees | 5,184 | 5,170 | 5,161 | 5,171 | ||||||||||||||||
Transfer agent fees | 3,621 | 3,910 | 3,844 | 3,844 | ||||||||||||||||
Fund accounting fees | 25,611 | 20,090 | 52,009 | 38,880 | ||||||||||||||||
Interest | 299 | 12 | 9 | 21 | ||||||||||||||||
Other | 5,442 | 5,960 | 6,152 | 5,783 | ||||||||||||||||
Total expenses | 205,096 | 160,164 | 238,303 | 194,669 | ||||||||||||||||
Waiver of management fees | (36,009 | ) | (24,012 | ) | (21,972 | ) | (20,734 | ) | ||||||||||||
Expenses assumed by the Adviser | (132,780 | ) | (112,128 | ) | (194,351 | ) | (153,182 | ) | ||||||||||||
Net expenses | 36,307 | 24,024 | 21,980 | 20,753 | ||||||||||||||||
Net investment income | 150,950 | 169,786 | 108,195 | 193,618 | ||||||||||||||||
Net realized gain (loss) on: | ||||||||||||||||||||
Investments | (1,079,886 | )(a) | (1,078,466 | ) | (459,550 | )(a) | (1,036,352 | ) | ||||||||||||
In-kind redemptions | 213,342 | — | — | — | ||||||||||||||||
Foreign currency transactions and foreign denominated assets and liabilities | (35,410 | ) | (26,943 | ) | (11,860 | ) | (7,893 | ) | ||||||||||||
Net realized loss | (901,954 | ) | (1,105,409 | ) | (471,410 | ) | (1,044,245 | ) | ||||||||||||
Net change in unrealized appreciation (depreciation) on: | ||||||||||||||||||||
Investments | (266,560 | ) | (75,351 | ) | 28,794 | 145,824 | ||||||||||||||
Foreign currency transactions and foreign denominated assets and liabilities | 1,791 | 2,792 | 1,180 | 420 | ||||||||||||||||
Net change in unrealized appreciation (depreciation) | (264,769 | ) | (72,559 | ) | 29,974 | 146,244 | ||||||||||||||
Net Decrease in Net Assets Resulting from Operations | $ | (1,015,773 | ) | $ | (1,008,182 | ) | $ | (333,241 | ) | $ | (704,383 | ) |
(a) | Net of foreign taxes of $14,763 and $5,550 for MSCI Emerging Markets Quality ETF and MSCI International Quality ETF, respectively. |
See Notes to Financial Statements
16 |
[This Page Intentionally Left Blank.]
MARKET VECTORS ETF TRUST
STATEMENTS OF CHANGES IN NET ASSETS
MSCI Emerging Markets Quality ETF | MSCI Emerging Markets Quality Dividend ETF | |||||||||||||||
For the Year Ended September 30, 2015 | For the Period January 21, 2014* through September 30, 2014 | For the Year Ended September 30, 2015 | For the Period January 21, 2014* through September 30, 2014 | |||||||||||||
Operations: | ||||||||||||||||
Net investment income | $ | 150,950 | $ | 96,459 | $ | 169,786 | $ | 193,536 | ||||||||
Net realized gain (loss) | (901,954 | ) | 26,059 | (1,105,409 | ) | 23,972 | ||||||||||
Net change in unrealized appreciation (depreciation) | (264,769 | ) | 265,458 | (72,559 | ) | 48,432 | ||||||||||
Net increase (decrease) in net assets resulting from operations | (1,015,773 | ) | 387,976 | (1,008,182 | ) | 265,940 | ||||||||||
Dividends and Distributions to shareholders: | ||||||||||||||||
Dividends from net investment income | (191,400 | ) | (41,240 | ) | (202,370 | ) | (92,780 | ) | ||||||||
Distributions from net realized capital gains | (23,900 | ) | — | (25,700 | ) | — | ||||||||||
Total Dividends and Distributions | (215,300 | ) | (41,240 | ) | (228,070 | ) | (92,780 | ) | ||||||||
Share transactions:** | ||||||||||||||||
Proceeds from sale of shares | 5,389,218 | 5,028,438 | — | 5,026,356 | ||||||||||||
Cost of shares redeemed | (5,093,119 | ) | — | — | — | |||||||||||
Increase in net assets resulting from share transactions | 296,099 | 5,028,438 | — | 5,026,356 | ||||||||||||
Total increase (decrease) in net assets | (934,974 | ) | 5,375,174 | (1,236,252 | ) | 5,199,516 | ||||||||||
Net Assets, beginning of period | 5,375,174 | — | 5,199,516 | — | ||||||||||||
Net Assets, end of period† | $ | 4,440,200 | $ | 5,375,174 | $ | 3,963,264 | $ | 5,199,516 | ||||||||
† Including undistributed (accumulated) net investment income (loss) | $ | (33,241 | ) | $ | 57,468 | $ | 39,485 | $ | 99,028 | |||||||
** Shares of Common Stock Issued (no par value) | ||||||||||||||||
Shares sold | 100,000 | 100,000 | — | 100,000 | ||||||||||||
Shares redeemed | (100,000 | ) | — | — | — | |||||||||||
Net increase | — | 100,000 | — | 100,000 |
* Commencement of operations
See Notes to Financial Statements
18 |
MSCI International Quality ETF | MSCI International Quality Dividend ETF | |||||||||||||
For the Year Ended September 30, 2015 | For the Period January 21, 2014* through September 30, 2014 | For the Year Ended September 30, 2015 | For the Period January 21, 2014* through September 30, 2014 | |||||||||||
$ | 108,195 | $ | 182,146 | $ | 193,618 | $ | 256,691 | |||||||
(471,410 | ) | 222,931 | (1,044,245 | ) | (8,556 | ) | ||||||||
29,974 | (35,583 | ) | 146,244 | (150,245 | ) | |||||||||
(333,241 | ) | 369,494 | (704,383 | ) | 97,890 | |||||||||
(130,860 | ) | (145,310 | ) | (275,700 | ) | (123,500 | ) | |||||||
(84,600 | ) | — | (800 | ) | — | |||||||||
(215,460 | ) | (145,310 | ) | (276,500 | ) | (123,500 | ) | |||||||
— | 10,091,205 | — | 5,039,718 | |||||||||||
— | (5,298,176 | ) | — | — | ||||||||||
— | 4,793,029 | — | 5,039,718 | |||||||||||
(548,701 | ) | 5,017,213 | (980,883 | ) | 5,014,108 | |||||||||
5,017,213 | — | 5,014,108 | — | |||||||||||
$ | 4,468,512 | $ | 5,017,213 | $ | 4,033,225 | $ | 5,014,108 | |||||||
$ | (11,239 | ) | $ | 9,408 | $ | 33,884 | $ | 123,924 | ||||||
— | 200,000 | — | 100,000 | |||||||||||
— | (100,000 | ) | — | — | ||||||||||
— | 100,000 | — | 100,000 |
See Notes to Financial Statements
19 |
MARKET VECTORS ETF TRUST
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Not Annualized |
(d) | Annualized |
See Notes to Financial Statements
20 |
MARKET VECTORS ETF TRUST
FINANCIAL HIGHLIGHTS
For a share outstanding throughout each period:
(a) | Commencement of operations |
(b) | Total return is calculated assuming an initial investment made at the net asset value at the beginning of period, reinvestment of any dividends and distributions at net asset value on the dividend/distributions payment date and a redemption at the net asset value on the last day of the period. The return does not reflect the deduction of taxes that a shareholder would pay on Fund dividends/distributions or the redemption of Fund shares. |
(c) | Not Annualized |
(d) | Annualized |
See Notes to Financial Statements
21 |
MARKET VECTORS ETF TRUST
September 30, 2015
Note 1—Fund Organization—Market Vectors ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended, as an open-end management investment company. The Trust was incorporated in Delaware as a statutory trust on March 15, 2001. The Trust operates as a series fund, and as of September 30, 2015, offers fifty-eight investment portfolios, each of which represents a separate series of the Trust.
These financial statements relate only to the following investment portfolios: MSCI Emerging Markets Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI International Quality ETF and MSCI International Quality Dividend ETF (each a “Fund” and, together, the “Funds”). Each Fund was created to provide investors with the opportunity to purchase a security representing a proportionate undivided interest in a portfolio of securities consisting of substantially all of the common stocks in substantially the same weighting, in an index published by MSCI.
At a meeting held on September 3, 2015, the Board of Trustees of the Trust unanimously approved the termination and winding down of each Fund. Each Fund ceased trading its shares on NYSE Arca, Inc. after the close of business on September 18, 2015. Thereafter, each Fund has commenced liquidation and distributed its remaining proceeds or assets to shareholders (the “Liquidating Distribution”) on October 16, 2015.
The Funds’ commencement of operations dates and their respective indices are presented below:
Fund | Commencement of Operations |
Index | ||
MSCI Emerging Markets Quality ETF | January 21, 2014 | MSCI Emerging Markets Quality Index | ||
MSCI Emerging Markets Quality Dividend ETF | January 21, 2014 | MSCI Emerging Markets High Dividend Yield Index | ||
MSCI International Quality ETF | January 21, 2014 | MSCI ACWI ex USA Quality Index | ||
MSCI International Quality Dividend ETF | January 21, 2014 | MSCI ACWI ex USA High Dividend Quality Index |
Note 2—Significant Accounting Policies—The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.
The Funds are investment companies and are following accounting and reporting requirements of Accounting Standards Codification (“ASC”) 946 Financial Services — Investment Companies.
The following is a summary of significant accounting policies followed by the Funds.
A. | Security Valuation—The Funds value their investments in securities and other assets and liabilities carried at fair value daily. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Securities traded on national exchanges or traded on the NASDAQ National Market System are valued at the last sales price as reported at the close of each business day. Securities traded on the NASDAQ Stock Market are valued at the NASDAQ official closing price. Over-the-counter securities not included in the NASDAQ National Market System and listed securities for which no sale was reported are valued at the mean of the bid and ask prices. To the extent these securities are actively traded they are categorized as Level 1 in the fair value hierarchy (described below). Certain foreign securities, whose values may be affected by market direction or events occurring before the Funds’ pricing time (4:00 p.m. Eastern Standard Time) but after the last close of the securities’ primary market, are fair valued using a pricing service and are categorized as Level 2 in the fair value hierarchy. The pricing service, using methods approved by the Board of Trustees, considers the correlation of the trading patterns of the foreign security to intraday trading in the U.S. markets, based on indices of domestic securities and other appropriate indicators such as prices of relevant ADR’s and futures contracts. The Funds may also fair value securities in other situations, such as, when a particular foreign market is closed but the Fund is open. Short-term obligations with sixty days or less to maturity are valued at amortized cost, which with accrued interest approximates fair value. Money market fund investments are valued at net asset value and are considered to be Level 1 in the fair value hierarchy. Securities for which quotations are not available are stated at fair value as determined by the Pricing Committee of Van Eck Associates Corporation (the “Adviser”) appointed by the Board of Trustees. The Pricing Committee provides oversight of the Funds’ valuation policies and procedures, which are approved by the |
22 |
Funds’ Board of Trustees. Among other things, these procedures allow the Funds to utilize independent pricing services, quotations from securities dealers, and other market sources to determine fair value. The Pricing Committee convenes regularly to review the fair value of financial instruments for which market prices are not readily available. The Pricing Committee employs various methods for calibrating the valuation approaches utilized to determine fair value, including a regular review of key inputs and assumptions, transactional back-testing and disposition analysis. | |
Certain factors such as economic conditions, political events, market trends, the nature of and duration of any restrictions on disposition, trading in similar securities of the issuer or comparable issuers and other security specific information are used to determine the fair value of these securities. Depending on the relative significance of valuation inputs, these securities may be classified either as Level 2 or Level 3 in the fair value hierarchy. The price which the Funds may realize upon sale of an investment may differ materially from the value presented in the Schedules of Investments. | |
The Funds utilize various methods to measure the fair value of its investments on a recurring basis which includes a hierarchy that prioritizes inputs to valuation methods used to measure fair value. The fair value hierarchy gives highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The transfers between levels of the fair value hierarchy assume the financial instruments were transferred at the beginning of the reporting period. The three levels of the fair value hierarchy are described below: | |
Level 1 – Quoted prices in active markets for identical securities. | |
Level 2 – Significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). | |
Level 3 – Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments). | |
A summary of the inputs, the levels used to value the Funds’ investments, and transfers between levels are located in the Schedules of Investments. Additionally, tables that reconcile the valuation of the Funds’ Level 3 investments and that present additional information about valuation methodologies and unobservable inputs, if applicable, are located in the Schedules of Investments. | |
B. | Federal Income Taxes—It is each Fund’s policy to comply with the provisions of the Internal Revenue Code applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Therefore, no federal income tax provision is required. |
C. | Dividends and Distributions to Shareholders—Dividends to shareholders from net investment income, if any, are declared and paid quarterly by each Fund. Distributions from net realized capital gains, if any, are declared and paid annually. Income dividends and capital gain distributions are determined in accordance with U.S. income tax regulations, which may differ from such amounts determined in accordance with GAAP. |
D. | Currency Translation—Assets and liabilities denominated in foreign currencies and commitments under foreign currency contracts are translated into U.S. dollars at the closing prices of such currencies each business day. Purchases and sales of investments are translated at the exchange rates prevailing when such investments are acquired or sold. Foreign denominated income and expenses are translated at the exchange rates prevailing when accrued. The portion of realized and unrealized gains and losses on investments that result from fluctuations in foreign currency exchange rates is not separately disclosed in the financial statements. Recognized gains or losses attributable to foreign currency fluctuations on foreign currency denominated assets, other than investments, and liabilities are recorded as net realized gain (loss) on foreign currency transactions and foreign denominated assets and liabilities in the Statements of Operations. |
E. | Restricted Securities—The Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities, if any, is included at the end of each Fund’s Schedule of Investments. |
23 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
September 30, 2015 (continued)
F. | Use of Derivative Instruments—The Funds may invest in derivative instruments, including, but not limited to, options, futures, swaps and other derivatives relating to foreign currency transactions. A derivative is an instrument whose value is derived from underlying assets, indices, reference rates or a combination of these factors. Derivative instruments may be privately negotiated contracts (often referred to as over-the-counter (“OTC”) derivatives) or they may be listed and traded on an exchange. Derivative contracts may involve future commitments to purchase or sell financial instruments at specified terms on a specified date, or to exchange interest payment streams or currencies based on a notional or contractual amount. Derivative instruments may involve a high degree of financial risk. The use of derivative instruments also involves the risk of loss if the Adviser is incorrect in its expectation of the timing or level of fluctuations in securities prices, interest rates or currency prices. Investments in derivative instruments also include the risk of default by the counterparty, the risk that the investment may not be liquid and the risk that a small movement in the price of the underlying security or benchmark may result in a disproportionately large movement, unfavorable or favorable, in the price of the derivative instruments. The Funds held no derivative instruments during the year ended September 30, 2015. |
G. | Repurchase Agreements—The Funds may enter into repurchase agreements with financial institutions, deemed to be creditworthy by the Adviser, to generate income from their excess cash balances and to invest securities lending cash collateral. A repurchase agreement is an agreement under which a Fund acquires securities from a seller, subject to resale to the seller at an agreed upon price and date. A Fund, through its custodian/securities lending agent, takes possession of securities collateralizing the repurchase agreement. Pursuant to the terms of the repurchase agreement, such securities must have an aggregate market value greater than or equal to the terms of the repurchase price plus accrued interest at all times. If the value of the underlying securities falls below the value of the repurchase price plus accrued interest, the Funds will require the seller to deposit additional collateral by the next business day. If the request for additional collateral is not met, or the seller defaults on its repurchase obligation, the Funds maintain their right to sell the underlying securities at market value and may claim any resulting loss against the seller. As of September 30, 2015 the Funds held no repurchase agreements. |
H. | Offsetting Assets and Liabilities—In the ordinary course of business, the Funds enter into transactions subject to enforceable master netting or other similar agreements. Generally, the right of setoff in those agreements allows the Funds to set off any exposure to a specific counterparty with any collateral received or delivered to that counterparty based on the terms of the agreements. The Funds may pledge or receive cash and/or securities as collateral for derivative instruments, securities lending and repurchase agreements. For financial reporting purposes, the Funds present securities lending and repurchase agreement assets and liabilities on a gross basis in the Statements of Assets and Liabilities. As of September 30, 2015, the Funds held no financial instruments that would require additional disclosure. |
I. | Other—Security transactions are accounted for on trade date. Transactions in certain securities may take longer than the customary settlement cycle to be completed. The counterparty is required to collateralize such trades with cash in excess of the market value of the transaction, which is held at the custodian and marked to market daily. Realized gains and losses are calculated on the identified cost basis. Dividend income is recorded on the ex-dividend date except that certain dividends from foreign securities are recognized upon notification of the ex-dividend date/rate. Interest income, including amortization of premiums and discounts, is accrued as earned. |
In the normal course of business, the Funds enter into contracts that contain a variety of general indemnifications. The Funds’ maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Funds that have not yet occurred. However, the Adviser believes the risk of loss under these arrangements to be remote. |
Note 3—Investment Management and Other Agreements—The Adviser is the investment adviser to the Funds. The Adviser receives a management fee, calculated daily and payable monthly based on an annual rate of each Fund’s average daily net assets. The Adviser has agreed, at least until February 1, 2016, to voluntarily waive or limit its fees and to assume as its own expense certain expenses otherwise payable by the Funds so that each Fund’s total annual operating expenses does not exceed the expense limitations (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) listed in the table below.
24 |
The current management fee rate, expense limitations and the amounts waived/assumed by the Adviser for the year ended September 30, 2015, are as follows:
Expenses | ||||||||||||||||
Waiver of | Assumed | |||||||||||||||
Management Fee | Expense | Management | by the | |||||||||||||
Fund | Rate | Limitations | Fees | Adviser | ||||||||||||
MSCI Emerging Markets Quality ETF | 0.50 | % | 0.50 | % | $36,009 | $ | 132,780 | |||||||||
MSCI Emerging Markets Quality Dividend ETF | 0.50 | 0.50 | 24,012 | 112,128 | ||||||||||||
MSCI International Quality ETF | 0.45 | 0.45 | 21,972 | 194,351 | ||||||||||||
MSCI International Quality Dividend ETF | 0.45 | 0.45 | 20,734 | 153,182 |
In addition, Van Eck Securities Corporation, an affiliate of the Adviser, acts as the Funds’ Distributor. Certain officers and a Trustee of the Trust are officers, directors or stockholders of the Adviser and Distributor.
Note 4—Investments—For the year ended September 30, 2015, the cost of purchases and proceeds from sales of investments other than U.S. government obligations and short-term obligations (excluding in-kind transactions described in Note 6) were as follows:
Cost of Investments | Proceeds from | |||||||
Fund | Purchased | Investments Sold | ||||||
MSCI Emerging Markets Quality ETF | $4,409,330 | $ | 8,830,265 | |||||
MSCI Emerging Markets Quality Dividend ETF | 1,231,014 | 5,057,038 | ||||||
MSCI International Quality ETF | 798,268 | 5,329,670 | ||||||
MSCI International Quality Dividend ETF | 1,311,173 | 5,374,106 |
Note 5—Income Taxes—As of September 30, 2015, for Federal income tax purposes, the identified cost of investments owned, net unrealized depreciation, gross unrealized appreciation, and gross unrealized depreciation of investments were as follows:
Net Unrealized | ||||||||||||||||
Cost of | Gross Unrealized | Gross Unrealized | Appreciation | |||||||||||||
Fund | Investments | Appreciation | Depreciation | (Depreciation) | ||||||||||||
MSCI Emerging Markets Quality Dividend ETF | $158,721 | $601 | $(25,640 | ) | $(25,039 | ) | ||||||||||
MSCI International Quality ETF | 28,767 | 149 | (5,238 | ) | (5,089 | ) | ||||||||||
MSCI International Quality Dividend ETF | 30,051 | 135 | (3,644 | ) | (3,509 | ) |
At September 30, 2015, the components of accumulated earnings (deficit) on a tax basis, for each Fund, were as follows:
Undistributed | Accumulated | Qualified | Other | Unrealized | ||||||||||||||||||||
Ordinary | Capital | Late Year | Temporary | Appreciation | ||||||||||||||||||||
Fund | Income | Losses | Losses | Difference | (Depreciation) | Total | ||||||||||||||||||
MSCI Emerging Markets Quality ETF | $ | — | $ | (1,065,126 | ) | $ | (33,219 | ) | $ | (23 | ) | $ | 689 | $ | (1,097,679 | ) | ||||||||
MSCI Emerging Markets Quality Dividend ETF | 39,502 | (1,078,450 | ) | — | (17 | ) | (24,127 | ) | (1,063,092 | ) | ||||||||||||||
MSCI International Quality ETF | — | (454,027 | ) | (11,220 | ) | (20 | ) | (5,609 | ) | (470,876 | ) | |||||||||||||
MSCI International Quality Dividend ETF | 33,900 | (1,036,376 | ) | — | (16 | ) | (4,001 | ) | (1,006,493 | ) |
The tax character of dividends and distributions paid to shareholders during the fiscal year ended September 30, 2015 and September 30, 2014 were as follows:
2015 # | 2014* | |||||||
Ordinary | Ordinary | |||||||
Fund | Income | Income | ||||||
MSCI Emerging Markets Quality ETF | $ | 215,300 | $ | 41,240 | ||||
MSCI Emerging Markets Quality Dividend ETF | 228,070 | 92,780 | ||||||
MSCI International Quality ETF | 215,460 | 145,310 | ||||||
MSCI International Quality Dividend ETF | 276,500 | 123,500 |
* | For the period from January 21, 2014 (commencement of operations) through September 30, 2014. |
# | Includes short-term capital gains. |
25 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
September 30, 2015 (continued)
Qualified late-year losses comprised of post-October capital losses incurred after October 31, 2014, and certain late year ordinary losses. Late-year ordinary losses represent ordinary losses incurred after December 31, 2014 and specified losses incurred after October 31, 2014. These losses are deemed to arise on the first day of the Funds next taxable year. For the year ended September 30, 2015, the Funds’ intend to defer to October 1, 2015 for federal tax purposes qualified late-year losses as follows:
Late Year | ||||
Fund | Ordinary Losses | |||
MSCI Emerging Markets Quality ETF | $ | 33,219 | ||
MSCI International Quality ETF | 11,220 |
At September 30, 2015, the Funds had capital loss carryforwards available to offset future capital gains, as follows:
Post-Effective- | Post-Effective- | |||||||
No Expiration | No Expiration | |||||||
Short-Term | Long-Term | |||||||
Fund | Capital Losses | Capital Losses | ||||||
MSCI Emerging Markets Quality ETF | $ | 760,870 | $304,256 | |||||
MSCI Emerging Markets Quality Dividend ETF | 244,642 | 833,808 | ||||||
MSCI International Quality ETF | 163,948 | 290,079 | ||||||
MSCI International Quality Dividend ETF | 267,649 | 768,727 |
During the year ended September 30, 2015, as a result of permanent book to tax differences, primarily due to investments in Passive Foreign Investment Companies, foreign currency gains and losses, net operating losses, and tax treatment of in-kind redemptions, the Funds’ incurred differences that affected undistributed net investment income (loss), accumulated net realized gain (loss) on investments and aggregate paid in capital by the amounts in the table below. Net assets were not affected by these reclassifications.
Increase (Decrease) | Increase (Decrease) | Increase (Decrease) | ||||||||||
in Accumulated Net | in Accumulated Net | in Aggregate | ||||||||||
Fund | Investment Income/Loss | Realized Gain/Loss | Paid in Capital | |||||||||
MSCI Emerging Markets Quality ETF | $(50,259 | ) | $(163,083 | ) | $213,342 | |||||||
MSCI Emerging Markets Quality Dividend ETF | (26,959 | ) | 26,959 | — | ||||||||
MSCI International Quality ETF | 2,018 | (754 | ) | (1,264 | ) | |||||||
MSCI International Quality Dividend ETF | (7,958 | ) | 7,958 | — |
The Funds recognize the tax benefits of uncertain tax positions only where the position is “more-likely-than-not” to be sustained assuming examination by applicable tax authorities. Management has analyzed the Funds’ tax positions, and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on return filings for all open tax years, or expected to be taken in the Funds’ current tax year. The Funds do not have exposure for additional years that might still be open in certain foreign jurisdictions. Therefore, no provision for income tax is required in the Funds’ financial statements.
The Funds recognize interest and penalties, if any, related to uncertain tax positions as income tax expense in the Statements of Operations. During the year ended September 30, 2015, the Funds did not incur any interest or penalties.
Note 6—Capital Share Transactions—As of September 30, 2015, there were an unlimited number of capital shares of beneficial interest authorized by the Trust with no par value. Shares are issued and redeemed by the Funds only in Creation Units, consisting of 100,000 shares, or multiples thereof. The consideration for the purchase or redemption of Creation Units of the Funds generally consists of the in-kind contribution or distribution of securities constituting the Funds’ underlying index plus a small amount of cash. For the year ended September 30, 2015, the following Funds had in-kind contributions and redemptions:
Fund | In-Kind Contributions | In-Kind Redemptions | ||||||
MSCI Emerging Markets Quality ETF | $2,569,911 | $2,366,522 | ||||||
MSCI Emerging Markets Quality Dividend ETF | 7,457 | — |
MSCI International Quality ETF and MSCI International Quality Dividend ETF had no in-kind contributions or redemptions during the year ended September 30, 2015.
26 |
The in-kind contributions and in-kind redemptions in this table represent the accumulation of each Fund’s daily net shareholder transactions including rebalancing activity, while the Statements of Changes in Net Assets reflect shareholder transactions including any cash component of the transactions.
Note 7—Concentration of Risk—The investment objective of each Fund is to seek investment results that correspond generally to the price and yield performance, before fees and expenses, of its underlying index, as indicated in the name of each Fund. The Adviser uses a “passive” or index approach to achieve each Fund’s investment objective by investing in a portfolio of securities that generally replicates the Funds’ index. Each of the Funds is classified as a non-diversified fund under the 1940 Act. Non-diversified funds generally hold securities of fewer issuers than diversified funds and may be more susceptible to the risks associated with these particular issuers, or to a single economic, political or regulatory occurrence affecting these issuers. The Funds may purchase securities on foreign exchanges. Securities of foreign issuers involve special risks and considerations not typically associated with investing in U.S. issuers. These risks include devaluation of currencies, currency controls, less reliable information about issuers, different securities transaction clearance and settlement practices, future adverse political and economic developments and local/regional conflicts. These risks are heightened for investments in emerging market countries. Moreover, securities of many foreign issuers and their markets may be less liquid and their prices more volatile than those of comparable U.S. issuers.
At September 30, 2015, the Adviser owned approximately 73% of MSCI Emerging Markets Quality ETF and 63% of MSCI International Quality ETF.
Note 8—Trustee Deferred Compensation Plan—The Trust has a Deferred Compensation Plan (the “Plan”) for Trustees under which the Trustees can elect to defer receipt of their trustee fees until retirement, disability or termination from the Board of Trustees. The fees otherwise payable to the participating Trustees are deemed invested in shares of the Funds as directed by the Trustees.
The expense for the Plan is included in “Trustees’ fees and expenses” in the Statements of Operations. The liability for the Plan is shown as “Deferred Trustee fees” in the Statements of Assets and Liabilities.
Note 9—Securities Lending—To generate additional income, each of the Funds may lend its securities pursuant to a securities lending agreement with The Bank of New York Mellon, the securities lending agent and also the Funds’ custodian. Each Fund may lend up to 33% of its investments requiring that the loan be continuously collateralized by cash, U.S. government or U.S. government agency securities, shares of an investment trust or mutual fund, or any combination of cash and such securities at all times equal to at least 102% (105% for foreign securities) of the market value plus accrued interest on the securities loaned. During the term of the loan, the Funds will continue to receive any dividends, interest or amounts equivalent thereto, on the securities loaned while receiving a fee from the borrower or earning interest on the investment of the cash collateral. Such fees and interest are shared with the securities lending agent under the terms of the securities lending agreement. The Funds may pay reasonable finders’, administrative and custodial fees in connection with a loan of its securities and shares the interest earned on the collateral and borrowing fees received with the securities lending agent. Securities lending income is disclosed as such in the Statements of Operations. The collateral for securities loaned is recognized in the Schedules of Investments and the Statements of Assets and Liabilities. The cash collateral is maintained on the Funds’ behalf by the lending agent and is invested in repurchase agreements collateralized by obligations of the U.S. Treasury and/or Government Agencies. Loans are subject to termination at the option of the borrower or the Funds. Upon termination of the loan, the borrower will return to the lender securities identical to the securities loaned. The Funds bear the risk of delay in recovery of, or even loss of rights in, the securities loaned should the borrower of the securities fail financially. At September 30, 2015, the Funds had no securities on loan.
27 |
MARKET VECTORS ETF TRUST
NOTES TO FINANCIAL STATEMENTS
September 30, 2015 (continued)
Note 10—Bank Line of Credit—The Funds may participate in a $200 million committed credit facility (the “Facility”) to be utilized for temporary financing until the settlement of sales or purchases of portfolio securities, the repurchase or redemption of shares of the Funds at the request of the shareholders and other temporary or emergency purposes. The Funds have agreed to pay commitment fees, pro rata, based on the unused but available balance. Interest is charged to the Funds at rates based on prevailing market rates in effect at the time of borrowings. During the year ended September 30, 2015, the following Funds borrowed under this Facility:
Days | Average Daily | Average | ||||||||||
Fund | Outstanding | Loan Balance | Interest Rate | |||||||||
MSCI Emerging Markets Quality ETF | 21 | $ | 339,740 | 1.51 | % | |||||||
MSCI Emerging Markets Quality Dividend ETF | 2 | 139,572 | 1.50 | |||||||||
MSCI International Quality ETF | 2 | 106,265 | 1.50 | |||||||||
MSCI International Quality Dividend ETF | 2 | 247,177 | 1.50 |
At September 30, 2015, the Funds had no outstanding loan balances.
Note 11—Custodian Fees—The Funds have entered into an expense offset agreement with the custodian wherein they receive a credit toward the reduction of custodian fees whenever there are uninvested cash balances. The Funds could have invested their cash balances elsewhere if they had not agreed to a reduction in fees under the expense offset agreement with the custodian. For the year ended September 30, 2015, there were no offsets to custodian fees.
Note 12—Subsequent Event Review—The Funds have evaluated subsequent events and transactions for potential recognition or disclosure through the date the financial statements were issued.
On October 16, 2015, the Funds liquidated. The following Liquidating Distributions were paid by the Funds to shareholders:
Fund | Payable Date | Rate Per Share | ||||
MSCI Emerging Markets Quality ETF | 10/16/2015 | $44.39892 | ||||
MSCI Emerging Markets Quality Dividend ETF | 10/16/2015 | $39.61686 | ||||
MSCI International Quality ETF | 10/16/2015 | $44.68016 | ||||
MSCI International Quality Dividend ETF | 10/16/2015 | $40.32661 |
28 |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Trustees and Shareholders of Market Vectors ETF Trust
We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of MSCI Emerging Markets Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI International Quality ETF and MSCI International Quality Dividend ETF (four of the series constituting Market Vectors ETF Trust) (the “Funds”) as of September 30, 2015, and the related statements of operations, the statements of changes in net assets and the financial highlights for the periods indicated therein. These financial statements and financial highlights are the responsibility of the Funds’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. We were not engaged to perform an audit of the Funds’ internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements and financial highlights, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2015, by correspondence with the custodian and brokers or by other appropriate auditing procedures where replies from brokers were not received. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of MSCI Emerging Markets Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI International Quality ETF and MSCI International Quality Dividend ETF (four of the series constituting Market Vectors ETF Trust) at September 30, 2015, the results of their operations, the changes in their net assets and the financial highlights for the periods indicated therein, in conformity with U.S. generally accepted accounting principles.
New York, New York
November 24, 2015
29 |
MARKET VECTORS ETF TRUST
BOARD OF TRUSTEES AND OFFICERS
September 30, 2015 (unaudited)
Name, Address1 and Year of Birth | Position(s) Held with the Trust | Term of Office2 and Length of Time Served | Principal Occupation(s) During Past Five Years | Number of Portfolios in Fund Complex3 Overseen | Other Directorships Held By Trustee During Past Five Years | |||||
Independent Trustees: | ||||||||||
David H. Chow, 1957*† | Chairman Trustee | Since 2008 Since 2006 | Founder and CEO, DanCourt Management LLC (financial/ strategy consulting firm and Registered Investment Adviser), March 1999 to present. | 58 | Director, Forward Management LLC and Audit Committee Chairman, January 2008 to present; Trustee, Berea College of Kentucky and Vice-Chairman of the Investment Committee, May 2009 to present; Member of the Governing Council of the Independent Directors Council, October 2012 to present; President, July 2013 to present; Secretary and Board Member of the CFA Society of Stamford, July 2009 to present; Advisory Board member, MainStay Fund Complex4, June 2015 to present. | |||||
R. Alastair Short, 1953*† | Trustee | Since 2006 | President, Apex Capital Corporation (personal investment vehicle), January 1988 to present; Vice Chairman, W.P. Stewart & Co., Inc. (asset management firm), September 2007 to September 2008; and Managing Director, The GlenRock Group, LLC (private equity investment firm), May 2004 to September 2007. | 69 | Chairman and Independent Director, EULAV Asset Management, January 2011 to present; Independent Director, Tremont offshore funds, June 2009 to present; Director, Kenyon Review. | |||||
Peter J. Sidebottom, 1962*† | Trustee | Since 2012 | Partner, PWC/Strategy & Financial Services Advisory, February 2015 to present; Founder and Board Member, AspenWoods Risk Solutions, September 2013 to present; Independent consultant, June 2013 to February 2015; Partner, Bain & Company (management consulting firm), April 2012 to December 2013; Executive Vice President and Senior Operating Committee Member, TD Ameritrade (on-line brokerage firm), February 2009 to January 2012 | 58 | Board Member, Special Olympics, New Jersey, November 2011 to September 2013; Director, The Charlotte Research Institute, December 2000 to present; Board Member, Social Capital Institute, University of North Carolina Charlotte, November 2004 to January 2012; Board Member, NJ-CAN, July 2014 to present. | |||||
Richard D. Stamberger, 1959*† | Trustee | Since 2006 | Director, President and CEO, SmartBrief, Inc. (media company). | 69 | Director, Food and Friends, Inc., 2013 to present. | |||||
Interested Trustee: | ||||||||||
Jan F. van Eck, 19635 | Trustee, President and Chief Executive Officer | Trustee (Since 2006); President and Chief Executive Officer (Since 2009) | Director, President and Owner of the Adviser, Van Eck Associates Corporation; Director and President, Van Eck Securities Corporation (“VESC”); Director and President, Van Eck Absolute Return Advisers Corp. (“VEARA”). | 58 | Director, National Committee on US-China Relations. |
1 | The address for each Trustee and officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Each Trustee serves until resignation, death, retirement or removal. Officers are elected yearly by the Trustees. |
3 | The Fund Complex consists of the Van Eck Funds, Van Eck VIP Trust and the Trust. |
4 | The MainStay Fund Complex consists of MainStay Funds Trust, MainStay Funds, MainStay VP Funds Trust, Private Advisors Alternative Strategies Master Fund, Private Advisors Alternative Strategies Fund and MainStay DefinedTerm Municipal Opportunities Fund. |
5 | “Interested person” of the Trust within the meaning of the 1940 Act. Mr. van Eck is an officer of the Adviser. |
* | Member of the Audit Committee. |
† | Member of the Nominating and Corporate Governance Committee. |
30 |
Officer’s Name, Address1 and Year of Birth | Position(s) Held with the Trust | Term of Office2 and Length of Time Served | Principal Occupation(s) During The Past Five Years | |||
Officers: | ||||||
Russell G. Brennan, 1964 | Assistant Vice President and Assistant Treasurer | Since 2008 | Assistant Vice President and Assistant Treasurer of the Adviser (since 2008); Manager (Portfolio Administration) of the Adviser, September 2005 to October 2008; Officer of other investment companies advised by the Adviser. | |||
Charles T. Cameron, 1960 | Vice President | Since 2006 | Director of Trading (since 1995) and Portfolio Manager (since 1997) for the Adviser; Officer of other investment companies advised by the Adviser. | |||
Simon Chen, 1971 | Assistant Vice President | Since 2012 | Greater China Director of the Adviser (Since January 2012); General Manager, SinoMarkets Ltd. (June 2007 to December 2011). | |||
John J. Crimmins, 1957 | Vice President, Treasurer, Chief Financial Officer and Principal Accounting Officer | Vice President, Chief Financial Officer and Principal Accounting Officer (Since 2012); Treasurer (Since 2009) | Vice President of Portfolio Administration of the Adviser, June 2009 to present; Vice President of VESC and VEARA, June 2009 to present; Chief Financial, Operating and Compliance Officer, Kern Capital Management LLC, September 1997 to February 2009; Officer of other investment companies advised by the Adviser. | |||
Eduardo Escario, 1975 | Vice President | Since 2012 | Regional Director, Business Development/Sales for Southern Europe and South America of the Adviser (since July 2008); Regional Director (Spain, Portugal, South America and Africa) of Dow Jones Indexes and STOXX Ltd. (May 2001 - July 2008). | |||
Lars Hamich, 1968 | Vice President | Since 2012 | Managing Director and Chief Executive Officer of Van Eck Global (Europe) GmbH (since 2009); Chief Executive Officer of Market Vectors Index Solutions GmbH (“MVIS”) (since June 2011); Managing Director of STOXX Limited (until 2008). | |||
Wu-Kwan Kit, 1981 | Assistant Vice President and Assistant Secretary | Since 2011 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2011); Associate, Schulte Roth & Zabel (September 2007 - 2011); University of Pennsylvania Law School (August 2004 - May 2007). | |||
Susan C. Lashley, 1955 | Vice President | Since 2006 | Vice President of the Adviser and VESC; Officer of other investment companies advised by the Adviser. | |||
Laura I. Martínez, 1980 | Assistant Vice President and Assistant Secretary | Since 2008 | Assistant Vice President, Associate General Counsel and Assistant Secretary of the Adviser, VESC and VEARA (since 2008); Associate, Davis Polk & Wardwell (October 2005 - June 2008); Officer of other investment companies advised by the Adviser. | |||
Ferat Oeztuerk, 1983 | Assistant Vice President | Since 2012 | Sales Associate, Van Eck Global (Europe) GmbH (since November 2011); Account Manager, Vodafone Global Enterprise Limited (January 2011 to October 2011). | |||
James Parker, 1969 | Assistant Treasurer | Since June 2014 | Manager (Portfolio Administration) of the Adviser (Since June 2010); Vice President of JPMorgan Chase & Co. (April 1999 to January 2010). | |||
Jonathan R. Simon, 1974 | Vice President, Secretary and Chief Legal Officer | Vice President (Since 2006) and Secretary and Chief Legal Officer (Since 2014) | Vice President (since 2006), General Counsel and Secretary (since 2014) of the Adviser, VESC and VEARA; Officer of other investment companies advised by the Adviser. | |||
Bruce J. Smith, 1955 | Senior Vice President | Since 2006 | Senior Vice President, Chief Financial Officer, Treasurer and Controller of the Adviser, VESC and VEARA (since 1997); Director of the Adviser, VESC and VEARA (since October 2010); Officer of other investment companies advised by the Adviser. | |||
Janet Squitieri, 1961 | Chief Compliance Officer | Since September 2013 | Vice President, Global Head of Compliance of the Adviser, VESC and VEARA (since September 2013); Chief Compliance Officer and Senior Vice President North America of HSBC Global Asset Management NA (August 2010 - September 2013); Chief Compliance Officer North America of Babcock & Brown LP (July 2008 - June 2010). |
1 | The address for each Officer is 666 Third Avenue, 9th Floor, New York, New York 10017. |
2 | Officers are elected yearly by the Trustees. |
31 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited)
At a meeting held on December 4, 2014 (the “December Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), considered and approved an investment management agreement between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “December Investment Management Agreement”) with respect to the Market Vectors Morningstar International Wide Moat ETF (the “New December Fund”). In addition, at a meeting held on March 2, 2015 (the “March Meeting”), the Board, including all of the Independent Trustees, considered and approved investment management agreements (the “March Investment Management Agreement”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Market Vectors Australia Equal Weight ETF, Market Vectors Australia Hedged Equal Weight ETF, Market Vectors Brazil Equal Weight ETF, Market Vectors China Equal Weight ETF, Market Vectors Europe Equal Weight ETF, Market Vectors Europe Hedged Equal Weight ETF, Market Vectors Germany Equal Weight ETF, Market Vectors Global Spin-Off ETF, Market Vectors Hong Kong Equal Weight ETF, Market Vectors India Equal Weight ETF, Market Vectors Italy Equal Weight ETF, Market Vectors Japan Equal Weight ETF, Market Vectors Japan Hedged Equal Weight ETF, Market Vectors Mexico Equal Weight ETF, Market Vectors Russia Equal Weight ETF, Market Vectors South Africa Equal Weight ETF, Market Vectors South Korea Equal Weight ETF, Market Vectors Spain Equal Weight ETF, Market Vectors Taiwan Equal Weight ETF and Market Vectors United Kingdom Equal Weight ETF (the “New March Funds”). In addition, at a meeting held on September 3, 2015 (the “September Meeting”), the Board, including all of the Independent Trustees, considered and approved an investment management agreement (the “September Investment Management Agreement”) with respect to the Market Vectors Generic Drugs ETF (and collectively, with the New December Fund and the New March Funds, the “Funds”). The December Investment Management Agreement, the March Investment Management Agreement and the September Investment Management Agreement are collectively referred to as the “Investment Management Agreements.”
The Board’s approval of each Investment Management Agreement was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In advance of the relevant meeting, the Trustees received materials from the Adviser, including expense information for other funds. The Adviser provided the Trustees with information regarding, among other things, the various aspects of each Fund’s proposed investment program, fee arrangements and service provider arrangements. The Independent Trustees’ consideration of each Investment Management Agreement was based, in part, on information obtained through discussions with the Adviser at the December Meeting, March Meeting and September Meeting (as applicable) regarding the management of the Funds, information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others proposed to be involved in the management and administration of the Funds. The Trustees also considered the terms and scope of services that the Adviser would provide under each Investment Management Agreement, including the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of at least one year following the effective date of each Fund’s respective registration statement.
The Trustees considered the benefits, other than the fees under the Investment Management Agreements, that the Adviser would receive from serving as adviser to each Fund, including any benefits it may receive from serving as administrator to each Fund and from an affiliate of the Adviser serving as distributor to each Fund. The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability of each of the Funds to the Adviser because the Funds had not yet commenced operations. In addition, because the Funds had not yet commenced operations, the Trustees could not consider the historical performance or the quality of services previously provided to each of the Funds by the Adviser, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the December Meeting, the March Meeting and September Meeting (as applicable) as part of their consideration of the Investment Management Agreements.
32 |
In voting to approve the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of the Investment Management Agreements are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
* * *
At a meeting held on June 9, 2015 (the “Renewal Meeting”), the Board of Trustees (the “Board”) of Market Vectors ETF Trust (the “Trust”), including all of the Trustees that are not interested persons of the Trust (the “Independent Trustees”), approved the continuation of the investment management agreements between the Trust and Van Eck Associates Corporation (the “Adviser”) (the “Investment Management Agreements”) with respect to the Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Biotech ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Environmental Services ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Gaming ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Morningstar Wide Moat ETF, MSCI International Quality Dividend ETF, MSCI International Quality ETF, MSCI Emerging Markets Quality Dividend ETF, MSCI Emerging Markets Quality ETF, Pharmaceutical ETF, Retail ETF, Russia Equal Weight ETF, Semiconductor ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF (collectively, the “Funds”).
The Board’s approval of the Investment Management Agreements was based on a comprehensive consideration of all of the information available to the Trustees and was not the result of any single factor. Some of the factors that figured particularly in the Trustees’ deliberations and how the Trustees considered those factors are described below, although individual Trustees may have evaluated the information presented differently, giving different weights to various factors.
In preparation for the Renewal Meeting, the Trustees held a meeting on May 15, 2015. At that meeting, the Trustees discussed the information the Adviser and Lipper Inc. (“Lipper”), an independent third party data provider, had provided to them in advance. The information provided to the Trustees included, among other things, information about the performance (for those Funds which had begun operations) and expenses of the Funds and the Funds’ peer funds (other index-based exchange-traded funds (“ETFs”)), information about the advisory services provided to the Funds and the personnel providing those services, and the profitability and other benefits enjoyed by the Adviser and its affiliates as a result of the Adviser’s relationship with the Funds. In reviewing performance information for the Funds against their peer groups, the Trustees considered that each Fund generally invests in a different group of issuers than the funds in its designated peer group. In addition, the Trustees reviewed certain performance information for each Fund that was not provided by Lipper. For these and other reasons, the Trustees noted that the peer group information did not necessarily provide meaningful direct comparisons to the Funds.
The Independent Trustees’ consideration of the Investment Management Agreements was based, in part, on their review of information obtained through discussions with the Adviser at the Renewal Meeting and the May 15, 2015 meeting regarding the management of the Funds and information obtained at other meetings of the Trustees and/or based on their review of the materials provided by the Adviser, including the background and experience of the portfolio managers and others involved in the management and administration of the Funds. The Trustees also considered the terms of, and scope of services that the Adviser provides under, the Investment Management Agreements, including, where applicable, the Adviser’s commitment to waive certain fees and/or pay expenses of each of the Funds to the extent necessary to prevent the operating expenses of each of the Funds from exceeding agreed upon limits for a period of time.
The Trustees concluded that the Adviser has the requisite expertise and skill to manage the Funds’ portfolios. In evaluating the performance over relevant periods of each of the Funds that had commenced operations prior to the date of the Renewal Meeting (the “Operating Funds”), the Trustees reviewed various performance metrics but relied principally on a comparison of the “gross” performance of each Operating Fund (i.e., measured without regard to the impact of fees and expenses) to the performance of its benchmark index, in each case incorporating any fair value adjustments to the underlying securities. Based on the foregoing, the Trustees concluded that the investment performance of the Operating Funds was satisfactory.
33 |
MARKET VECTORS ETF TRUST
APPROVAL OF INVESTMENT MANAGEMENT AGREEMENTS
September 30, 2015 (unaudited)
The Trustees also considered information relating to the financial condition of the Adviser and the current status, as they understood it, of the Adviser’s compliance environment.
As noted above, the Trustees were also provided various data from Lipper comparing the Operating Funds’ expenses and performance to that of other ETFs. The Trustees noted that the information provided showed that each Operating Fund had a total expense ratio (after the effect of any applicable expense limitation) below or equal to the average and/or median of its respective peer group of funds, except for each of Market Vectors Gaming ETF and Morningstar Wide Moat ETF, which had a total expense ratio (after the effect of any applicable expense limitation) greater than the average and median of its peer group of funds. With respect to these Operating Funds, the Trustees reviewed the amount by which these Operating Funds’ total expense ratios (after the effect of any applicable expense limitation) exceeded the average and median of their respective peer groups. The Trustees concluded, in light of this information and the other information available to them, that the fees paid by the Operating Funds were reasonable in light of the performance of the Operating Funds and the quality of services received.
The Trustees also considered the benefits, other than fees under the Investment Management Agreements, received by the Adviser from serving as adviser to the Funds, including any benefits it may receive from serving as administrator to the Funds and from an affiliate of the Adviser serving as distributor for the Funds.
The Trustees also considered information provided by the Adviser about the overall profitability of the Adviser and its profitability or loss in respect of each Operating Fund. The Trustees reviewed each Fund’s asset size, expense ratio and expense cap and noted that the Investment Management Agreements do not include breakpoints in the advisory fee rates as asset levels in a Fund increase. The Trustees considered the potential variability in net assets of these Funds and the sustainability of any potential economies of scale which may exist. The Trustees also evaluated the extent to which management fees for the Operating Funds effectively incorporate the benefits of economies of scale. The Trustees noted that the Adviser has capped expenses on each Operating Fund since its inception. Based on the foregoing and the other information available to them, the Trustees determined that the advisory fee rate for each Fund is reasonable and appropriate in relation to the current asset size of each Fund and the other factors discussed above and currently reflects an appropriate sharing of any economies of scale which may exist with shareholders. The Trustees also determined that the profits earned by the Adviser in respect of the Funds that were profitable to the Adviser were reasonable in light of the nature and quality of the services received by such Funds.
The Trustees did not consider historical information about the cost of the services provided by the Adviser or the profitability to the Adviser of Market Vectors Asia ex Japan Equal Weight ETF, Australia Equal Weight ETF, Australia Hedged Equal Weight ETF, Brazil Equal Weight ETF, China Equal Weight ETF, Europe Equal Weight ETF, Europe Hedged Equal Weight ETF, Germany Equal Weight ETF, Global Chemicals ETF, Global Spin-Off ETF, Hong Kong Equal Weight ETF, India Equal Weight ETF, Italy Equal Weight ETF, Japan Equal Weight ETF, Japan Hedged Equal Weight ETF, Mexico Equal Weight ETF, Morningstar International Moat ETF, Russia Equal Weight ETF, South Africa Equal Weight ETF, South Korea Equal Weight ETF, Spain Equal Weight ETF, Taiwan Equal Weight ETF and United Kingdom Equal Weight ETF to the Adviser because the Funds had not yet commenced operations at the time of the Renewal Meeting. The Trustees also could not consider the historical performance or the quality of services previously provided to each of these Funds, although they concluded that the nature, quality and extent of the services to be provided by the Adviser were appropriate based on the Trustees’ knowledge of the Adviser and its personnel and the operations of the other series of the Trust.
The Independent Trustees were advised by and met in executive session with their independent counsel at the Renewal Meeting and at their May 15, 2015 meeting as part of their consideration of the Investment Management Agreements.
In voting to approve the continuation of the Investment Management Agreements, the Trustees, including the Independent Trustees, concluded that the terms of each Investment Management Agreement are reasonable and fair in light of the services to be performed, expenses to be incurred and such other matters as the Trustees considered relevant in the exercise of their reasonable judgment. The Trustees further concluded that each Investment Management Agreement is in the best interest of each Fund and such Fund’s shareholders.
34 |
This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by a Market Vectors ETF Trust (the “Trust”) Prospectus and Summary Prospectus, which includes more complete information. An investor should consider the investment objective, risks, and charges and expenses of the Funds carefully before investing. The prospectus and summary prospectus contains this and other information about the investment company. Please read the prospectus and summary prospectus carefully before investing.
Additional information about the Trust’s Board of Trustees/Officers and a description of the policies and procedures the Trust uses to determine how to vote proxies relating to portfolio securities are provided in the Statement of Additional Information. The Statement of Additional Information and information regarding how the Trust voted proxies relating to portfolio securities during the most recent twelve month period ending June 30 is available, without charge, by calling 1.800.826.2333, or by visiting www.vaneck.com, or on the Securities and Exchange Commission’s website at http://www.sec.gov.
The Trust files its complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarters of each fiscal year on Form N-Q. The Trust’s Form N-Qs are available on the Commission’s website at http://www.sec.gov and may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1.202.942.8090. The Funds’ complete schedules of portfolio holdings are also available by calling 1.800.826.2333 or by visiting www.vaneck.com.
Investment Adviser: Van Eck Associates Corporation
Distributor: Van Eck Securities Corporation 666 Third Avenue New York, NY 10017 vaneck.com
Account Assistance: 1.800.826.2333 www.vaneck.com |
MVQUALAR
Item 2. CODE OF ETHICS. (a) The Registrant has adopted a code of ethics (the "Code of Ethics") that applies to the principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. (b) Not applicable. (c) The Registrant has not amended its Code of Ethics during the period covered by the shareholder report presented in Item 1 hereto. (d) The Registrant has not granted a waiver or an implicit waiver from a provision of its Code of Ethics during the period covered by the shareholder report presented in Item 1 hereto. (e) Not applicable. (f) The Registrant's Code of Ethics is attached as an Exhibit hereto. Item 3. AUDIT COMMITTEE FINANCIAL EXPERT. The Registrant's Board of Trustees has determined that David Chow, R. Alastair Short and Richard Stamberger, members of the Audit and Governance Committees, are "audit committee financial experts" and "independent" as such terms are defined in the instructions to Form N-CSR Item 3(a)(2). Item 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES. The principal accountant fees disclosed in Item 4(a), 4(b), 4(c), 4(d) and 4(g) are for the Funds of the Registrant for which the fiscal year end is September 30. (a) Audit Fees. The aggregate Audit Fees of Ernst & Young for professional services billed for the audits of the financial statements, or services that are normally provided in connection with statutory and regulatory filings or engagements for the fiscal years ended September 30, 2015 and September 30, 2014, were $319,530 and $288,095 respectively. (b) Audit-Related Fees. Not applicable. (c) Tax Fees. The aggregate Tax Fees of Ernst & Young for professional services billed for the review of Federal, state and excise tax returns and other tax compliance consultations for the fiscal years ended September 30, 2015 and September 30, 2014, were $260,451 and $209,313 respectively. (d) All Other Fees None. (e) The Audit Committee will pre-approve all audit and non-audit services, to be provided to the Fund, by the independent accountants as required by Section 10A of the Securities Exchange Act of 1934. The Audit Committee has authorized the Chairman of the Audit Committee to approve, between meeting dates, appropriate non-audit services. The Audit Committee after considering all factors, including a review of independence issues, will recommend to the Board of Trustees the independent auditors to be selected to audit the financial statements of the Funds.(f) Not applicable. (g) Not applicable. (h) Not applicable. Item 5. AUDIT COMMITTEE OF LISTED REGISTRANTS. The Registrant's Board has an Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act (15 U.S.C. 78c(a)(58)(A)) consisting of four Independent Trustees. Messrs. Chow, Short, Sidebottom and Stamberger currently serve as members of the Audit Committee. Mr. Short is the Chairman of the Audit Committee. Item 6. SCHEDULE OF INVESTMENTS. Information included in Item 1. Item 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. Not applicable. Item 8. PORTFOLIO MANAGER OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES. Not applicable. Item 9. PURCHASE OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS. Not applicable. Item 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. None. Item 11. CONTROLS AND PROCEDURES. (a) The registrant's principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the "1940 Act") (17 CFR 270.30a-3 (c)) are effective, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15 (b)). (b) There were no changes in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a(d)) that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. Item 12. EXHIBITS. (a)(1) The code of ethics is attached as EX-99.CODE ETH (a)(2) A separate certification for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2 under the Act (17 CFR 270.30a-2) is attached as Exhibit 99.CERT. (b) Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 is furnished as Exhibit 99.906CERT. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. (Registrant) MARKET VECTORS ETF TRUST By (Signature and Title) /s/ John J. Crimmins, Treasurer and CFO --------------------------------------- Date December 8, 2015 ---------------- Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. By (Signature and Title) /s/ Jan F. van Eck, CEO -------------------------- Date December 8, 2015 ---------------- By (Signature and Title) /s/ John J. Crimmins, Treasurer and CFO ------------------------------------------ Date December 8, 2015 ----------------